{"meta":{"query_hash":"dfbf89c62eed","filters":{"venue":"Expert Review of Pharmacoeconomics & Outcomes Research"},"cohort_total":174,"direct_labels_cover":1,"predictions_cover":174,"exported":174,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/dfbf89c62eed","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Review+of+Pharmacoeconomics+%26+Outcomes+Research"},"results":[{"id":"W1481750383","doi":"10.1586/erp.09.35","title":"Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature","year":2009,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Waterloo; McMaster University","funders":"Social Sciences and Humanities Research Council of Canada; University of Toronto; McMaster University","keywords":"Life expectancy; Confounding; Expectancy theory; Econometrics; Critical appraisal; Disease; Productivity; Medicine; Computer science; Psychology; Economics; Environmental health; Alternative medicine; Internal medicine; Pathology","score_opus":0.28845724143087487,"score_gpt":0.6434372225078191,"score_spread":0.35497998107694423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481750383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003211204,0.9922559,0.00016197968,0.006132912,0.00068608037,0.00002033899,0.000042525902,0.0000041644057,0.00037493758],"genre_scores_gemma":[0.015157144,0.9751746,0.00070605637,0.0046956968,0.00398141,0.00007509887,0.00006536218,0.000010595078,0.0001340994],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9857819,0.005806774,0.0031718046,0.0009922804,0.0039653135,0.00028190122],"domain_scores_gemma":[0.7109766,0.25918585,0.010850645,0.0017717276,0.016155073,0.0010600967],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.041107904,0.0018549946,0.004519936,0.014361809,0.000875147,0.0043334994,0.0028225337,0.0046021417,0.0038300867],"category_scores_gemma":[0.13617697,0.0009990333,0.0035094765,0.0071525886,0.0039556683,0.005550783,0.002120068,0.0055911443,0.0008294457],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017942698,0.00012215177,0.00269995,0.13335751,0.00448388,0.0004198297,0.00059711933,0.0020155834,0.0004406442,0.02050311,0.045138318,0.7884277],"study_design_scores_gemma":[0.00050928124,0.0017004213,0.0157973,0.48658204,0.016846156,0.0022399565,0.0023726984,0.0025500713,0.0012948379,0.086235024,0.38357547,0.00029681379],"about_ca_topic_score_codex":0.0030514724,"about_ca_topic_score_gemma":0.003587773,"teacher_disagreement_score":0.9588921,"about_ca_system_score_codex":0.008032189,"about_ca_system_score_gemma":0.0051133605,"threshold_uncertainty_score":0.21740198},"labels":[],"label_agreement":null},{"id":"W1810391666","doi":"10.1586/14737167.2015.1077118","title":"‘The patient’: at the center of patient-reported outcomes","year":2015,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Popularity; Consumerism; Health care; Patient satisfaction; Medicine; Quality of life (healthcare); Patient experience; Psychology; Nursing; Psychiatry; Social psychology","score_opus":0.041992357672781755,"score_gpt":0.5008352364340154,"score_spread":0.45884287876123364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1810391666","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082535866,0.10787627,0.0006739288,0.11281989,0.7775639,0.000030521354,0.000049649647,0.000054329623,0.00084897],"genre_scores_gemma":[0.0009946962,0.06591402,0.0005000185,0.053320065,0.87690157,0.000052280193,0.000029011055,0.000047324862,0.002240948],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98283494,0.0073418124,0.0035749704,0.0014664368,0.0043408293,0.0004410733],"domain_scores_gemma":[0.9007494,0.06883042,0.0043460587,0.0018001562,0.02133312,0.002940881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02145991,0.0029175095,0.006145654,0.0031233279,0.0020947633,0.008265998,0.004445416,0.015735677,0.004123806],"category_scores_gemma":[0.07693334,0.0011507401,0.0029710976,0.0023717564,0.0058522522,0.009498944,0.0025612887,0.02801376,0.0039736624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009011796,0.000014193853,0.0001292182,0.0027993638,0.00009301745,0.00024252062,0.0001821513,0.000036470443,0.00010055475,0.0018041426,0.9535218,0.04098644],"study_design_scores_gemma":[0.00011759678,0.000070222864,0.0008310558,0.008401187,0.00023842494,0.0011980422,0.00037252656,0.00022159734,0.00015248111,0.004376459,0.98396564,0.000054817498],"about_ca_topic_score_codex":0.0014751084,"about_ca_topic_score_gemma":0.0030829622,"teacher_disagreement_score":0.02145991,"about_ca_system_score_codex":0.0034295274,"about_ca_system_score_gemma":0.005137854,"threshold_uncertainty_score":0.11349219},"labels":[],"label_agreement":null},{"id":"W1964112803","doi":"10.1586/erp.12.14","title":"Comparing prognostic factors in patients with spinal metastases: a literature review","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); MEDLINE; Radiation therapy; Palliative care; Cancer; Performance status; Oncology; Intensive care medicine; Internal medicine; Physical therapy","score_opus":0.1065348030208714,"score_gpt":0.5338673770234766,"score_spread":0.42733257400260527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964112803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043771855,0.99920315,0.000034059125,0.00009729747,0.000038736118,0.0000231163,0.000052737316,0.0000017804089,0.00011147074],"genre_scores_gemma":[0.0033813715,0.99617434,0.00018087304,0.000097794014,0.000040971503,0.000032027903,0.000056033194,7.6970076e-7,0.000035743036],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983463,0.0003506134,0.00073408964,0.00016326434,0.00035444944,0.000051367522],"domain_scores_gemma":[0.9927166,0.005231158,0.0013143288,0.00006125159,0.00060206046,0.000074548545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022315525,0.0010002704,0.003567499,0.009904136,0.00037278445,0.0012746122,0.0012167153,0.0010598908,0.0032222746],"category_scores_gemma":[0.010131062,0.00047422573,0.0024456193,0.01329594,0.0004730309,0.001834018,0.00061463856,0.00055977976,0.0002864545],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021319199,0.00005459784,0.0029534714,0.6599288,0.0021748364,0.00042244236,0.00026665383,0.00016913067,0.0002719786,0.0003829581,0.004616124,0.32854587],"study_design_scores_gemma":[0.00019998502,0.0004826219,0.028409712,0.8168219,0.037006285,0.0055971504,0.0010050242,0.00023397927,0.0006032722,0.00094567914,0.108603716,0.00009061004],"about_ca_topic_score_codex":0.004139146,"about_ca_topic_score_gemma":0.008052879,"teacher_disagreement_score":0.009904136,"about_ca_system_score_codex":0.0013141625,"about_ca_system_score_gemma":0.004214001,"threshold_uncertainty_score":0.01180172},"labels":[],"label_agreement":null},{"id":"W1968240659","doi":"10.1586/erp.12.41","title":"Symptom clusters in patients with metastatic cancer: a literature review","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"CINAHL; Medicine; Cluster (spacecraft); Demographics; MEDLINE; Cancer; Population; Meta-analysis; Internal medicine; Psychiatry; Demography; Environmental health; Psychological intervention","score_opus":0.05813687790055526,"score_gpt":0.5303319916875033,"score_spread":0.47219511378694806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968240659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007328068,0.9986339,0.00004285688,0.00019644854,0.00004789231,0.00003945259,0.00007628001,0.0000024077387,0.0002280504],"genre_scores_gemma":[0.005503086,0.993893,0.00021198153,0.00018260206,0.000047094767,0.00004885051,0.0000697192,0.0000012579148,0.00004247526],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99776816,0.0006006675,0.00085358066,0.00020661321,0.0005031969,0.00006782515],"domain_scores_gemma":[0.990036,0.0073816357,0.0016569175,0.00009003948,0.0007350522,0.00010033964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002859343,0.00093023403,0.0029051933,0.011323209,0.0005936889,0.0015722518,0.001307426,0.0010893672,0.0027386164],"category_scores_gemma":[0.013400678,0.0004937219,0.002551343,0.012615478,0.00067146466,0.0018088397,0.0009787929,0.00074448856,0.0002857693],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016934944,0.000054349748,0.0029186835,0.6046581,0.0018082742,0.00049478625,0.00077733566,0.00019611818,0.00022380339,0.0005866007,0.008404546,0.37970805],"study_design_scores_gemma":[0.00014595939,0.00032079188,0.029230336,0.8277192,0.014128089,0.0059689227,0.0024029042,0.00015947431,0.000322158,0.0010464841,0.118458785,0.00009703946],"about_ca_topic_score_codex":0.005998561,"about_ca_topic_score_gemma":0.013250695,"teacher_disagreement_score":0.011323209,"about_ca_system_score_codex":0.0020040742,"about_ca_system_score_gemma":0.005626796,"threshold_uncertainty_score":0.015121818},"labels":[],"label_agreement":null},{"id":"W1975745084","doi":"10.1586/erp.12.64","title":"Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pegfilgrastim; Filgrastim; Medicine; Pharmacoeconomics; Neutropenia; Chemotherapy; Intensive care medicine; Febrile neutropenia; Oncology; Internal medicine","score_opus":0.1316690055090296,"score_gpt":0.5811431270060594,"score_spread":0.4494741214970298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975745084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003617393,0.9992718,0.00003437031,0.0003181456,0.00011249393,0.0000040869604,0.000013233496,0.0000018084654,0.00020786248],"genre_scores_gemma":[0.00021840174,0.9993204,0.00009342311,0.0001700136,0.000090558635,0.0000047008916,0.000013111428,5.053332e-7,0.000089052926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995233,0.00011192152,0.000109708315,0.000054997763,0.00017584335,0.00002419252],"domain_scores_gemma":[0.9986255,0.0008439384,0.00020803334,0.000020153258,0.00025853261,0.00004374974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012435309,0.0009005779,0.0020452898,0.0035376423,0.00028369424,0.0010012429,0.00090050715,0.0011151471,0.0037608335],"category_scores_gemma":[0.002265792,0.00034821132,0.0010069242,0.005298725,0.0003999397,0.001221748,0.0005327597,0.001395111,0.0009298167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008925619,0.00007472997,0.00018426005,0.07260059,0.0003345111,0.00015671972,0.0000649064,0.00030681773,0.00037964407,0.0023848354,0.0430237,0.8804001],"study_design_scores_gemma":[0.00006120544,0.00016614755,0.001802269,0.051576372,0.00092607335,0.0013110185,0.00011792822,0.00016840371,0.00026111197,0.0020278718,0.9415429,0.000038664133],"about_ca_topic_score_codex":0.002357753,"about_ca_topic_score_gemma":0.0047910092,"teacher_disagreement_score":0.0037608335,"about_ca_system_score_codex":0.0010121593,"about_ca_system_score_gemma":0.002263998,"threshold_uncertainty_score":0.012581289},"labels":[],"label_agreement":null},{"id":"W1978211511","doi":"10.1586/14737167.3.1.13","title":"Methods and models in health-related quality of life (HRQOL) research: a state-of-the-art review","year":2003,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of life (healthcare); Health related quality of life; Quality-adjusted life year; Quality (philosophy); Medicine; Public economics; Management science; Gerontology; Psychology; Political science; Risk analysis (engineering); MEDLINE; Economics; Nursing; Cost effectiveness; Epistemology","score_opus":0.5899748143793366,"score_gpt":0.7220822389076271,"score_spread":0.1321074245282905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978211511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050317976,0.9971584,0.00090282434,0.0012354223,0.00026973643,0.000024734978,0.00001480026,0.0000069655725,0.0003367663],"genre_scores_gemma":[0.0010501918,0.99586535,0.0021008798,0.000497331,0.00025075593,0.00013798753,0.000023773504,0.00000983538,0.00006395596],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.95612264,0.027261926,0.006252735,0.0023311889,0.0075084786,0.00052301574],"domain_scores_gemma":[0.63046414,0.3466448,0.0074829985,0.004776461,0.009879757,0.0007517733],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06834866,0.0024270965,0.006256014,0.017215697,0.001791298,0.010663567,0.004271099,0.0048196274,0.006727423],"category_scores_gemma":[0.11630892,0.0025185654,0.0055234185,0.026819568,0.008379471,0.015650185,0.0044866996,0.0073393174,0.0014834943],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010642809,0.0001530851,0.0009768403,0.17722726,0.00076457055,0.0001008407,0.0017865223,0.0008504821,0.00012235367,0.058565665,0.021343011,0.73800296],"study_design_scores_gemma":[0.000085361615,0.00016072542,0.0026841837,0.4567782,0.0012011146,0.0006129003,0.0016895613,0.0009837555,0.00021102332,0.053924173,0.48149768,0.00017145035],"about_ca_topic_score_codex":0.008671427,"about_ca_topic_score_gemma":0.009532097,"teacher_disagreement_score":0.93165135,"about_ca_system_score_codex":0.011477915,"about_ca_system_score_gemma":0.016874854,"threshold_uncertainty_score":0.3614666},"labels":[],"label_agreement":null},{"id":"W1978364785","doi":"10.1586/14737167.3.5.535","title":"The cost-effectiveness of short-term dynamic psychotherapy","year":2003,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Mental Health Research Topics","field":"Psychology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Psychotherapist; Term (time); Mental health; Medicine; Psychology; Psychiatry","score_opus":0.12764640455676426,"score_gpt":0.638922858774024,"score_spread":0.5112764542172598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978364785","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11445074,0.8483351,0.005357586,0.0086498065,0.00093918864,0.00068231614,0.0018770129,0.00008163066,0.019626647],"genre_scores_gemma":[0.6256836,0.36154443,0.00552606,0.0014034011,0.000796929,0.0006085934,0.0010112273,0.000016676946,0.003408979],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997556,0.0011426997,0.0002257669,0.00015480652,0.00081530405,0.00010540178],"domain_scores_gemma":[0.9946748,0.0039769947,0.00079576473,0.00010810062,0.00028845447,0.00015588534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024275053,0.0003717402,0.0016828802,0.0012859177,0.00022360026,0.0011710598,0.00064572366,0.0011063367,0.007988263],"category_scores_gemma":[0.009944513,0.00014736726,0.0016937129,0.0012955378,0.00038331244,0.00088955695,0.00065988814,0.0010568061,0.0003338585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006313787,0.000838731,0.0043382933,0.01898136,0.004777897,0.00022735843,0.000077025754,0.002847462,0.0011461081,0.0063618384,0.005669801,0.94842035],"study_design_scores_gemma":[0.017080031,0.06463983,0.3748211,0.085797764,0.059808593,0.014087582,0.0022429633,0.02278413,0.01154425,0.08197917,0.26476756,0.00044701976],"about_ca_topic_score_codex":0.0021015452,"about_ca_topic_score_gemma":0.0026363328,"teacher_disagreement_score":0.007988263,"about_ca_system_score_codex":0.0018660182,"about_ca_system_score_gemma":0.0013680944,"threshold_uncertainty_score":0.026723444},"labels":[],"label_agreement":null},{"id":"W1978999841","doi":"10.1586/14737167.7.2.155","title":"Cost–effectiveness of tumor necrosis factor-α antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis","year":2007,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Psoriatic arthritis; Ankylosing spondylitis; Medicine; Rheumatoid arthritis; Tumor necrosis factor alpha; Psoriasis; Arthritis; Infliximab; Immunology; Internal medicine; Physical therapy","score_opus":0.0399645177156194,"score_gpt":0.4733243647249319,"score_spread":0.4333598470093125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978999841","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16415833,0.7929325,0.0033188807,0.014357869,0.00037349405,0.00022930432,0.0013949409,0.000035989844,0.023198657],"genre_scores_gemma":[0.7965485,0.1969426,0.00254699,0.0017076379,0.00035808014,0.00013985805,0.0004512194,0.000010808697,0.0012943314],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99181783,0.006293168,0.00035315377,0.00015115539,0.0012313172,0.000153385],"domain_scores_gemma":[0.993869,0.0049329605,0.00074906164,0.00005973831,0.0002949511,0.000094362345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004727068,0.0003335092,0.0013217076,0.0019636257,0.0001298352,0.0013972444,0.00032670167,0.0009634996,0.002475445],"category_scores_gemma":[0.013756786,0.00017743847,0.0015243908,0.0020985974,0.0003339276,0.0006004233,0.00025669005,0.00048743666,0.00012975438],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011163442,0.0005855008,0.026717708,0.009271184,0.012102362,0.00051027705,0.00009990668,0.055835508,0.001366978,0.017361866,0.008977918,0.85600734],"study_design_scores_gemma":[0.015698852,0.0195827,0.4499271,0.026273618,0.063113615,0.008961948,0.0018872898,0.12704042,0.010333189,0.09463461,0.18181135,0.0007354515],"about_ca_topic_score_codex":0.0042296974,"about_ca_topic_score_gemma":0.0056245043,"teacher_disagreement_score":0.004727068,"about_ca_system_score_codex":0.0027491616,"about_ca_system_score_gemma":0.0013869235,"threshold_uncertainty_score":0.02499944},"labels":[],"label_agreement":null},{"id":"W1981248934","doi":"10.1586/14737167.2015.1039519","title":"How do we value a cure?","year":2015,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Value (mathematics); Medicine; Opportunity cost; Public economics; Actuarial science; Economics; Microeconomics","score_opus":0.47286612823180724,"score_gpt":0.6358779464822236,"score_spread":0.16301181825041638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981248934","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015293839,0.09401115,0.0074698646,0.8464649,0.0028720684,0.0000606163,0.0006466762,0.000023376151,0.033157475],"genre_scores_gemma":[0.7207021,0.12945984,0.009020828,0.12691794,0.008293805,0.0002221653,0.0005027157,0.00008864802,0.004791972],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98207897,0.011972285,0.0008049947,0.00063886226,0.0038310667,0.0006738319],"domain_scores_gemma":[0.9220802,0.059077688,0.006495946,0.0019338606,0.0063093463,0.0041029556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023094121,0.00045708907,0.0016385191,0.0021967127,0.0012740217,0.008149636,0.0010344032,0.005223913,0.008082785],"category_scores_gemma":[0.1275029,0.00025232334,0.0007381211,0.0019774889,0.009558397,0.012648568,0.002151116,0.0071131024,0.0012842807],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007649186,0.00026666815,0.016046809,0.0031700218,0.0011761653,0.00031914114,0.0011967982,0.0038050765,0.0002821431,0.5107121,0.11033826,0.35192198],"study_design_scores_gemma":[0.00015537426,0.0002532561,0.008719514,0.0058219805,0.00039265794,0.0007553803,0.0026068364,0.0015384811,0.00021261298,0.8287672,0.15066364,0.000113158094],"about_ca_topic_score_codex":0.0034222812,"about_ca_topic_score_gemma":0.0032092915,"teacher_disagreement_score":0.023094121,"about_ca_system_score_codex":0.0042543323,"about_ca_system_score_gemma":0.004192725,"threshold_uncertainty_score":0.122134805},"labels":[],"label_agreement":null},{"id":"W1986501424","doi":"10.1586/14737167.2014.908711","title":"Mapping algorithms from QLQ-C30 to EQ-5D utilities: no firm ground to stand on yet","year":2014,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Algorithm; Computer science; Data mining","score_opus":0.46976802272431906,"score_gpt":0.5974585316459563,"score_spread":0.12769050892163725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986501424","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03472672,0.017595792,0.9286954,0.005687318,0.0010582935,0.0006897167,0.0017705824,0.0019226125,0.007853672],"genre_scores_gemma":[0.33248088,0.009281711,0.64484,0.0025653655,0.00078113895,0.0020412148,0.00443378,0.0012353893,0.0023406148],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.977644,0.015195597,0.0015763091,0.0021597783,0.0031515104,0.00027290845],"domain_scores_gemma":[0.91951376,0.063803725,0.0033621998,0.006641094,0.0064028297,0.00027641462],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.033197947,0.0012196405,0.00144474,0.0030844633,0.0004711169,0.003886643,0.0022762853,0.0014169039,0.0049523613],"category_scores_gemma":[0.18659283,0.0004995241,0.0021646905,0.003558904,0.0010724963,0.0028640206,0.0030564535,0.003178245,0.0023443822],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005303255,0.00016707026,0.025454113,0.0014120484,0.0014256239,0.00007137963,0.00037961535,0.027563218,0.0005655481,0.018244142,0.012721016,0.9114659],"study_design_scores_gemma":[0.0012153019,0.0017332352,0.07693042,0.0076908437,0.0026059072,0.0018745754,0.0013459006,0.45125064,0.01343651,0.32178977,0.11947776,0.00064909627],"about_ca_topic_score_codex":0.0024830017,"about_ca_topic_score_gemma":0.0012067362,"teacher_disagreement_score":0.96680206,"about_ca_system_score_codex":0.0011992239,"about_ca_system_score_gemma":0.002196745,"threshold_uncertainty_score":0.17556965},"labels":[],"label_agreement":null},{"id":"W1988142324","doi":"10.1586/14737167.3.6.691","title":"Impact of socioeconomic status on cardiovascular outcomes in Canada","year":2003,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research","keywords":"Socioeconomic status; Medicine; Environmental health; Gerontology; Population","score_opus":0.055164637274325065,"score_gpt":0.5322028403494637,"score_spread":0.47703820307513867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988142324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8901248,0.031202974,0.00034623247,0.015633725,0.00024765308,0.00009959667,0.01771875,0.000038725088,0.0445876],"genre_scores_gemma":[0.9877456,0.008946335,0.00016029815,0.0003483558,0.000030498039,0.000013153958,0.0012981638,0.0000046251066,0.0014530102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994281,0.00004836864,0.00002405256,0.00004222258,0.000273658,0.00018355016],"domain_scores_gemma":[0.998887,0.00006700845,0.00014099908,0.000016701322,0.0005626938,0.0003257232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004707921,0.00015417524,0.00029762427,0.0012031386,0.0018903572,0.0009330853,0.0003888104,0.00022149029,0.003194874],"category_scores_gemma":[0.002391053,0.00007181375,0.00034364662,0.0031589034,0.00043717894,0.00019621052,0.00083216827,0.0004825083,0.000106094994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037341422,0.000069433285,0.85467964,0.00039202036,0.00032496094,0.0004675109,0.0011587013,0.0006580563,0.00025011992,0.0032824543,0.018847475,0.119496234],"study_design_scores_gemma":[0.000019602274,0.000025085013,0.9924298,0.00015530868,0.0001123497,0.00008307969,0.0006837284,0.00036884856,0.000072776085,0.00030375036,0.0057292585,0.00001652233],"about_ca_topic_score_codex":0.994696,"about_ca_topic_score_gemma":0.9969382,"teacher_disagreement_score":0.024053289,"about_ca_system_score_codex":0.024053289,"about_ca_system_score_gemma":0.055646546,"threshold_uncertainty_score":0.17451966},"labels":[],"label_agreement":null},{"id":"W1988429877","doi":"10.1586/14737167.4.5.581","title":"The truly remarkable universality of half a standard deviation: confirmation through another look","year":2004,"lang":"en","type":"letter","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":483,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Universality (dynamical systems); Standard deviation; Pharmacoeconomics; Medicine; Quality-adjusted life year; Quality of life (healthcare); Statistics; Actuarial science; Mathematics; Intensive care medicine; Economics; Nursing; Cost effectiveness","score_opus":0.28652802241202247,"score_gpt":0.5832951058488585,"score_spread":0.296767083436836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988429877","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003469651,0.0024342674,0.00026862885,0.9836288,0.012625164,0.000007927959,0.00003611641,0.00001350254,0.0006385236],"genre_scores_gemma":[0.0043119285,0.0019465638,0.00066934776,0.9657163,0.026087396,0.000048087903,0.000018433828,0.000020138898,0.0011818393],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9553628,0.01387219,0.008488934,0.0062239477,0.014823642,0.0012285169],"domain_scores_gemma":[0.63956326,0.30466005,0.011913294,0.006681701,0.03276664,0.00441508],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.054293696,0.0005693709,0.0028207651,0.0013298285,0.0028348903,0.0047818236,0.0036223927,0.043924037,0.0040478064],"category_scores_gemma":[0.2609869,0.000934297,0.0019294223,0.0022126776,0.008018887,0.008291853,0.0028253722,0.04157214,0.003076266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018283677,0.000054514872,0.00128509,0.0004704981,0.000115855706,0.0017977878,0.00076376,0.00006440456,0.00030603193,0.011990186,0.9486923,0.034276783],"study_design_scores_gemma":[0.00047433312,0.00030714722,0.00469993,0.0018771109,0.00027015372,0.004697495,0.0023308294,0.0006655444,0.0010415053,0.036921166,0.9464497,0.00026501314],"about_ca_topic_score_codex":0.005118739,"about_ca_topic_score_gemma":0.009900605,"teacher_disagreement_score":0.9457063,"about_ca_system_score_codex":0.005394634,"about_ca_system_score_gemma":0.0073742457,"threshold_uncertainty_score":0.2871359},"labels":[],"label_agreement":null},{"id":"W1990993569","doi":"10.1586/erp.09.65","title":"Response to Lichtenberg","year":2009,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Global Health Care Issues","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Waterloo; McMaster University","funders":"","keywords":"Economics; Medicine; Intensive care medicine","score_opus":0.11855973815134505,"score_gpt":0.6720263448568282,"score_spread":0.5534666067054832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990993569","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011743512,0.0027600902,0.00007236873,0.9278091,0.067636654,0.000026800086,0.00009280673,0.000040041417,0.0014446469],"genre_scores_gemma":[0.0006584409,0.00087647274,0.00011307881,0.9582993,0.03259371,0.000050475028,0.000032678476,0.00002117729,0.007354685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99238235,0.0015170058,0.0008496118,0.0012061705,0.0030394867,0.0010053597],"domain_scores_gemma":[0.97496164,0.009672465,0.002382345,0.001015875,0.0074501587,0.0045175455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00872728,0.0015082497,0.0029142504,0.001803387,0.003676023,0.005822587,0.0033858486,0.059687715,0.018426465],"category_scores_gemma":[0.054583106,0.0010548026,0.0023875409,0.0014554954,0.0030805569,0.0035489595,0.004558599,0.03826999,0.014693979],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025777797,0.000009057217,0.00006450165,0.00009776841,0.00001222495,0.00015481954,0.00004589976,0.0000146458415,0.00004748983,0.00037312577,0.99588794,0.0032667546],"study_design_scores_gemma":[0.000041485615,0.000029324514,0.00059458334,0.0004324904,0.000026886984,0.00025995533,0.00022056674,0.00006901591,0.000078924095,0.00077316817,0.9974402,0.000033309014],"about_ca_topic_score_codex":0.0049191113,"about_ca_topic_score_gemma":0.008550837,"teacher_disagreement_score":0.059687715,"about_ca_system_score_codex":0.005640598,"about_ca_system_score_gemma":0.008310609,"threshold_uncertainty_score":0.061642706},"labels":[],"label_agreement":null},{"id":"W1991060162","doi":"10.1586/14737167.2.2.129","title":"Quality of life issues following autologous bone marrow transplantation","year":2002,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Medicine; Quality of life (healthcare); Bone marrow transplantation; Bone marrow; Transplantation; Stem cell; Chemotherapy; Intensive care medicine; Bone marrow transplant; Oncology; Surgery; Internal medicine","score_opus":0.09326120565520794,"score_gpt":0.531702048610625,"score_spread":0.438440842955417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991060162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7439568,0.22135459,0.002322943,0.0062158396,0.00045079915,0.00026384633,0.00079327455,0.000021802955,0.024620127],"genre_scores_gemma":[0.9729912,0.024320696,0.0004941388,0.0009818478,0.00017768532,0.00007617585,0.00025102997,0.0000053300537,0.00070184283],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970409,0.0014789306,0.0004091802,0.000106210166,0.0008254687,0.00013928214],"domain_scores_gemma":[0.9905211,0.0049998024,0.0028583235,0.00010600825,0.0012146885,0.00030007737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005171191,0.00013455364,0.00073106645,0.0007944889,0.00043774818,0.0010272783,0.00021049935,0.0003084251,0.0020265528],"category_scores_gemma":[0.017093671,0.000053816537,0.0005858752,0.001467936,0.00042393547,0.00048016495,0.00056464295,0.0005779656,0.00014767179],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017508676,0.0007274381,0.37197724,0.005336385,0.001502519,0.0039459965,0.004624577,0.0010379959,0.0020745876,0.0022789626,0.005607058,0.59913635],"study_design_scores_gemma":[0.00016722655,0.005694385,0.9238503,0.0033371425,0.0018274203,0.011966038,0.007715079,0.0010248362,0.0025976398,0.005421089,0.03631977,0.000079119796],"about_ca_topic_score_codex":0.00070492644,"about_ca_topic_score_gemma":0.0012570436,"teacher_disagreement_score":0.005171191,"about_ca_system_score_codex":0.0007141025,"about_ca_system_score_gemma":0.0006186161,"threshold_uncertainty_score":0.02734822},"labels":[],"label_agreement":null},{"id":"W1995653782","doi":"10.1586/erp.10.66","title":"Priority setting in healthcare: towards guidelines for the program budgeting and marginal analysis framework","year":2010,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Premise; Scarcity; Health care; Rationality; Context (archaeology); Resource allocation; Service (business); Management science; Health care rationing; Economics; Resource (disambiguation); Economic evaluation; Public economics; Business; Process management; Computer science; Marketing; Microeconomics; Political science; Management; Economic growth","score_opus":0.5203760409301671,"score_gpt":0.7048308742472107,"score_spread":0.1844548333170436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995653782","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000659323,0.0756602,0.8586792,0.05233909,0.0013754811,0.0013478978,0.0001754554,0.00020002353,0.009563347],"genre_scores_gemma":[0.022208592,0.038104143,0.92239136,0.010148288,0.001072413,0.0047617075,0.00017725176,0.00013832121,0.0009979949],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.80936575,0.1505141,0.014928238,0.0034893658,0.019810142,0.001892344],"domain_scores_gemma":[0.8291746,0.13736647,0.008207736,0.004452967,0.019264795,0.0015335369],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23396899,0.0030273555,0.0069831153,0.0112020215,0.0025390596,0.011677002,0.012169758,0.011879164,0.0024560567],"category_scores_gemma":[0.19715597,0.0027975289,0.003912725,0.012381002,0.019998858,0.011364463,0.0071881167,0.026202038,0.0018694086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037437596,0.00006169803,0.00023513679,0.0034548552,0.00012028639,0.00008208391,0.0012423685,0.008004214,0.0001286788,0.8816841,0.014999889,0.08994922],"study_design_scores_gemma":[0.000101493875,0.000054309337,0.000339651,0.009388673,0.00010999272,0.00012481127,0.0004956068,0.00806105,0.00032324833,0.88920283,0.09171358,0.00008481983],"about_ca_topic_score_codex":0.012333306,"about_ca_topic_score_gemma":0.014212929,"teacher_disagreement_score":0.23396899,"about_ca_system_score_codex":0.019863673,"about_ca_system_score_gemma":0.038420066,"threshold_uncertainty_score":0.9446526},"labels":[],"label_agreement":null},{"id":"W1999497775","doi":"10.1586/14737167.6.3.275","title":"Application of economic principles in healthcare priority setting","year":2006,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Scarcity; Set (abstract data type); Health care; Health economics; Context (archaeology); Economic evaluation; Management science; Economics; Key (lock); Economic model; Resource (disambiguation); Public economics; Environmental economics; Computer science; Risk analysis (engineering); Business; Microeconomics; Economic growth","score_opus":0.2715915393809169,"score_gpt":0.6172442776277653,"score_spread":0.34565273824684845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999497775","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004745375,0.0151122855,0.90956414,0.034746375,0.0010258938,0.0006251839,0.00010708108,0.00005579558,0.03401784],"genre_scores_gemma":[0.31523702,0.019032262,0.6502352,0.007122649,0.0020704493,0.0020370712,0.0000851933,0.0001154518,0.0040647113],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8755314,0.10434933,0.003743954,0.0032075348,0.011755191,0.0014127063],"domain_scores_gemma":[0.8769786,0.10946874,0.0044842926,0.0025243203,0.0057513183,0.00079272647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09237235,0.0017144955,0.0027299034,0.0055202763,0.0022195026,0.007310968,0.0030942338,0.004368639,0.004000816],"category_scores_gemma":[0.1311219,0.0011972118,0.0019761682,0.005635762,0.016802434,0.008980861,0.0049892454,0.009039531,0.0005650451],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020288304,0.000034961693,0.00042244894,0.00048086344,0.00007117713,0.00006653471,0.00039748245,0.013742058,0.000042182754,0.9554011,0.001995384,0.027325535],"study_design_scores_gemma":[0.000026861828,0.00002527961,0.00021138924,0.0003704015,0.000018825202,0.000047793357,0.00018002106,0.009526983,0.00010202569,0.9793067,0.010159286,0.000024441299],"about_ca_topic_score_codex":0.004113366,"about_ca_topic_score_gemma":0.0036046216,"teacher_disagreement_score":0.09237235,"about_ca_system_score_codex":0.0105985785,"about_ca_system_score_gemma":0.010311346,"threshold_uncertainty_score":0.48851752},"labels":[],"label_agreement":null},{"id":"W2000189078","doi":"10.1586/14737167.2014.864560","title":"Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30","year":2013,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Quality of life (healthcare); Predictive value; Cancer; Internal medicine; Physical therapy; Oncology","score_opus":0.09709511255596895,"score_gpt":0.55860675729414,"score_spread":0.4615116447381711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000189078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969637,0.0012170325,0.00028408866,0.00016050779,0.000008347137,0.000027274498,0.0007899197,0.0000050110275,0.00054422393],"genre_scores_gemma":[0.99919385,0.00015553656,0.00011299931,0.000018639634,0.000006971169,0.000014447562,0.0004286482,7.193086e-7,0.000068116344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964905,0.00012990642,0.000035987116,0.00004950518,0.00009591953,0.00003963229],"domain_scores_gemma":[0.99871826,0.00051504094,0.00047863272,0.00003271266,0.00014151014,0.00011380359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008757697,0.0001824127,0.00033638423,0.0004830523,0.00011861558,0.00025409437,0.00014753612,0.00024653165,0.0015121873],"category_scores_gemma":[0.0035510478,0.00007760964,0.00037878484,0.00063718366,0.0001530013,0.00020323582,0.00024173886,0.00040907657,0.00013064142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015966975,0.000027753642,0.99466056,0.000018232955,0.000088811306,0.000020297157,0.000016297625,0.00025735216,0.00009916418,0.000010811242,0.00017905986,0.004462086],"study_design_scores_gemma":[0.000024711488,0.0001774628,0.9983399,0.0000129199625,0.000054692035,0.00012399774,0.00003529678,0.00089378556,0.000058592388,0.00004318013,0.00023187003,0.0000035554606],"about_ca_topic_score_codex":0.0013711929,"about_ca_topic_score_gemma":0.0019015914,"teacher_disagreement_score":0.0015121873,"about_ca_system_score_codex":0.0001602158,"about_ca_system_score_gemma":0.00017948808,"threshold_uncertainty_score":0.005058825},"labels":[],"label_agreement":null},{"id":"W2000750461","doi":"10.1586/14737167.3.2.125","title":"Incorporation of environmental factors into outcomes research","year":2003,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut de Réadaptation en Déficience Physique de Québec; World Health Organization","keywords":"International Classification of Functioning, Disability and Health; Outcome (game theory); Psychological intervention; Conceptual framework; Intervention (counseling); Psychology; Applied psychology; Medicine; Gerontology; Management science; Political science; Sociology; Physical therapy; Rehabilitation; Engineering; Psychiatry; Social science","score_opus":0.06869346703765089,"score_gpt":0.518327579767542,"score_spread":0.44963411272989107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000750461","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07351615,0.05393958,0.714618,0.06948613,0.00430359,0.0077444687,0.004807691,0.00044094634,0.071143374],"genre_scores_gemma":[0.565971,0.022741357,0.38097307,0.009919491,0.0015613997,0.0149154235,0.0011888425,0.00018790802,0.0025414948],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.65056753,0.29072878,0.019565914,0.009343313,0.028107984,0.0016864638],"domain_scores_gemma":[0.6094556,0.3203869,0.02294859,0.023014061,0.022609828,0.0015850612],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2731149,0.0015000185,0.0029801175,0.011503431,0.002156761,0.009146802,0.0025908945,0.00207447,0.003882171],"category_scores_gemma":[0.2892052,0.00071753346,0.0030653733,0.012413042,0.00781329,0.010524114,0.008212419,0.0043333657,0.0004967104],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033048043,0.0006464251,0.08217327,0.011260568,0.0040288917,0.00029611195,0.011535039,0.0042520007,0.00037437843,0.28507143,0.003985004,0.5960464],"study_design_scores_gemma":[0.000307052,0.0018938016,0.124360524,0.025341427,0.0038508982,0.00048605923,0.014625348,0.008990866,0.0017852895,0.7121056,0.105834484,0.00041869885],"about_ca_topic_score_codex":0.0070665814,"about_ca_topic_score_gemma":0.008386839,"teacher_disagreement_score":0.2731149,"about_ca_system_score_codex":0.0055540293,"about_ca_system_score_gemma":0.01311218,"threshold_uncertainty_score":0.89637876},"labels":[],"label_agreement":null},{"id":"W2000996016","doi":"10.1586/14737167.2014.861742","title":"Cost–effectiveness of abatacept for moderate-to-severe rheumatoid arthritis","year":2013,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Rituximab; Internal medicine; Rheumatology; Antirheumatic Agents; Antirheumatic drugs; Clinical trial; Intensive care medicine; Physical therapy","score_opus":0.11924781409295578,"score_gpt":0.5584130695508618,"score_spread":0.439165255457906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000996016","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020331529,0.99931824,0.000027299831,0.00015851585,0.000038678376,0.0000072118314,0.000036536196,0.0000012404126,0.00020892748],"genre_scores_gemma":[0.0032041485,0.9963381,0.00013977138,0.000120110475,0.000053843978,0.00001565027,0.000037942653,8.7472944e-7,0.00008941615],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998836,0.0003944974,0.00027092945,0.00009766045,0.00034791752,0.000053051866],"domain_scores_gemma":[0.9980228,0.0014059443,0.00034622845,0.000017777691,0.0001815001,0.000025739855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022600084,0.0008796083,0.0038607533,0.0030342443,0.00017880618,0.0013590844,0.0010822822,0.0012354973,0.005548538],"category_scores_gemma":[0.004154056,0.0003591315,0.0029747044,0.0033653267,0.00029529422,0.00081904425,0.0004085748,0.0010230961,0.00044977566],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072774786,0.000083739425,0.00047734976,0.1837668,0.0040885843,0.00014498491,0.00003365672,0.0005940351,0.00041427487,0.0016115872,0.009090631,0.7989666],"study_design_scores_gemma":[0.0019077419,0.0017486418,0.016224708,0.36479846,0.050649997,0.003933651,0.0003955173,0.0015470419,0.0027094216,0.0063229683,0.5495946,0.0001672897],"about_ca_topic_score_codex":0.002669393,"about_ca_topic_score_gemma":0.004452861,"teacher_disagreement_score":0.005548538,"about_ca_system_score_codex":0.0018787313,"about_ca_system_score_gemma":0.002347106,"threshold_uncertainty_score":0.01856172},"labels":[],"label_agreement":null},{"id":"W2003521686","doi":"10.1586/14737167.2014.906305","title":"Costs of multiple sclerosis – extrapolation of Czech data to Polish patients","year":2014,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Czech; Health economics; Medicine; Humanities; Gynecology; Philosophy; Public health; Pathology","score_opus":0.1972629982515317,"score_gpt":0.5399980957932524,"score_spread":0.3427350975417207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003521686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.945769,0.013982298,0.009972543,0.0008919667,0.00007316829,0.00041658618,0.021828229,0.00005392581,0.007012229],"genre_scores_gemma":[0.9784849,0.0067900745,0.003242499,0.00016137147,0.00002277775,0.0003556535,0.010383921,0.000030968375,0.0005277968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985008,0.00048610134,0.0003678956,0.00017421119,0.00037005547,0.00010090256],"domain_scores_gemma":[0.9981831,0.00049950526,0.00074641296,0.00017464007,0.00034293858,0.000053343854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00261594,0.00055941654,0.00070923194,0.0027394188,0.00017795543,0.0011437301,0.00056400074,0.00033181027,0.0016214633],"category_scores_gemma":[0.0072166896,0.00040698063,0.0019985067,0.0028665876,0.00020769765,0.0009628416,0.0010081327,0.000690918,0.00024863015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050050453,0.00031678277,0.6859853,0.0065423655,0.008261185,0.0012486108,0.0007499774,0.08172891,0.0018038959,0.006458047,0.008734846,0.19316496],"study_design_scores_gemma":[0.00064624636,0.0005114273,0.9497157,0.0020158729,0.0018159066,0.0019087064,0.00053945155,0.022360768,0.0017752559,0.003284457,0.015325987,0.000100168276],"about_ca_topic_score_codex":0.015396819,"about_ca_topic_score_gemma":0.009058221,"teacher_disagreement_score":0.015396819,"about_ca_system_score_codex":0.0014221057,"about_ca_system_score_gemma":0.0012563338,"threshold_uncertainty_score":0.030614436},"labels":[],"label_agreement":null},{"id":"W2004350586","doi":"10.1586/14737167.2015.1021336","title":"Do different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies","year":2015,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Economic model; Interactivity; Computer science; Population; Management science; Aggregate (composite); Risk analysis (engineering); Resource (disambiguation); Medicine; Economics; Environmental health; Microeconomics","score_opus":0.7532850886981337,"score_gpt":0.6895764805842648,"score_spread":0.06370860811386891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004350586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019782924,0.98730904,0.0064886278,0.0012052732,0.0003784489,0.0013193433,0.00044870377,0.000024705,0.0008476222],"genre_scores_gemma":[0.0748621,0.8944292,0.021420388,0.0025886125,0.0003936839,0.0049921633,0.0009647967,0.00008424954,0.0002647963],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8003034,0.1311692,0.04016545,0.007003003,0.020314187,0.0010447757],"domain_scores_gemma":[0.4763381,0.46902087,0.025457487,0.0076525984,0.020916672,0.0006143247],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22878331,0.0030629232,0.011935985,0.009971644,0.0009879628,0.006728634,0.004680627,0.0033272617,0.0055270204],"category_scores_gemma":[0.47762272,0.001906054,0.022183586,0.010210804,0.0023497115,0.005129454,0.0029602717,0.0028472345,0.0005838294],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001252484,0.00010240034,0.0039730268,0.688192,0.08360749,0.000116304676,0.00061027956,0.0018786337,0.00018497976,0.004622294,0.0028222848,0.21263781],"study_design_scores_gemma":[0.0012020144,0.0008208682,0.006415899,0.77361715,0.17111379,0.00032400657,0.00070479116,0.0019343377,0.0007674353,0.0091608055,0.033770334,0.00016859006],"about_ca_topic_score_codex":0.005151584,"about_ca_topic_score_gemma":0.008620774,"teacher_disagreement_score":0.7712167,"about_ca_system_score_codex":0.00658916,"about_ca_system_score_gemma":0.012256349,"threshold_uncertainty_score":0.9510475},"labels":[],"label_agreement":null},{"id":"W2006962844","doi":"10.1586/erp.11.55","title":"A literature review of symptom clusters in patients with breast cancer","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; CINAHL; Cluster (spacecraft); Medicine; Nausea; Depression (economics); MEDLINE; Distress; Clinical psychology; Cancer; Psychiatry; Internal medicine; Psychological intervention","score_opus":0.04215226886319817,"score_gpt":0.4983006085158836,"score_spread":0.4561483396526854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006962844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023918124,0.996305,0.00010903183,0.00037339758,0.00008862856,0.00007749334,0.00020102892,0.000006462261,0.00044723667],"genre_scores_gemma":[0.02046213,0.9777771,0.00067101116,0.0005201429,0.00008240714,0.00013844311,0.00028586836,0.000004557115,0.00005823336],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.993508,0.002050352,0.0028973105,0.0004651105,0.0009108897,0.00016845153],"domain_scores_gemma":[0.9573827,0.03506473,0.004644706,0.00039649318,0.0022159908,0.0002953612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054342165,0.0010170727,0.0031670039,0.016548341,0.0009207171,0.0024505346,0.0016680921,0.0013307711,0.0028508108],"category_scores_gemma":[0.033061624,0.00069903635,0.003788402,0.020800121,0.0010827606,0.0029167316,0.001488286,0.0010787259,0.00023987202],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002338169,0.000044341905,0.0047812867,0.778023,0.0021750808,0.00038777746,0.0024852783,0.00018197787,0.00020239895,0.00058942835,0.0061762054,0.20471951],"study_design_scores_gemma":[0.00011593683,0.00028958084,0.03507409,0.88851607,0.013268691,0.0033384934,0.004365855,0.00012202748,0.00023742729,0.001049176,0.05353129,0.000091259186],"about_ca_topic_score_codex":0.007358556,"about_ca_topic_score_gemma":0.01434485,"teacher_disagreement_score":0.016548341,"about_ca_system_score_codex":0.0034271472,"about_ca_system_score_gemma":0.008391909,"threshold_uncertainty_score":0.028739214},"labels":[],"label_agreement":null},{"id":"W2008460730","doi":"10.1586/14737167.2015.982100","title":"The use of EGFR inhibitors in colorectal cancer: is it clinically efficacious and cost-effective?","year":2014,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Panitumumab; Cetuximab; Medicine; Colorectal cancer; EGFR inhibitors; Rash; Oncology; Chemotherapy; Internal medicine; Cancer; KRAS; Dermatology; Epidermal growth factor receptor","score_opus":0.13067305424483958,"score_gpt":0.5835743669959681,"score_spread":0.45290131275112855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008460730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009080485,0.99939966,0.000018847953,0.00027012496,0.000024458986,0.000002283476,0.000010088418,6.9542466e-7,0.00018306613],"genre_scores_gemma":[0.00094987726,0.9987318,0.000065841115,0.00014546156,0.000042579028,0.000004418793,0.000010982668,3.8624978e-7,0.000048632483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992768,0.00025540576,0.00014523632,0.00007006705,0.0002191552,0.00003328383],"domain_scores_gemma":[0.99839205,0.0011819005,0.00023898178,0.000016398659,0.00014585374,0.000024797628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015869795,0.00044651667,0.002165553,0.0019924887,0.00017545273,0.0010686065,0.000779193,0.0010887261,0.003955779],"category_scores_gemma":[0.002898069,0.00023547819,0.0012323826,0.0026256456,0.00040713334,0.0010985725,0.00041767294,0.0009476515,0.0005279771],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001828375,0.000058719543,0.00028605817,0.106380984,0.0008411739,0.00013948968,0.000048634825,0.0002327214,0.00044950724,0.0022309234,0.00867565,0.8804733],"study_design_scores_gemma":[0.0003733555,0.0008258194,0.006320387,0.15288964,0.005821605,0.0029433637,0.0004356843,0.00034088793,0.000969009,0.005160862,0.8238377,0.00008178186],"about_ca_topic_score_codex":0.0015172816,"about_ca_topic_score_gemma":0.0035835772,"teacher_disagreement_score":0.003955779,"about_ca_system_score_codex":0.0007098957,"about_ca_system_score_gemma":0.0015264939,"threshold_uncertainty_score":0.013233423},"labels":[],"label_agreement":null},{"id":"W2016358693","doi":"10.1586/erp.11.105","title":"Measuring and managing patient expectations for breast reconstruction: impact on quality of life and patient satisfaction","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"National Cancer Institute","keywords":"Patient satisfaction; Quality of life (healthcare); Quality (philosophy); Medicine; Intensive care medicine; Psychology; Nursing","score_opus":0.1415307429407712,"score_gpt":0.5188150079756331,"score_spread":0.3772842650348619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016358693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018296026,0.99653435,0.00015067507,0.0006283228,0.00006430617,0.000021052523,0.0000442573,0.0000023892003,0.0007251105],"genre_scores_gemma":[0.014608325,0.9839378,0.00077439647,0.00030544796,0.00008118952,0.000044318673,0.00006546422,0.000001672464,0.00018139994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977997,0.0010981224,0.00035756847,0.00009922805,0.0005830309,0.000062281906],"domain_scores_gemma":[0.996203,0.0026442576,0.00064325973,0.00003589885,0.00041426867,0.00005934099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033653905,0.0005153863,0.0020050185,0.0013222535,0.0001820183,0.0010827499,0.00073153054,0.00090763404,0.002021198],"category_scores_gemma":[0.0075577456,0.00016594715,0.0014935903,0.0017514494,0.0002654876,0.0007477639,0.0004457911,0.0008478247,0.000279294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015094996,0.000120801546,0.0029969853,0.06556838,0.0014627523,0.0001150433,0.00020583947,0.00028041514,0.00033510572,0.00088087557,0.005275112,0.92260766],"study_design_scores_gemma":[0.00062282773,0.0025695076,0.10645708,0.32757062,0.015790742,0.008360288,0.003501893,0.0015709061,0.0028706936,0.0058685504,0.5244976,0.0003192683],"about_ca_topic_score_codex":0.0020563263,"about_ca_topic_score_gemma":0.004229577,"teacher_disagreement_score":0.0033653905,"about_ca_system_score_codex":0.00071199395,"about_ca_system_score_gemma":0.0016493803,"threshold_uncertainty_score":0.017798126},"labels":[],"label_agreement":null},{"id":"W2016418149","doi":"10.1586/14737167.1.2.121","title":"Quality of life and rhinitis: nothing to be sneezed at!","year":2001,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Nothing; Quality (philosophy); Quality of life (healthcare); Medicine; Intensive care medicine; Environmental health; Business; Risk analysis (engineering); Economics; Actuarial science; Philosophy; Nursing; Epistemology","score_opus":0.08381683654808018,"score_gpt":0.5322960264331951,"score_spread":0.44847918988511487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016418149","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042433854,0.10996394,0.00015247334,0.04492886,0.84380484,0.00001951039,0.000069342655,0.000029513125,0.0009891076],"genre_scores_gemma":[0.00092047546,0.08017576,0.00031866244,0.057907008,0.85568845,0.000049603983,0.00005976561,0.00003025538,0.0048500514],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99557376,0.0012442468,0.0008192134,0.0003787562,0.0017693186,0.00021460689],"domain_scores_gemma":[0.9666814,0.018741142,0.0015052792,0.00052651286,0.011251712,0.0012940512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010748221,0.002676335,0.0075104604,0.002998188,0.0018506654,0.0053706043,0.0030357966,0.013507627,0.006696764],"category_scores_gemma":[0.031109668,0.0010545392,0.0027234398,0.0024787537,0.0020193397,0.0036420915,0.0011871866,0.01974331,0.004578467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008371282,0.000014577716,0.000044855784,0.0015953926,0.00015630116,0.000107850414,0.000017497796,0.000020325675,0.00004253646,0.00035086204,0.9785398,0.019026186],"study_design_scores_gemma":[0.00037817642,0.000090713664,0.0011353903,0.0062695094,0.0009866229,0.00069482136,0.00013466028,0.00019843961,0.00013153083,0.0018113153,0.9881015,0.00006737411],"about_ca_topic_score_codex":0.0030917784,"about_ca_topic_score_gemma":0.008405943,"teacher_disagreement_score":0.013507627,"about_ca_system_score_codex":0.0020287277,"about_ca_system_score_gemma":0.0031791239,"threshold_uncertainty_score":0.056842685},"labels":[],"label_agreement":null},{"id":"W2018521022","doi":"10.1586/erp.12.70","title":"Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Brain tumor; Internal medicine; Oncology; Cancer; Analysis of variance; Primary tumor; Brain metastasis; Physical therapy; Metastasis; Psychiatry","score_opus":0.15806372043667594,"score_gpt":0.5813890627586904,"score_spread":0.42332534232201446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018521022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04570592,0.95195735,0.00015162553,0.00020542537,0.00006635346,0.00011163629,0.0010461633,0.0000025488014,0.0007528971],"genre_scores_gemma":[0.45938495,0.53523624,0.0011144098,0.00080650207,0.0002524423,0.00076055824,0.0021985988,0.000005739675,0.00024054466],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9939873,0.0020517611,0.0019388271,0.00052423665,0.0013536091,0.00014425057],"domain_scores_gemma":[0.98553616,0.00911095,0.0039977888,0.00014708086,0.0010554368,0.0001525402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00589598,0.0005575141,0.0037899576,0.010043637,0.0002868568,0.0013667257,0.00054054795,0.0007244684,0.0016987191],"category_scores_gemma":[0.020278616,0.0002677219,0.0034129284,0.01030757,0.0005479489,0.0011261018,0.0007549864,0.0004651962,0.00013099507],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033723237,0.0002160472,0.2073289,0.46020877,0.05964727,0.00084743503,0.0013646786,0.00074866804,0.0010220225,0.00058619335,0.00284604,0.2618116],"study_design_scores_gemma":[0.001690204,0.0044573327,0.63831395,0.22700089,0.08515095,0.007888411,0.0033286249,0.00065263046,0.0009305453,0.0013837874,0.029004514,0.00019816204],"about_ca_topic_score_codex":0.0018762989,"about_ca_topic_score_gemma":0.004485439,"teacher_disagreement_score":0.010043637,"about_ca_system_score_codex":0.0012740508,"about_ca_system_score_gemma":0.0015497104,"threshold_uncertainty_score":0.031181335},"labels":[],"label_agreement":null},{"id":"W2019140346","doi":"10.1586/erp.12.79","title":"Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review","year":2013,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Medicine; Pharmacoeconomics; Atrial fibrillation; Stroke (engine); Warfarin; Intensive care medicine; Randomized controlled trial; Rivaroxaban; Tolerability; Clinical trial; Intracerebral hemorrhage; Adverse effect; Internal medicine","score_opus":0.11936775832910658,"score_gpt":0.5295670421916127,"score_spread":0.4101992838625061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019140346","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046664305,0.99864084,0.000084359526,0.00032941677,0.000053591248,0.00008679336,0.00012876694,0.000002231768,0.00020740303],"genre_scores_gemma":[0.005363371,0.9937827,0.0003439952,0.00025902037,0.000038249986,0.00008237096,0.00006848991,0.000001299124,0.000060559785],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99713373,0.0010606059,0.0009201654,0.00017111351,0.00063933106,0.00007493898],"domain_scores_gemma":[0.9883295,0.0088652475,0.0017818973,0.000090675516,0.0008347157,0.00009797659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046143266,0.0010541762,0.004904258,0.0055984613,0.00029801187,0.001635771,0.00092218147,0.0012092319,0.0037135705],"category_scores_gemma":[0.020061044,0.0005737369,0.0049239825,0.0059858747,0.00037676987,0.0012975162,0.00066014985,0.0008172741,0.00023227742],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002497767,0.000041728308,0.0008812035,0.8218074,0.014287258,0.00012905129,0.000103663384,0.0002796633,0.00015765394,0.000664104,0.0035526794,0.15784584],"study_design_scores_gemma":[0.0005165203,0.00032695735,0.006090788,0.82545197,0.10967751,0.0008404394,0.00027308174,0.0003771818,0.00035434068,0.0013130419,0.054716166,0.00006200949],"about_ca_topic_score_codex":0.0056699086,"about_ca_topic_score_gemma":0.01661145,"teacher_disagreement_score":0.0056699086,"about_ca_system_score_codex":0.0024428058,"about_ca_system_score_gemma":0.006972589,"threshold_uncertainty_score":0.024403155},"labels":[],"label_agreement":null},{"id":"W2019643134","doi":"10.1586/erp.10.13","title":"Patient outcomes after anti TNF-α drugs for Crohn’s disease","year":2010,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Hamilton Health Sciences; McMaster University; St. Joseph’s Healthcare Hamilton; McMaster University Medical Centre; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Adalimumab; Infliximab; Medicine; Crohn's disease; Etanercept; Disease; Inflammatory bowel disease; Intensive care medicine; Tumor necrosis factor alpha; Internal medicine","score_opus":0.028068408167996415,"score_gpt":0.4779436429454193,"score_spread":0.44987523477742286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019643134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010339157,0.9972083,0.000053170585,0.00039990363,0.00007715548,0.0000073679553,0.000068167246,0.000002551689,0.001149496],"genre_scores_gemma":[0.012783896,0.9858876,0.00015275957,0.00035701727,0.00017524094,0.000021198079,0.00013101331,0.0000012967316,0.00049000606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911195,0.0003346208,0.00012841774,0.00007561784,0.00029793993,0.00005141996],"domain_scores_gemma":[0.9989697,0.00054487603,0.00028383752,0.000012419749,0.00014978212,0.000039392417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011559399,0.0004519525,0.002227636,0.0008327371,0.00015902695,0.00072891265,0.0005030783,0.00073255226,0.0028597235],"category_scores_gemma":[0.0025862223,0.00009156338,0.0010691544,0.0016838481,0.00017903087,0.00045510413,0.00032957722,0.00075134577,0.0005148462],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007099909,0.0001249487,0.0027207248,0.03238919,0.0012741922,0.00047876607,0.00009094876,0.00030849775,0.00054367137,0.0011701836,0.013086703,0.9471022],"study_design_scores_gemma":[0.0013830038,0.0032919468,0.10584444,0.095573805,0.011432366,0.012514844,0.0008254816,0.00064939464,0.00256773,0.007748111,0.75802606,0.00014291957],"about_ca_topic_score_codex":0.0010994012,"about_ca_topic_score_gemma":0.0021124813,"teacher_disagreement_score":0.0028597235,"about_ca_system_score_codex":0.00064967066,"about_ca_system_score_gemma":0.00093361264,"threshold_uncertainty_score":0.009566665},"labels":[],"label_agreement":null},{"id":"W2022136588","doi":"10.1586/14737167.4.2.207","title":"Health-related quality of life in prenatal diagnosis","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Amniocentesis; Chorionic villus sampling; Medicine; Prenatal diagnosis; Conceptualization; Quality of life (healthcare); Genetic counseling; Sampling (signal processing); Pregnancy; Obstetrics; Nursing; Fetus; Computer science; Genetics","score_opus":0.0964317475110463,"score_gpt":0.5443969354600094,"score_spread":0.4479651879489631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022136588","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044628507,0.99201244,0.00029393725,0.00122671,0.00021293241,0.00004162862,0.00020707495,0.000002766079,0.0015395954],"genre_scores_gemma":[0.08777447,0.9082266,0.0015239883,0.0012101304,0.0003684008,0.00019962745,0.00040452153,0.0000036347456,0.00028857432],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99594337,0.0022323115,0.00056615693,0.0002599866,0.00083742425,0.00016073762],"domain_scores_gemma":[0.98705053,0.010240187,0.0016463993,0.00012511325,0.0007907265,0.00014709265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004315698,0.00044020452,0.0016072256,0.002379485,0.00021903652,0.0013861338,0.0006510181,0.0009782835,0.002339933],"category_scores_gemma":[0.01788177,0.0001948306,0.0017626163,0.0030471468,0.00063329923,0.00097568135,0.00087542186,0.0016746449,0.0001830284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005258853,0.00017914185,0.024877883,0.110849984,0.0031653438,0.00033771477,0.00150903,0.0011389491,0.00026276053,0.008326569,0.009135106,0.8396916],"study_design_scores_gemma":[0.00030874225,0.0018326328,0.32424152,0.3202311,0.008972894,0.0041172956,0.0029801452,0.001377716,0.00075213576,0.016139539,0.31878376,0.000262499],"about_ca_topic_score_codex":0.002742804,"about_ca_topic_score_gemma":0.0031532042,"teacher_disagreement_score":0.004315698,"about_ca_system_score_codex":0.00201669,"about_ca_system_score_gemma":0.0015800617,"threshold_uncertainty_score":0.02282387},"labels":[],"label_agreement":null},{"id":"W2025995033","doi":"10.1586/14737167.5.1.95","title":"Quality of life of children with attention deficit hyperactivity disorder","year":2005,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Attention deficit hyperactivity disorder; Psychosocial; Quality of life (healthcare); Population; Mental health; Psychology; Clinical psychology; Psychiatry; Attention deficit; EQ-5D; Family life; Medicine; Health related quality of life; Environmental health; Disease","score_opus":0.07417197884581685,"score_gpt":0.5208451884034226,"score_spread":0.4466732095576058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025995033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007741644,0.9983083,0.000033199736,0.00018742071,0.000050333554,0.000029397517,0.00039731243,0.0000021356361,0.00021771785],"genre_scores_gemma":[0.009386168,0.989546,0.00016454153,0.00035854924,0.000064423766,0.000113189046,0.00030159316,0.0000021077499,0.00006341615],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9971961,0.0007471833,0.0010579495,0.00028117024,0.0006210551,0.00009656457],"domain_scores_gemma":[0.9906984,0.0064990073,0.0019897302,0.00009042597,0.0006327351,0.00008962358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031834547,0.00076659693,0.0035241954,0.0061439616,0.00023629956,0.0015366926,0.00096014474,0.0011366014,0.004574101],"category_scores_gemma":[0.014205235,0.00037536075,0.0030478756,0.006380359,0.00041531658,0.0010543313,0.00091728725,0.0009739761,0.00033275143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038151207,0.000035410827,0.005740804,0.68592757,0.007677252,0.00015853271,0.000255483,0.00013516318,0.00018176732,0.0003980335,0.007973538,0.29113492],"study_design_scores_gemma":[0.0003841349,0.0003731143,0.051093794,0.82760453,0.03766725,0.001644885,0.0006800498,0.00012170671,0.00033280047,0.00069652044,0.07932497,0.000076243145],"about_ca_topic_score_codex":0.0038013149,"about_ca_topic_score_gemma":0.007828142,"teacher_disagreement_score":0.0061439616,"about_ca_system_score_codex":0.0016125552,"about_ca_system_score_gemma":0.002212921,"threshold_uncertainty_score":0.016835928},"labels":[],"label_agreement":null},{"id":"W2028043880","doi":"10.1586/erp.12.57","title":"Cost–effectiveness of rituximab in follicular lymphoma","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Oncology; Lymphoma; Life expectancy; Cost effectiveness; Internal medicine; Follicular phase; Quality-adjusted life year; Refractory (planetary science); Intensive care medicine; Population; Risk analysis (engineering)","score_opus":0.13706052877003747,"score_gpt":0.5745074355120686,"score_spread":0.4374469067420311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028043880","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006523187,0.99830437,0.00015940901,0.00027749533,0.00004565673,0.000015936257,0.00004918755,0.0000019533193,0.00049366575],"genre_scores_gemma":[0.018848166,0.9801189,0.00050097104,0.0001567851,0.00009310016,0.000040395018,0.000072411676,0.0000022239815,0.00016706281],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99865144,0.00072132045,0.00018866605,0.000080592516,0.000305096,0.00005280782],"domain_scores_gemma":[0.99758613,0.0018176611,0.000385507,0.000022625944,0.00016340394,0.000024651938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023314862,0.0010036028,0.0028225256,0.0024849996,0.00012682758,0.0013232864,0.0012384452,0.0012810524,0.0036721462],"category_scores_gemma":[0.0063012736,0.00035796675,0.0028873272,0.0029864984,0.00025280277,0.0009749811,0.00043776716,0.0008607645,0.00029115845],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082510395,0.0001055722,0.0010550186,0.11888731,0.0062517296,0.00021418628,0.000039845745,0.006191663,0.00033020892,0.0054077953,0.008185695,0.85250586],"study_design_scores_gemma":[0.003193077,0.0027144465,0.038223937,0.330079,0.07024878,0.00928814,0.00060160377,0.017007254,0.004930213,0.037722886,0.48569313,0.00029752162],"about_ca_topic_score_codex":0.0040361565,"about_ca_topic_score_gemma":0.00425113,"teacher_disagreement_score":0.0040361565,"about_ca_system_score_codex":0.0030134118,"about_ca_system_score_gemma":0.0018431776,"threshold_uncertainty_score":0.021863997},"labels":[],"label_agreement":null},{"id":"W2029653428","doi":"10.1586/14737167.7.4.403","title":"Economic evaluations of anticoagulants for the prophylaxis of venous thromboembolism following major trauma","year":2007,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Venous thromboembolism; Medicine; Intensive care medicine; Major bleeding; Surgery; Thrombosis; Internal medicine","score_opus":0.062173957247856876,"score_gpt":0.538545075325487,"score_spread":0.4763711180776301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029653428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.270373,0.69562876,0.0074314587,0.005504776,0.00065357203,0.0033852223,0.0033306198,0.000038782862,0.01365384],"genre_scores_gemma":[0.91241187,0.08235534,0.0028096582,0.0005017774,0.00013697601,0.0008264154,0.0005921507,0.000007803849,0.00035803107],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.96501076,0.029858751,0.0020916774,0.00036014494,0.002322291,0.0003564361],"domain_scores_gemma":[0.93537766,0.05728579,0.0043656225,0.000416192,0.002179293,0.000375451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023104936,0.0009701831,0.0026574528,0.0028112517,0.00026187804,0.001717298,0.00062900456,0.001307241,0.0019796272],"category_scores_gemma":[0.09018759,0.00043508067,0.004825896,0.0022927087,0.00045835375,0.0010114999,0.00054052344,0.0010372042,0.00009455003],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0743834,0.0017110923,0.044295974,0.20383611,0.14832552,0.0010980061,0.0004747084,0.1895658,0.0012761292,0.02348448,0.0052311607,0.3063176],"study_design_scores_gemma":[0.04455242,0.047320087,0.10468277,0.113751985,0.3680808,0.0031050623,0.001980787,0.21075885,0.0065312632,0.052409064,0.046322912,0.00050395326],"about_ca_topic_score_codex":0.0037638794,"about_ca_topic_score_gemma":0.0043676603,"teacher_disagreement_score":0.023104936,"about_ca_system_score_codex":0.0057502873,"about_ca_system_score_gemma":0.0039944877,"threshold_uncertainty_score":0.122192025},"labels":[],"label_agreement":null},{"id":"W2029853213","doi":"10.1586/erp.09.7","title":"Optimizing the use of patient data to improve outcomes for patients: narcotics for chronic noncancer pain","year":2009,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre","funders":"","keywords":"Interpretability; Medicine; Chronic pain; MEDLINE; Randomized controlled trial; Construct (python library); Intensive care medicine; Physical therapy; Machine learning; Internal medicine; Computer science","score_opus":0.15770703632192212,"score_gpt":0.5547374014007826,"score_spread":0.3970303650788605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029853213","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014666564,0.62096465,0.25318727,0.053362746,0.0057428787,0.017747905,0.018877735,0.0009068478,0.014543436],"genre_scores_gemma":[0.21670622,0.29190654,0.4206808,0.026397107,0.0030672203,0.032538403,0.00705125,0.00032190714,0.0013305265],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.38331273,0.5334773,0.05319822,0.0070341877,0.022201356,0.0007762055],"domain_scores_gemma":[0.23977926,0.6704527,0.047259454,0.028446041,0.013367894,0.0006946574],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.4215007,0.0031841872,0.015321117,0.008929017,0.00080927456,0.00872936,0.0048134904,0.006889492,0.0077508003],"category_scores_gemma":[0.6284648,0.0020899335,0.01683166,0.014937463,0.0031316157,0.009347678,0.0040621953,0.0071757333,0.0015624736],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058679315,0.0007031921,0.010138698,0.19183834,0.05336,0.0001227,0.0008894892,0.0055703386,0.00096944073,0.029190337,0.016903833,0.68444574],"study_design_scores_gemma":[0.033647537,0.010445657,0.04512744,0.29326287,0.15101151,0.000995975,0.0013391742,0.015118388,0.009166207,0.2059219,0.23279455,0.001168936],"about_ca_topic_score_codex":0.001889866,"about_ca_topic_score_gemma":0.0022039046,"teacher_disagreement_score":0.4215007,"about_ca_system_score_codex":0.0031559498,"about_ca_system_score_gemma":0.008021842,"threshold_uncertainty_score":0.7133926},"labels":[],"label_agreement":null},{"id":"W2031265340","doi":"10.1586/erp.11.77","title":"Radiotherapy-induced nausea and vomiting","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Nausea and vomiting management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Nausea; Vomiting; Radiation therapy; Medicine; Intensive care medicine; Quality of life (healthcare); Surgery; Nursing","score_opus":0.16474860508659253,"score_gpt":0.5891252085508254,"score_spread":0.4243766034642329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031265340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053229084,0.99698347,0.00016667072,0.0003166787,0.00012398275,0.000033771037,0.0000724259,0.000010698175,0.0017599176],"genre_scores_gemma":[0.0046733655,0.9936388,0.00033849775,0.00049156253,0.000103763654,0.00003502877,0.0000837903,0.0000020038865,0.000633155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992235,0.00023625993,0.00014845961,0.00007516503,0.00027359725,0.000043119333],"domain_scores_gemma":[0.9993181,0.00033869513,0.00020805975,0.000014197991,0.000102445905,0.00001840369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007762326,0.0006199619,0.0021683439,0.0010825637,0.00021742085,0.00081342587,0.00066701754,0.0009362662,0.004068723],"category_scores_gemma":[0.0019988918,0.0002119595,0.0011245073,0.001412906,0.00032124753,0.0005869259,0.00055897655,0.0010096605,0.0008869971],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020200895,0.000070290625,0.0006423426,0.062546626,0.00073795917,0.0003012124,0.00006383807,0.0001970387,0.0010819816,0.0012591231,0.017970597,0.9149268],"study_design_scores_gemma":[0.00048729358,0.00090438913,0.019116621,0.069307275,0.0026614524,0.013948565,0.00035668723,0.00027561246,0.0027604112,0.0031359873,0.88696826,0.00007742414],"about_ca_topic_score_codex":0.0024297014,"about_ca_topic_score_gemma":0.00457659,"teacher_disagreement_score":0.004068723,"about_ca_system_score_codex":0.0006502988,"about_ca_system_score_gemma":0.0012792923,"threshold_uncertainty_score":0.013611257},"labels":[],"label_agreement":null},{"id":"W2031939437","doi":"10.1586/14737167.4.2.179","title":"Evaluating the true cost of hypertension management: evidence from actual practice","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GLS Industries (Canada)","funders":"","keywords":"Observational study; Medicine; Intensive care medicine; Cost effectiveness; Pharmacotherapy; Argument (complex analysis); Internal medicine; Risk analysis (engineering)","score_opus":0.3416650622691229,"score_gpt":0.586591635498591,"score_spread":0.24492657322946804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031939437","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08699948,0.8162163,0.008928934,0.05474844,0.0013999239,0.00083166594,0.004922308,0.000039670354,0.025913324],"genre_scores_gemma":[0.5711346,0.41092905,0.0061036306,0.008178659,0.0013083969,0.00046083494,0.0013047885,0.00003537375,0.0005447598],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.92486286,0.054175317,0.006590105,0.002518634,0.011162934,0.00069018477],"domain_scores_gemma":[0.34732857,0.59699345,0.03452495,0.008023041,0.012207866,0.0009221813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06308051,0.0010985872,0.0034039677,0.0036432461,0.00048940955,0.0042226296,0.0026861262,0.0029280207,0.008959887],"category_scores_gemma":[0.37861568,0.0010184404,0.0033930666,0.006393017,0.0030272147,0.0039462014,0.0024904665,0.0031078483,0.0007694979],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011514837,0.0007643454,0.12769619,0.09778508,0.03292987,0.00032843094,0.0009403277,0.013988059,0.00018091069,0.04875063,0.016670533,0.64845073],"study_design_scores_gemma":[0.010430499,0.0065435064,0.2710246,0.32388774,0.06578933,0.00157349,0.0027866862,0.025839921,0.0021907887,0.14525127,0.14422922,0.00045298212],"about_ca_topic_score_codex":0.015446844,"about_ca_topic_score_gemma":0.009298831,"teacher_disagreement_score":0.06308051,"about_ca_system_score_codex":0.0071738926,"about_ca_system_score_gemma":0.008041038,"threshold_uncertainty_score":0.3336056},"labels":[],"label_agreement":null},{"id":"W2034059477","doi":"10.1586/14737167.4.5.537","title":"Cost-effectiveness lessons from disease-modifying drugs in the treatment of multiple sclerosis","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Multiple sclerosis; Medicine; Disease; Economic evaluation; Intensive care medicine; Public economics; Cost effectiveness; Risk analysis (engineering); Actuarial science; Business; Economics; Psychiatry; Pathology","score_opus":0.2600594200026353,"score_gpt":0.5632930046194284,"score_spread":0.3032335846167931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034059477","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064467415,0.509337,0.04372276,0.4133848,0.004131409,0.000101235506,0.0003183374,0.00006880099,0.02248894],"genre_scores_gemma":[0.34418687,0.54232526,0.03676942,0.05628148,0.015973477,0.0004486039,0.0002101117,0.00015784828,0.0036469258],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9841007,0.011300612,0.0007793363,0.00051770196,0.0029227384,0.00037892978],"domain_scores_gemma":[0.9063332,0.08761191,0.0012253246,0.00082246744,0.00339629,0.0006106987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028736616,0.0020518163,0.0030097682,0.0030899253,0.0008876223,0.004016795,0.0022282435,0.0061997403,0.0060882145],"category_scores_gemma":[0.09798294,0.0005978474,0.002179492,0.0022955835,0.0052436795,0.010264444,0.0026142558,0.010110521,0.00059613306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016167014,0.00032422013,0.00276851,0.0060374714,0.0012904841,0.00072990445,0.0004480021,0.03214205,0.00033594374,0.43136603,0.04151016,0.4814305],"study_design_scores_gemma":[0.00038358828,0.00030608408,0.0017174027,0.0045041074,0.0005266649,0.00032088166,0.0004648322,0.0063173273,0.00030499228,0.936425,0.048649944,0.000079258985],"about_ca_topic_score_codex":0.0066046286,"about_ca_topic_score_gemma":0.005974202,"teacher_disagreement_score":0.028736616,"about_ca_system_score_codex":0.005300899,"about_ca_system_score_gemma":0.0037737926,"threshold_uncertainty_score":0.15197557},"labels":[],"label_agreement":null},{"id":"W2036184384","doi":"10.1586/14737167.6.3.337","title":"Statistical analysis of cost–effectiveness data from randomized clinical trials","year":2006,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Randomized controlled trial; Clinical trial; Medicine; Quality-adjusted life year; Cost effectiveness; Intensive care medicine; Computer science; Actuarial science; Risk analysis (engineering); Economics; Internal medicine","score_opus":0.7149237058138445,"score_gpt":0.7380444397128959,"score_spread":0.02312073389905145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036184384","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019413918,0.07095448,0.8603494,0.004747445,0.0034371873,0.014263304,0.020511096,0.0021158648,0.0042073033],"genre_scores_gemma":[0.2959254,0.03300673,0.55796784,0.004187371,0.0022782437,0.07660178,0.026880788,0.0010871426,0.0020646197],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.43365815,0.47936457,0.042415157,0.0116639985,0.03165949,0.0012386085],"domain_scores_gemma":[0.19067965,0.75120944,0.02644541,0.022901854,0.0082474,0.0005162479],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.29269058,0.002435787,0.009354282,0.01339096,0.0006455062,0.0038222824,0.004064571,0.0025985565,0.008822276],"category_scores_gemma":[0.67130977,0.001208228,0.010459468,0.015593659,0.0029073844,0.0028689534,0.002825051,0.0073717693,0.0014718826],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013476193,0.00049057475,0.033255376,0.07352257,0.086709514,0.0010750272,0.00075351814,0.0943801,0.0010758903,0.0578383,0.055868655,0.5815543],"study_design_scores_gemma":[0.0079128975,0.0073899874,0.057219114,0.024501672,0.03653352,0.0022940242,0.00082860043,0.28312528,0.0051375106,0.4287499,0.14555922,0.0007483947],"about_ca_topic_score_codex":0.0011265192,"about_ca_topic_score_gemma":0.0006864239,"teacher_disagreement_score":0.7073094,"about_ca_system_score_codex":0.0026938964,"about_ca_system_score_gemma":0.003788669,"threshold_uncertainty_score":0.87223846},"labels":[],"label_agreement":null},{"id":"W2038136090","doi":"10.1586/14737167.4.1.71","title":"Self-management interventions to improve outcomes in patients suffering from COPD","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Pulmonary disease; Exacerbation; COPD; Self-management; Quality of life (healthcare); Disease management; Psychological intervention; Intensive care medicine; Emergency department; Health care; Disease; Chronic disease; Physical therapy; Nursing; Internal medicine","score_opus":0.031314055381687717,"score_gpt":0.4755504933186976,"score_spread":0.44423643793700984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038136090","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74504703,0.1617279,0.0046818648,0.032393776,0.0027189872,0.0019611614,0.0005068493,0.00038829038,0.05057409],"genre_scores_gemma":[0.89685553,0.075230554,0.011773673,0.0076271608,0.0021637438,0.0013624409,0.00048546257,0.000022839351,0.0044785715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995289,0.00024647318,0.00004116228,0.00003269747,0.00011138899,0.000039428603],"domain_scores_gemma":[0.9992324,0.00035028395,0.0001934247,0.000029784871,0.00006204214,0.0001320206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011085512,0.00022547483,0.00048177165,0.00048747385,0.00025249322,0.00032700706,0.0003018021,0.00060091744,0.004022111],"category_scores_gemma":[0.003262333,0.00005223857,0.00055248523,0.0002991328,0.00017037964,0.00027030747,0.00033347774,0.000740198,0.00040736762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008732892,0.010677578,0.016937496,0.003333877,0.00045340337,0.00021687061,0.0004401742,0.00029511764,0.0016383444,0.0008016046,0.010302892,0.95402944],"study_design_scores_gemma":[0.010733347,0.057125043,0.77796215,0.011259344,0.002837549,0.0021381322,0.00204837,0.0025842895,0.0057639484,0.010881769,0.11656868,0.00009739068],"about_ca_topic_score_codex":0.00039234894,"about_ca_topic_score_gemma":0.0010959922,"teacher_disagreement_score":0.004022111,"about_ca_system_score_codex":0.00019110339,"about_ca_system_score_gemma":0.00053245586,"threshold_uncertainty_score":0.013455331},"labels":[],"label_agreement":null},{"id":"W2041711455","doi":"10.1586/erp.11.66","title":"The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Neurocognitive; Cancer; Brain metastasis; Clinical trial; Disease; Performance status; Lung cancer; Brain tumor; Intensive care medicine; Internal medicine; Oncology; Physical therapy; Metastasis; Cognition; Pathology; Psychiatry","score_opus":0.18769281300790022,"score_gpt":0.6054999516974523,"score_spread":0.4178071386895521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041711455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033627282,0.99881244,0.00008573027,0.00029224512,0.00005960376,0.000053557123,0.00015833836,0.0000040826126,0.00019771128],"genre_scores_gemma":[0.0039991583,0.9947994,0.0003544788,0.00032538144,0.00009498335,0.00013141922,0.00022662728,0.0000028040592,0.00006580121],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967386,0.00083179533,0.0012649479,0.00029533033,0.00074213045,0.00012711427],"domain_scores_gemma":[0.98567355,0.009939238,0.0025636528,0.0001358066,0.001553895,0.00013397321],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0051105083,0.0011919048,0.0038883293,0.013939302,0.00059528055,0.0017653502,0.0019965065,0.0015703405,0.0039285608],"category_scores_gemma":[0.015263364,0.0005377403,0.0038471643,0.018720273,0.0007066049,0.002658278,0.001018828,0.0009772638,0.00049200974],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001931926,0.00007431742,0.002777634,0.5645071,0.0016391816,0.00034452477,0.0002795836,0.0003363273,0.00023809567,0.0005546779,0.01382189,0.41523337],"study_design_scores_gemma":[0.00017656514,0.000351338,0.018948162,0.8262636,0.013324691,0.0027420758,0.0007898598,0.0003341029,0.0003517443,0.001137057,0.13549702,0.00008369269],"about_ca_topic_score_codex":0.0050546597,"about_ca_topic_score_gemma":0.007859067,"teacher_disagreement_score":0.9948895,"about_ca_system_score_codex":0.002809838,"about_ca_system_score_gemma":0.006093757,"threshold_uncertainty_score":0.02702725},"labels":[],"label_agreement":null},{"id":"W2044413755","doi":"10.1586/erp.10.90","title":"Health technology assessment: a European collaboration","year":2011,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer UK; York University; Univerzita Karlova v Praze","keywords":"Pharmacoeconomics; Relevance (law); Theme (computing); Health technology; Political science; Medicine; Medical education; Public relations; Engineering ethics; Health care; Engineering; Computer science","score_opus":0.41807078900201194,"score_gpt":0.650000208972152,"score_spread":0.2319294199701401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044413755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005763232,0.4228812,0.042301264,0.37797633,0.015461411,0.0014897686,0.0035702211,0.000676957,0.12987962],"genre_scores_gemma":[0.20452067,0.35322538,0.18104981,0.14786604,0.019217711,0.0057059354,0.015395942,0.0016523027,0.071366325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.84676313,0.089051455,0.018257387,0.008862422,0.03043885,0.0066267117],"domain_scores_gemma":[0.6894057,0.10709511,0.01868602,0.023733437,0.104953356,0.05612648],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22723827,0.0019959651,0.002732813,0.0112961875,0.0019419795,0.013210335,0.004049429,0.013357034,0.026253792],"category_scores_gemma":[0.16838197,0.0010958654,0.0023356634,0.01782807,0.004091867,0.0073576854,0.016578594,0.011122097,0.007867832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008517967,0.0008647441,0.0024191686,0.0052945074,0.0005860223,0.0004434758,0.0015533185,0.0015186867,0.001141059,0.10800049,0.2897397,0.5875871],"study_design_scores_gemma":[0.00030264162,0.00015650834,0.0033331942,0.0075226775,0.00011057081,0.00047335878,0.0004825352,0.00041303466,0.00056113035,0.02861095,0.9579901,0.00004327497],"about_ca_topic_score_codex":0.0028904125,"about_ca_topic_score_gemma":0.0011475021,"teacher_disagreement_score":0.7727617,"about_ca_system_score_codex":0.010451909,"about_ca_system_score_gemma":0.0728414,"threshold_uncertainty_score":0.9529528},"labels":[],"label_agreement":null},{"id":"W2047672685","doi":"10.1586/14737167.8.3.223","title":"Gefitinib: a consideration of cost","year":2008,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Gefitinib; Lung cancer; Medicine; Health care; Quality of life (healthcare); Oncology; Cost effectiveness; Cancer; Intensive care medicine; Internal medicine; Epidermal growth factor receptor; Economic growth; Risk analysis (engineering); Economics; Nursing","score_opus":0.09299769910041608,"score_gpt":0.5864324815195039,"score_spread":0.4934347824190878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047672685","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04612362,0.23412505,0.03667892,0.3609182,0.007634675,0.00042790084,0.002729026,0.00030948225,0.31105313],"genre_scores_gemma":[0.81679136,0.09544366,0.020299332,0.025833381,0.008016335,0.0003766998,0.0009681845,0.00021026735,0.03206086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606764,0.0015273428,0.00022653565,0.00023045178,0.0016778354,0.0002701804],"domain_scores_gemma":[0.9948862,0.0029533142,0.00038971053,0.0001305637,0.0012713086,0.0003688905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003709799,0.00074679754,0.0010154983,0.0017946563,0.00059720414,0.0047784047,0.0008413362,0.0022825904,0.008645711],"category_scores_gemma":[0.0155869685,0.00020105745,0.0011643192,0.0014879629,0.0006685137,0.002648578,0.0007368785,0.0022347218,0.0007434573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008647856,0.00014165533,0.006930746,0.0016673614,0.0008954002,0.0008751405,0.00019717315,0.0211167,0.0010823886,0.18335141,0.14290522,0.63997203],"study_design_scores_gemma":[0.00022807223,0.00096313364,0.030221375,0.004323137,0.0012162547,0.006052472,0.0011298839,0.019681593,0.0018963227,0.10784945,0.82626253,0.0001757042],"about_ca_topic_score_codex":0.006873484,"about_ca_topic_score_gemma":0.008359718,"teacher_disagreement_score":0.008645711,"about_ca_system_score_codex":0.0045965416,"about_ca_system_score_gemma":0.00383394,"threshold_uncertainty_score":0.033350408},"labels":[],"label_agreement":null},{"id":"W2050829965","doi":"10.1586/14737167.8.3.243","title":"NCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an illustrative study in a palliative setting","year":2008,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Queen's University","funders":"","keywords":"Medicine; Clinical trial; Palliative care; Oncology; Intensive care medicine; Internal medicine; Nursing","score_opus":0.48332090514655035,"score_gpt":0.6855886621517131,"score_spread":0.20226775700516275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050829965","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054635387,0.31379896,0.104077324,0.40303212,0.008368973,0.03216787,0.0030453545,0.00074599456,0.08012807],"genre_scores_gemma":[0.333921,0.08945622,0.31131527,0.21642539,0.009075884,0.03292468,0.0018599534,0.00075551827,0.004266153],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.30000713,0.62225544,0.031365126,0.0049790516,0.039063986,0.0023293311],"domain_scores_gemma":[0.091927856,0.7553131,0.028125694,0.034587033,0.08149068,0.008555598],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6471008,0.0015082195,0.00393853,0.00571294,0.005028874,0.017630162,0.005137264,0.014276705,0.0015536575],"category_scores_gemma":[0.67969346,0.0012344721,0.0027566825,0.017147103,0.016924629,0.0072754337,0.008408766,0.011613377,0.0006981675],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009459478,0.0017724644,0.043718316,0.03382819,0.0037632806,0.0052757785,0.038576238,0.008164805,0.0040828115,0.16961633,0.14753088,0.53421146],"study_design_scores_gemma":[0.011659715,0.017769707,0.052353833,0.042905368,0.002759286,0.0074739545,0.011924669,0.006416835,0.0049612774,0.049759883,0.7903871,0.0016283668],"about_ca_topic_score_codex":0.035049193,"about_ca_topic_score_gemma":0.061735734,"teacher_disagreement_score":0.3528992,"about_ca_system_score_codex":0.02130977,"about_ca_system_score_gemma":0.047005422,"threshold_uncertainty_score":0.43518758},"labels":[],"label_agreement":null},{"id":"W2051159858","doi":"10.1586/14737167.2.3.251","title":"Pharmacoeconomics in oncology","year":2002,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacoeconomics; Liberian dollar; Medicine; Health care; Population; Health economics; Economic evaluation; Family medicine; Oncology; Business; Intensive care medicine; Economic growth; Economics; Environmental health; Finance","score_opus":0.46152654362162,"score_gpt":0.6572164504131144,"score_spread":0.1956899067914944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051159858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036232253,0.47230744,0.009413,0.42693445,0.0035976598,0.00015011041,0.0005382237,0.000072349256,0.08336356],"genre_scores_gemma":[0.20350593,0.64607656,0.00875554,0.108002685,0.01583682,0.00041557362,0.0004902322,0.00007896132,0.016837614],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.98815095,0.0077290814,0.00055680604,0.00044173497,0.0028085762,0.00031277476],"domain_scores_gemma":[0.95597076,0.034274194,0.003636038,0.0009430661,0.004039162,0.0011368613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01327663,0.00044709613,0.001028519,0.0029681216,0.0007200331,0.00389118,0.0006468213,0.00485612,0.0090090595],"category_scores_gemma":[0.05547115,0.00025300097,0.0005247056,0.00740756,0.0037346182,0.0032665844,0.0014462776,0.004687074,0.00085698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007066418,0.000095210096,0.007472982,0.0015666811,0.00021885784,0.00030555687,0.0002545436,0.005804113,0.000090742134,0.40264282,0.26817644,0.31330135],"study_design_scores_gemma":[0.000085258594,0.00013138195,0.02127274,0.005598476,0.000091593414,0.0008704997,0.0006218548,0.004934476,0.00015938748,0.4651336,0.5010217,0.00007898851],"about_ca_topic_score_codex":0.009268092,"about_ca_topic_score_gemma":0.008938567,"teacher_disagreement_score":0.01327663,"about_ca_system_score_codex":0.0059434357,"about_ca_system_score_gemma":0.006604247,"threshold_uncertainty_score":0.07021439},"labels":[],"label_agreement":null},{"id":"W2051431260","doi":"10.1586/erp.11.45","title":"The German method for setting ceiling prices for drugs: in some cases less data are required","year":2011,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ceiling (cloud); Health care; Downstream (manufacturing); Quality (philosophy); German; Actuarial science; Risk analysis (engineering); Measure (data warehouse); Ceiling effect; Operations management; Medicine; Business; Economics; Computer science; Engineering; Alternative medicine; Data mining","score_opus":0.6466784590986426,"score_gpt":0.6770773854284348,"score_spread":0.03039892632979213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051431260","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016426682,0.0064739105,0.8370086,0.016555257,0.0027862166,0.004518255,0.00841436,0.0011103317,0.10670632],"genre_scores_gemma":[0.23656026,0.0041060406,0.7148536,0.008204399,0.0007358897,0.008393779,0.003984295,0.00052392273,0.022637835],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9654796,0.021156576,0.0027843781,0.0026239594,0.00713652,0.00081894646],"domain_scores_gemma":[0.9765647,0.012023445,0.0027309686,0.004459315,0.003954242,0.00026727814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031274118,0.0013433599,0.0016245964,0.0041349735,0.00097516645,0.0045122355,0.0018185412,0.0022791352,0.015579332],"category_scores_gemma":[0.07011791,0.0007466673,0.0016432139,0.0055554383,0.0017999755,0.0031743976,0.002793262,0.0038140137,0.003659608],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009944688,0.00014838377,0.009024259,0.0017264566,0.00069723296,0.0004623228,0.0009511893,0.0075391126,0.0016441662,0.35533518,0.1299987,0.49147856],"study_design_scores_gemma":[0.0011355354,0.00067020877,0.026902864,0.0019314911,0.0007471003,0.0014399923,0.00074155006,0.026057554,0.008248313,0.30929023,0.6223471,0.00048804365],"about_ca_topic_score_codex":0.00728447,"about_ca_topic_score_gemma":0.0070770523,"teacher_disagreement_score":0.031274118,"about_ca_system_score_codex":0.0033746215,"about_ca_system_score_gemma":0.005678038,"threshold_uncertainty_score":0.16539538},"labels":[],"label_agreement":null},{"id":"W2051874598","doi":"10.1586/14737167.2013.815420","title":"Values and evidence colliding: health technology assessment in child health","year":2013,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Health technology; Child health; Medicine; Psychology; Environmental health; Public economics; Health care; Economics; Family medicine; Economic growth","score_opus":0.11105481139131611,"score_gpt":0.6424723822282017,"score_spread":0.5314175708368856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051874598","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003882014,0.08950661,0.0011281603,0.10634294,0.80046254,0.00015097791,0.00021661221,0.00008526234,0.0020680877],"genre_scores_gemma":[0.0011134687,0.070550166,0.002799177,0.0647678,0.8562759,0.00027719585,0.0001338237,0.00011923466,0.0039633135],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.87143105,0.053563032,0.028290736,0.0042169276,0.040548984,0.0019492079],"domain_scores_gemma":[0.5110534,0.33394086,0.024406282,0.008489913,0.11435172,0.007757878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12168951,0.0044352114,0.010557679,0.015873792,0.004677767,0.016828654,0.007096751,0.024663633,0.012913973],"category_scores_gemma":[0.35396913,0.0036328179,0.0067260824,0.010729649,0.008118616,0.010729037,0.0045328643,0.033292253,0.0065895314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058965554,0.00001833046,0.000066510736,0.0066664866,0.0003246126,0.00006359957,0.000097915705,0.00006177993,0.000031748343,0.0012856296,0.9588607,0.032463733],"study_design_scores_gemma":[0.00031513543,0.000046261535,0.0005887839,0.03482639,0.0011941805,0.00024538254,0.00017155476,0.00027817473,0.00017279957,0.008410495,0.9536496,0.00010126443],"about_ca_topic_score_codex":0.0063673253,"about_ca_topic_score_gemma":0.01751142,"teacher_disagreement_score":0.12168951,"about_ca_system_score_codex":0.011681465,"about_ca_system_score_gemma":0.024581078,"threshold_uncertainty_score":0.6435634},"labels":[],"label_agreement":null},{"id":"W2054276704","doi":"10.1586/14737167.8.4.349","title":"Economic burden of cardiovascular diseases in China","year":2008,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"New York Institute of Technology","funders":"","keywords":"China; Medical insurance; Environmental health; Investment (military); Economic cost; Indirect costs; Medicine; Rural area; Medical costs; Population; Disease; Economic growth; Demography; Business; Socioeconomics; Health care; Geography; Economics; Actuarial science; Political science","score_opus":0.058280250156054945,"score_gpt":0.4526314600399395,"score_spread":0.39435120988388456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054276704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97377485,0.007923772,0.00041154292,0.004484456,0.00007989285,0.000051250496,0.0020798887,0.000014063327,0.011180257],"genre_scores_gemma":[0.99407685,0.00343802,0.00016925333,0.00016268183,0.000060626837,0.000014637426,0.0011021774,0.0000020019538,0.00097377953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994898,0.00013343307,0.000035941088,0.00003795368,0.00021509547,0.00008775986],"domain_scores_gemma":[0.9993555,0.0000895642,0.00021825574,0.00002806879,0.00017359808,0.00013507537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065278885,0.00020220173,0.0002466546,0.0019850913,0.00038722483,0.00078698964,0.00021741149,0.0002586135,0.0014772112],"category_scores_gemma":[0.0019889646,0.000117324525,0.00026898374,0.0022563331,0.00035551115,0.00041753938,0.00070539076,0.00031891005,0.00008213733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010093364,0.000055311815,0.9251105,0.00015840672,0.00030850392,0.0009557202,0.00038843715,0.005659046,0.00026293364,0.007618885,0.0076737576,0.051707588],"study_design_scores_gemma":[0.000014926145,0.000021826045,0.98958534,0.00003744582,0.00004370164,0.00019051155,0.00021254519,0.0041171713,0.00003665074,0.0011643299,0.0045648487,0.000010646056],"about_ca_topic_score_codex":0.07968791,"about_ca_topic_score_gemma":0.08801178,"teacher_disagreement_score":0.07968791,"about_ca_system_score_codex":0.0034623602,"about_ca_system_score_gemma":0.0025223622,"threshold_uncertainty_score":0.1584481},"labels":[],"label_agreement":null},{"id":"W2056297313","doi":"10.1586/erp.12.15","title":"Personalized medicine policy challenges: measuring clinical utility at point of care","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Personalized medicine; Pharmacogenomics; Precision medicine; Relevance (law); Point of care; Tipping point (physics); Medicine; Scale (ratio); MEDLINE; Data science; Computer science; Bioinformatics; Nursing; Pharmacology","score_opus":0.5349782942177395,"score_gpt":0.68611998141965,"score_spread":0.15114168720191057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056297313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006056227,0.66903335,0.06581813,0.22395937,0.0027958907,0.0008088747,0.0017088436,0.00015703333,0.029662272],"genre_scores_gemma":[0.25804323,0.56033754,0.11665755,0.050064553,0.0077240556,0.0032600267,0.0015248919,0.00013394895,0.002254232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.83229715,0.13540553,0.007958757,0.005151081,0.018296968,0.0008905164],"domain_scores_gemma":[0.6181079,0.33514974,0.015812078,0.008900858,0.020554913,0.0014744363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1239487,0.0017702121,0.006026623,0.005748603,0.0009721942,0.009833751,0.005999408,0.0070537026,0.0057890415],"category_scores_gemma":[0.25009245,0.00092939386,0.0021515777,0.008435765,0.006551032,0.011786104,0.0038673237,0.0072611994,0.0015661408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022659049,0.00021068714,0.008446432,0.013707995,0.0019129489,0.00015096008,0.0007964485,0.006068753,0.00019058792,0.12014775,0.036304675,0.81183624],"study_design_scores_gemma":[0.00031069532,0.00051943277,0.019336917,0.044645958,0.0022391195,0.0010427993,0.002975795,0.01135523,0.0011883972,0.66288286,0.25316733,0.00033546568],"about_ca_topic_score_codex":0.0050466857,"about_ca_topic_score_gemma":0.0033878009,"teacher_disagreement_score":0.1239487,"about_ca_system_score_codex":0.007821523,"about_ca_system_score_gemma":0.014191826,"threshold_uncertainty_score":0.65551126},"labels":[],"label_agreement":null},{"id":"W2058801790","doi":"10.1586/14737167.3.3.303","title":"Fixed and flexible formularies as cost-control mechanisms","year":2003,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Centre for Addiction and Mental Health","funders":"Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Health and Long-Term Care","keywords":"Formulary; Control (management); Cost control; Fixed cost; Operations management; Computer science; Medicine; Intensive care medicine; Operations research; Risk analysis (engineering); Business; Economics; Pharmacology; Mathematics; Accounting","score_opus":0.08692920275430051,"score_gpt":0.49891468068463857,"score_spread":0.4119854779303381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058801790","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008321092,0.96021044,0.011676016,0.0014242217,0.00045260484,0.00019047607,0.0000651939,0.000045950546,0.017613936],"genre_scores_gemma":[0.13232456,0.8431028,0.015773017,0.0012447345,0.0005345565,0.00036109396,0.0001058952,0.000025005009,0.0065282276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972115,0.000883803,0.00026262947,0.00027883804,0.0011559925,0.00020731289],"domain_scores_gemma":[0.9957801,0.0028203973,0.0008031181,0.00017455095,0.00035441568,0.0000673122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003094338,0.00064649805,0.0012570207,0.0013776853,0.00032959357,0.0024866704,0.0021318945,0.0014579181,0.003968706],"category_scores_gemma":[0.0072202976,0.00031917408,0.0011323905,0.0017998496,0.0016813242,0.0031034653,0.0008800988,0.001455178,0.00041087638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033548003,0.00014754542,0.00090933655,0.02964007,0.00041315032,0.00036680774,0.000279491,0.0067032184,0.002436977,0.31783015,0.007105737,0.6338321],"study_design_scores_gemma":[0.00031951276,0.0018104841,0.0049120844,0.019073639,0.0014784733,0.0016343404,0.0002913514,0.0070234016,0.009389879,0.11411273,0.83981675,0.00013737041],"about_ca_topic_score_codex":0.0012310394,"about_ca_topic_score_gemma":0.0010368234,"teacher_disagreement_score":0.003968706,"about_ca_system_score_codex":0.0013603696,"about_ca_system_score_gemma":0.0019876598,"threshold_uncertainty_score":0.016364634},"labels":[],"label_agreement":null},{"id":"W2059801681","doi":"10.1586/14737167.2015.1031113","title":"The economics of adalimumab for ulcerative colitis","year":2015,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Ulcerative colitis; Adalimumab; Medicine; Context (archaeology); Reimbursement; Infliximab; Refractory (planetary science); Intensive care medicine; Internal medicine; Inflammatory bowel disease; Disease; Economics; Health care","score_opus":0.04379355720676381,"score_gpt":0.485747436169095,"score_spread":0.4419538789623312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059801681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029403843,0.72670877,0.005518657,0.18110704,0.002224514,0.00028174435,0.0013964393,0.000060604754,0.05329844],"genre_scores_gemma":[0.55945915,0.4058334,0.005000192,0.017646126,0.004505382,0.00041902764,0.0006613193,0.000052124797,0.00642328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933842,0.0047806236,0.00027580504,0.00014025134,0.0012401921,0.00017896487],"domain_scores_gemma":[0.98428863,0.012503142,0.0014133537,0.00017745025,0.0010346156,0.00058281666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008025022,0.0005048691,0.0012267809,0.0014831659,0.00033935095,0.0034880321,0.00060905935,0.002148757,0.0072958297],"category_scores_gemma":[0.036076676,0.00027230152,0.0011801921,0.0014786511,0.0007153139,0.002293661,0.0009263147,0.002553804,0.00055653346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068384195,0.00040920492,0.006875048,0.007028956,0.0023838263,0.00068032934,0.00019578167,0.020190049,0.0006217201,0.1539285,0.07809873,0.72274935],"study_design_scores_gemma":[0.0067037563,0.0037652752,0.055548444,0.046247315,0.004375627,0.0039054586,0.0013797889,0.02804405,0.0013978651,0.3515981,0.49665415,0.00038014093],"about_ca_topic_score_codex":0.003613099,"about_ca_topic_score_gemma":0.0030370583,"teacher_disagreement_score":0.008025022,"about_ca_system_score_codex":0.006163787,"about_ca_system_score_gemma":0.004019001,"threshold_uncertainty_score":0.044721663},"labels":[],"label_agreement":null},{"id":"W2061009912","doi":"10.1586/erp.10.82","title":"Role of patient and public participation in health technology assessment and coverage decisions","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Health technology; Public health; Medicine; Technology assessment; Public relations; Political science; Management science; Health care; Economics; Nursing","score_opus":0.47714512788128166,"score_gpt":0.6665923030050922,"score_spread":0.18944717512381054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061009912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02915408,0.7907833,0.0126337325,0.08964025,0.00093285274,0.00075076084,0.0006311089,0.000045549954,0.0754283],"genre_scores_gemma":[0.420864,0.5513044,0.010580631,0.011169356,0.0019436695,0.0008702946,0.0003778755,0.000029356132,0.0028604672],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.86376685,0.11934807,0.0042190235,0.0017880814,0.009096015,0.0017819692],"domain_scores_gemma":[0.8111208,0.17137219,0.009064744,0.001723716,0.005172672,0.0015458424],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0694127,0.00073855807,0.0020477157,0.0024184943,0.0008466319,0.005218509,0.0015124456,0.00370388,0.0070635243],"category_scores_gemma":[0.108685754,0.00039656667,0.001413289,0.0034934364,0.0020496314,0.003787526,0.0031145376,0.0031497467,0.0008563089],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039070286,0.00044966256,0.01154235,0.016517924,0.00095059164,0.00037874051,0.0032831398,0.0013964147,0.00026922912,0.035424214,0.009758368,0.91963863],"study_design_scores_gemma":[0.00083501876,0.0012196201,0.043225814,0.09076112,0.0034658525,0.0034546934,0.009608606,0.003165255,0.002818429,0.12686706,0.7143307,0.00024786452],"about_ca_topic_score_codex":0.0026788777,"about_ca_topic_score_gemma":0.0027609593,"teacher_disagreement_score":0.9305873,"about_ca_system_score_codex":0.0029808655,"about_ca_system_score_gemma":0.010369547,"threshold_uncertainty_score":0.36709386},"labels":[],"label_agreement":null},{"id":"W2061175486","doi":"10.1586/14737167.2014.946012","title":"Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?","year":2014,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; St. Michael's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Vaccination; Human papillomavirus; Medicine; Cervical cancer; Incidence (geometry); Cancer; Cancer prevention; HPV vaccines; Cost effectiveness; Oncology; Cancer incidence; Intervention (counseling); HPV infection; Immunology; Internal medicine; Risk analysis (engineering)","score_opus":0.16595766804956705,"score_gpt":0.6326647950084321,"score_spread":0.46670712695886507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061175486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001908957,0.9818574,0.00011958532,0.013896538,0.003013955,0.000007691292,0.00003172811,0.000003039771,0.0008790012],"genre_scores_gemma":[0.0013391676,0.99104005,0.0001531271,0.0045432434,0.0024913708,0.000010913426,0.000020316507,0.0000016573448,0.00040014568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893516,0.00041362512,0.00020669495,0.00009962198,0.00029419668,0.000050604925],"domain_scores_gemma":[0.9970874,0.002102091,0.00036598378,0.000032894248,0.00036667343,0.000044950386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002032124,0.00048566415,0.0014712617,0.0012777464,0.00022365614,0.0011849734,0.00097581476,0.002947969,0.0042239153],"category_scores_gemma":[0.007590577,0.0001682451,0.0015281418,0.001404189,0.00057268713,0.0020649296,0.00039417844,0.0022456236,0.00092367554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028499134,0.00006422854,0.00077768945,0.082272425,0.0011572079,0.00050001324,0.00015193624,0.00031290087,0.0008326988,0.012417248,0.15767571,0.743553],"study_design_scores_gemma":[0.00012490134,0.0001860052,0.002127639,0.039763797,0.0015482167,0.0025455137,0.00023841532,0.00014395139,0.0005518131,0.0064047743,0.94631624,0.000048803406],"about_ca_topic_score_codex":0.0010823378,"about_ca_topic_score_gemma":0.0023024236,"teacher_disagreement_score":0.0042239153,"about_ca_system_score_codex":0.00071111746,"about_ca_system_score_gemma":0.00189521,"threshold_uncertainty_score":0.0141304135},"labels":[],"label_agreement":null},{"id":"W2063425914","doi":"10.1586/14737167.6.3.285","title":"Study design to determine the effects of widespread restrictions on hospital utilization to control an outbreak of SARS in Toronto, Canada","year":2006,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"COVID-19 epidemiological studies","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences","keywords":"Outbreak; Medicine; Health care; Population; Context (archaeology); Population health; Emergency department; Environmental health; Emergency medicine; Medical emergency; Geography; Nursing; Economic growth","score_opus":0.1992530823244886,"score_gpt":0.5676609632297727,"score_spread":0.3684078809052841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063425914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91676223,0.009855628,0.0042587277,0.0029617709,0.00022808622,0.02623006,0.02826775,0.000081190105,0.011354494],"genre_scores_gemma":[0.96470946,0.0044997996,0.0058121323,0.0021757327,0.000121789584,0.012011871,0.006061853,0.000011261166,0.004596028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640405,0.0011548961,0.00023499528,0.000501203,0.00081341754,0.0008914955],"domain_scores_gemma":[0.99575555,0.0005079076,0.0014169222,0.00023102666,0.0014077914,0.0006807226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037727025,0.00093418214,0.000623843,0.0009024101,0.0020791513,0.00079967425,0.0016164007,0.0008015594,0.003771359],"category_scores_gemma":[0.00477028,0.00048061647,0.0012872976,0.0019377567,0.0010670227,0.0003021418,0.0011471295,0.0006479711,0.00022651837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046732933,0.0021932004,0.9035723,0.004467822,0.002142446,0.0005581985,0.0016739194,0.004946016,0.0009967539,0.0025798643,0.014583861,0.057612397],"study_design_scores_gemma":[0.0018927185,0.0029175018,0.98221064,0.00080767233,0.0008860543,0.00011467105,0.0014887789,0.001701367,0.0003998802,0.00031835638,0.0071995566,0.00006293243],"about_ca_topic_score_codex":0.9780406,"about_ca_topic_score_gemma":0.9819417,"teacher_disagreement_score":0.054246504,"about_ca_system_score_codex":0.054246504,"about_ca_system_score_gemma":0.10673026,"threshold_uncertainty_score":0.39358777},"labels":[],"label_agreement":null},{"id":"W2064060536","doi":"10.1586/erp.11.67","title":"FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Neurocognitive; Quality of life (healthcare); Population; Cancer; Disease; Intensive care medicine; Brain tumor; Attrition; Radiation therapy; Brain metastasis; Oncology; Internal medicine; Cognition; Pathology; Metastasis; Psychiatry","score_opus":0.2131854687255755,"score_gpt":0.6148115635194263,"score_spread":0.4016260947938508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064060536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036516262,0.9987411,0.00007538166,0.00028839998,0.000061694045,0.00003301136,0.00015409054,0.00000455279,0.00027658953],"genre_scores_gemma":[0.0046764505,0.9942521,0.0003956049,0.00025599956,0.00007702439,0.00008689462,0.00019716081,0.0000025050183,0.000056359127],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99760205,0.0006171114,0.00087214296,0.0002167363,0.0006148559,0.000077113546],"domain_scores_gemma":[0.9843476,0.01152186,0.002660884,0.00013689358,0.0012047504,0.00012805343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003990339,0.0010526372,0.0027440195,0.011021827,0.00047444485,0.0017083781,0.0016086119,0.001319717,0.003533891],"category_scores_gemma":[0.0150986295,0.000434229,0.0031359969,0.013284753,0.0006921026,0.0022927665,0.00078159326,0.0011064975,0.00049819244],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017204924,0.0000709557,0.003206442,0.45646986,0.001498725,0.0002853576,0.00036464148,0.00033919414,0.00019892977,0.0010379003,0.016038314,0.52031755],"study_design_scores_gemma":[0.00013329224,0.00031829628,0.026924472,0.766238,0.011366703,0.0036023557,0.00087711134,0.00035226808,0.00034863353,0.0015312462,0.18819925,0.00010840882],"about_ca_topic_score_codex":0.004227272,"about_ca_topic_score_gemma":0.006767719,"teacher_disagreement_score":0.011021827,"about_ca_system_score_codex":0.001843611,"about_ca_system_score_gemma":0.004372658,"threshold_uncertainty_score":0.021103144},"labels":[],"label_agreement":null},{"id":"W2067950090","doi":"10.1586/14737167.2013.852470","title":"Cost–effectiveness analysis of rheumatic heart disease prevention strategies","year":2013,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba","funders":"","keywords":"Medicine; Intensive care medicine; Secondary prophylaxis; Antibiotic prophylaxis; Heart disease; Cost effectiveness; Developing country; Cost-effectiveness analysis; Pediatrics; Rheumatic fever; Secondary prevention; Primary prevention; Disease; Antibiotics; Internal medicine","score_opus":0.18090666093877766,"score_gpt":0.6249043478297438,"score_spread":0.44399768689096614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067950090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022154396,0.96495736,0.004272404,0.0016129382,0.0002693431,0.0010220142,0.0014743864,0.00002782954,0.004209258],"genre_scores_gemma":[0.3368332,0.651169,0.0074290754,0.00069817726,0.00028240852,0.0015676125,0.0010188929,0.000017582792,0.0009839847],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99553716,0.0033780714,0.00033889292,0.00015144613,0.00044659912,0.000147807],"domain_scores_gemma":[0.9925081,0.0065867826,0.00051482307,0.000055698813,0.0002584152,0.000076230775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005403919,0.0014943513,0.004386335,0.0021788513,0.00013463141,0.0011996336,0.0014196418,0.0013876845,0.007968743],"category_scores_gemma":[0.015264841,0.0005776847,0.00762454,0.0018595558,0.00020373463,0.00091360643,0.00054194365,0.0013807656,0.00025333551],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010726669,0.0008405383,0.0043490287,0.2119247,0.079188645,0.00041020548,0.000101329926,0.13190755,0.00061107735,0.016870031,0.0066949264,0.5363752],"study_design_scores_gemma":[0.02205158,0.017358547,0.038382463,0.19347559,0.39343143,0.0034687414,0.00081312197,0.19216383,0.0027893737,0.044709817,0.09100297,0.00035251005],"about_ca_topic_score_codex":0.0048443195,"about_ca_topic_score_gemma":0.0060017486,"teacher_disagreement_score":0.007968743,"about_ca_system_score_codex":0.0036999474,"about_ca_system_score_gemma":0.0031451823,"threshold_uncertainty_score":0.028578997},"labels":[],"label_agreement":null},{"id":"W2069805796","doi":"10.1586/14737167.2014.859525","title":"How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide","year":2013,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"Pfizer Canada; Mitacs; Pfizer","keywords":"Multiple-criteria decision analysis; Reimbursement; Decision analysis; Health care; Management science; Transparency (behavior); Context (archaeology); Computer science; Robustness (evolution); Risk analysis (engineering); Operations research; Medicine; Engineering; Economics","score_opus":0.5484630522706956,"score_gpt":0.7177037710194527,"score_spread":0.16924071874875712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069805796","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057326455,0.052565154,0.9031702,0.024831617,0.0013245093,0.0035109257,0.000719843,0.0011705942,0.012133817],"genre_scores_gemma":[0.002546869,0.019360472,0.9730118,0.0013572462,0.00022344325,0.0015076711,0.00020841823,0.000120866076,0.0016633039],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97825855,0.012955085,0.003086228,0.0006831722,0.0048140977,0.00020279903],"domain_scores_gemma":[0.94962585,0.036485355,0.00220111,0.0017376124,0.0092238365,0.00072619657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032417085,0.0041900775,0.0042720726,0.010113518,0.0015778549,0.0063426923,0.00576373,0.0046440405,0.012214637],"category_scores_gemma":[0.0586952,0.002710706,0.0036723223,0.0066753784,0.0029952032,0.0063864263,0.0040443745,0.011887495,0.012972395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081404294,0.00046875147,0.00067756226,0.01381178,0.00046760731,0.00094112236,0.002027595,0.014844737,0.0019584508,0.10129871,0.113634236,0.7497879],"study_design_scores_gemma":[0.00018737087,0.00016170814,0.0009351825,0.016623564,0.0001876248,0.0013056188,0.0013628982,0.024528323,0.0020028444,0.3477687,0.6046213,0.00031478825],"about_ca_topic_score_codex":0.004081837,"about_ca_topic_score_gemma":0.011182191,"teacher_disagreement_score":0.032417085,"about_ca_system_score_codex":0.0030626042,"about_ca_system_score_gemma":0.008413169,"threshold_uncertainty_score":0.17144},"labels":[],"label_agreement":null},{"id":"W2075481572","doi":"10.1586/14737167.2.4.309","title":"Change and stability in the Canadian healthcare system","year":2002,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pharmacoeconomics; Healthcare system; Health care; Outcomes research; Medicine; Intensive care medicine; Alternative medicine; Economics; Economic growth","score_opus":0.2943196533743676,"score_gpt":0.5080824382279704,"score_spread":0.21376278485360278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075481572","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15000974,0.14355424,0.0058101634,0.4710371,0.0029479188,0.00024757115,0.04536996,0.00028845572,0.1807349],"genre_scores_gemma":[0.9554644,0.024397489,0.0015990252,0.0057561533,0.00037611873,0.000049707865,0.0043838667,0.000029090394,0.007944178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960918,0.0002780865,0.00016653752,0.00024301928,0.0022138092,0.0010067855],"domain_scores_gemma":[0.9928879,0.00056926254,0.0006645022,0.0001161943,0.004607886,0.0011542699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028794596,0.0002950066,0.0003700185,0.0040637525,0.0059237694,0.0052227387,0.0011511692,0.0019023493,0.005783355],"category_scores_gemma":[0.016657993,0.00029408807,0.00068007136,0.009455604,0.002737348,0.0021519123,0.0021140832,0.001487734,0.0003717705],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00017998196,0.000039755327,0.10300776,0.0004623042,0.00021110562,0.0002618882,0.0051440885,0.008599235,0.00016714106,0.18950057,0.5160211,0.17640506],"study_design_scores_gemma":[0.000071809976,0.000037550726,0.64184445,0.0007406355,0.00019497128,0.00018029455,0.004610215,0.007836173,0.00023545203,0.05991163,0.28413266,0.00020413358],"about_ca_topic_score_codex":0.9967457,"about_ca_topic_score_gemma":0.9971449,"teacher_disagreement_score":0.8552067,"about_ca_system_score_codex":0.14479326,"about_ca_system_score_gemma":0.149029,"threshold_uncertainty_score":0.9919186},"labels":[],"label_agreement":null},{"id":"W2075687887","doi":"10.1586/14737167.7.6.559","title":"Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disorders","year":2007,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Escitalopram; Citalopram; Sertraline; Tolerability; Anxiety; Psychiatry; Major depressive disorder; Venlafaxine; Fluoxetine; Psychology; Medicine; Antidepressant; Internal medicine; Adverse effect; Mood","score_opus":0.026615920686915335,"score_gpt":0.49301292632263854,"score_spread":0.4663970056357232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075687887","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30095753,0.6860649,0.0010333097,0.0029805487,0.00011140646,0.00017972026,0.0005605877,0.000013567438,0.008098549],"genre_scores_gemma":[0.8156732,0.18133248,0.0008539694,0.0005177815,0.00023769504,0.000055037824,0.00026847978,0.0000055120786,0.0010558337],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99811745,0.00096030347,0.00020887972,0.0000894483,0.0005617449,0.00006215563],"domain_scores_gemma":[0.9981337,0.0009704162,0.0005661157,0.00005043064,0.0002201802,0.00005923358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002826302,0.00022660069,0.00094634364,0.00068478356,0.00009120653,0.00048512183,0.00032967844,0.0004645364,0.0014067274],"category_scores_gemma":[0.005080423,0.00013409306,0.0007869187,0.00088291,0.00024211415,0.0003623171,0.00018140115,0.00047252214,0.00014978326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018472357,0.0014565,0.020966444,0.005820982,0.0037256964,0.00031867495,0.00011621386,0.0056207753,0.0040050847,0.0018507353,0.0019018907,0.93574464],"study_design_scores_gemma":[0.019695545,0.0737678,0.76595646,0.008297668,0.015050978,0.005705882,0.00053942687,0.01165146,0.01082077,0.005909258,0.0824142,0.00019061769],"about_ca_topic_score_codex":0.0013838632,"about_ca_topic_score_gemma":0.0023081398,"teacher_disagreement_score":0.002826302,"about_ca_system_score_codex":0.00084743125,"about_ca_system_score_gemma":0.0004836427,"threshold_uncertainty_score":0.014947116},"labels":[],"label_agreement":null},{"id":"W2077262353","doi":"10.1586/14737167.2014.894464","title":"Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review","year":2014,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Engineering ethics; Scope (computer science); Health technology; Normative; Context (archaeology); Management science; Identification (biology); Ethical issues; Computer science; Knowledge management; Political science; Health care; Engineering","score_opus":0.7531599666848515,"score_gpt":0.7561822659407604,"score_spread":0.0030222992559089112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077262353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025256386,0.7194423,0.09385432,0.028017186,0.004777523,0.13825688,0.006050764,0.0004902973,0.006585039],"genre_scores_gemma":[0.025080057,0.3310593,0.32361358,0.008580558,0.0009592109,0.3058403,0.0036205733,0.00019546183,0.0010509182],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.3884469,0.37548116,0.17521428,0.006872353,0.051820405,0.0021649199],"domain_scores_gemma":[0.29848498,0.5039904,0.08798658,0.028633358,0.077873655,0.0030309765],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4563454,0.0033174877,0.0120103145,0.03860132,0.004336679,0.011609502,0.0068832333,0.009905379,0.008308212],"category_scores_gemma":[0.6685165,0.0038369575,0.014475581,0.030983176,0.006916335,0.01253015,0.008938821,0.007899462,0.0020812359],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034035678,0.00010306422,0.0010446535,0.7544844,0.003959463,0.00021199179,0.0028371208,0.00063111377,0.00038309625,0.01225389,0.01893732,0.20481357],"study_design_scores_gemma":[0.00068182824,0.00013089528,0.0010460787,0.90761274,0.006235444,0.00021393933,0.0011018957,0.00049696275,0.00046312102,0.011471893,0.0704211,0.00012411582],"about_ca_topic_score_codex":0.005043691,"about_ca_topic_score_gemma":0.0106169395,"teacher_disagreement_score":0.54365456,"about_ca_system_score_codex":0.0151115125,"about_ca_system_score_gemma":0.09827562,"threshold_uncertainty_score":0.6704229},"labels":[],"label_agreement":null},{"id":"W2078296345","doi":"10.1586/14737167.3.3.327","title":"Non-communicating children’s pain checklist: better pain assessment for severely disabled children","year":2003,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Checklist; Observational study; Physical therapy; Pain assessment; Medicine; Cognition; Pain catastrophizing; Psychology; Pain management; Physical medicine and rehabilitation; Chronic pain; Psychiatry","score_opus":0.03221263740502558,"score_gpt":0.4916838512620668,"score_spread":0.45947121385704126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078296345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7958996,0.050206404,0.03257844,0.021023804,0.0015792624,0.008013634,0.013803877,0.0010140555,0.07588094],"genre_scores_gemma":[0.7194755,0.050889216,0.18703048,0.0032837638,0.00075734436,0.013788268,0.009674912,0.00017949795,0.0149211],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827516,0.00069387653,0.000369182,0.00008146828,0.00045903353,0.000121318066],"domain_scores_gemma":[0.99560297,0.0011716365,0.0014498824,0.00012570246,0.0013445393,0.00030521132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027583372,0.00043939645,0.00091142673,0.0014708653,0.00028346822,0.000428852,0.0005293248,0.0005541938,0.004943539],"category_scores_gemma":[0.00754453,0.0001240452,0.0007431209,0.0009016636,0.00020259136,0.0006876198,0.00051539094,0.0008067026,0.00057558576],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043083864,0.0008175495,0.16551135,0.0037893828,0.0001676076,0.00097394054,0.0014409208,0.00065405294,0.002757137,0.0010993144,0.05887913,0.7634789],"study_design_scores_gemma":[0.00058662356,0.0013208108,0.92176044,0.0022931467,0.00019972265,0.005719245,0.0010937179,0.0009302509,0.001993107,0.0007361406,0.06325077,0.000116004056],"about_ca_topic_score_codex":0.0042590094,"about_ca_topic_score_gemma":0.012206355,"teacher_disagreement_score":0.004943539,"about_ca_system_score_codex":0.0005549769,"about_ca_system_score_gemma":0.0017998813,"threshold_uncertainty_score":0.016537845},"labels":[],"label_agreement":null},{"id":"W2078395542","doi":"10.1586/14737167.4.1.15","title":"Drotrecogin alfa (activated; Xigris®): an effective and cost-efficient treatment for severe sepsis","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Drotrecogin alfa; Medicine; Sepsis; Intensive care medicine; Severe sepsis; Population; Internal medicine; Septic shock","score_opus":0.12338931451961925,"score_gpt":0.5663270226182154,"score_spread":0.4429377080985962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078395542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02521689,0.9515175,0.0044400785,0.0077952305,0.0002873358,0.000060205195,0.00012930359,0.000049575756,0.010503804],"genre_scores_gemma":[0.1857759,0.79771644,0.0060351817,0.0026545469,0.0006995527,0.00007380498,0.00019365022,0.000010351376,0.006840652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977106,0.00008563065,0.000017865752,0.000016396161,0.0000957562,0.000013352607],"domain_scores_gemma":[0.9998497,0.000055542267,0.000045345118,0.000005789221,0.000028296665,0.000015451738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047723204,0.00015860642,0.00031045775,0.00055056385,0.00008399172,0.00033990026,0.00020828884,0.00041277584,0.001765467],"category_scores_gemma":[0.0005419514,0.000043636053,0.00023131825,0.00041218803,0.00015018313,0.00023275583,0.00019142327,0.00047238273,0.00043312853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004855073,0.00011568429,0.00082118943,0.0016088836,0.00013686158,0.00038792813,0.00002581802,0.00049424934,0.0077073853,0.0034149236,0.008385568,0.97641605],"study_design_scores_gemma":[0.0014743182,0.0041143615,0.027363498,0.0038557723,0.0008362792,0.014556344,0.00020421637,0.0018525729,0.022204727,0.01040604,0.91306496,0.000066894194],"about_ca_topic_score_codex":0.00038341476,"about_ca_topic_score_gemma":0.00065619394,"teacher_disagreement_score":0.001765467,"about_ca_system_score_codex":0.000353492,"about_ca_system_score_gemma":0.00037176357,"threshold_uncertainty_score":0.0059060454},"labels":[],"label_agreement":null},{"id":"W2083723328","doi":"10.1586/erp.12.21","title":"Modeling cost–effectiveness of pharmaceuticals in Alzheimer's disease","year":2012,"lang":"en","type":"letter","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Donepezil; Memantine; Medicine; Disease; Cognition; Alzheimer's disease; Cognitive decline; Intensive care medicine; Psychiatry; Dementia; Internal medicine","score_opus":0.5385332455298384,"score_gpt":0.6534947837921629,"score_spread":0.11496153826232447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083723328","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30738524,0.032967612,0.21976988,0.3129481,0.003483942,0.0005514314,0.0092131635,0.0005115257,0.11316906],"genre_scores_gemma":[0.9571667,0.007368073,0.015882969,0.006100421,0.00076925085,0.0003437605,0.0010403482,0.0000735183,0.011254915],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968154,0.0026141128,0.000079860205,0.00015467257,0.00018484186,0.00015109347],"domain_scores_gemma":[0.977639,0.020520268,0.0006835973,0.00026831217,0.00065316696,0.00023565623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005927382,0.0006348566,0.00092514954,0.0008585672,0.00031376566,0.0020761972,0.0014116592,0.003929386,0.0049456717],"category_scores_gemma":[0.034705117,0.000498177,0.0014274741,0.001397842,0.0007337557,0.0020294143,0.0010570035,0.0030947484,0.00055047544],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038677204,0.000095194024,0.0033027784,0.00028691604,0.0003370119,0.0002764246,0.000095006195,0.8333863,0.00011828505,0.1101576,0.025236424,0.02632129],"study_design_scores_gemma":[0.0003071815,0.00013649842,0.0022734415,0.00033518093,0.00024173623,0.00014994864,0.00013507991,0.7761198,0.00013215744,0.20255814,0.017557811,0.000053070708],"about_ca_topic_score_codex":0.026965244,"about_ca_topic_score_gemma":0.021859592,"teacher_disagreement_score":0.026965244,"about_ca_system_score_codex":0.006817857,"about_ca_system_score_gemma":0.002638746,"threshold_uncertainty_score":0.053616524},"labels":[],"label_agreement":null},{"id":"W2087798036","doi":"10.1586/14737167.2013.814937","title":"A review of cost–effectiveness evaluations as part of national health technology assessments of biologic DMARDs in the treatment of rheumatoid arthritis","year":2013,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rheumatoid arthritis; Medicine; Physical therapy; Alternative medicine; Intensive care medicine; Health technology; Outcomes research; Economic evaluation; Health care; Internal medicine; Economics; Economic growth","score_opus":0.17103024435723774,"score_gpt":0.6253007265049149,"score_spread":0.4542704821476771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087798036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012752827,0.99923277,0.00007716752,0.00013456843,0.000057435354,0.00003861669,0.000062767205,0.0000022148931,0.0002669659],"genre_scores_gemma":[0.0019041961,0.997494,0.0002737381,0.00014417227,0.000031421016,0.000049481725,0.00004670632,0.0000011695474,0.00005521385],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99411076,0.002359797,0.0014739387,0.0003204728,0.0015843048,0.00015064128],"domain_scores_gemma":[0.98411477,0.012325934,0.001877861,0.00016712405,0.0013799957,0.00013435444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074365693,0.001462305,0.0052097905,0.007174049,0.00034688384,0.0018033439,0.0015410555,0.0015229718,0.004219994],"category_scores_gemma":[0.022554921,0.00071541104,0.004640945,0.010158115,0.00048035444,0.0013954565,0.0007239377,0.00119819,0.000395764],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002995666,0.000036645313,0.00024596904,0.67966366,0.0052423123,0.00009322266,0.00008536452,0.00045077686,0.000283347,0.0012425029,0.0061839437,0.3061727],"study_design_scores_gemma":[0.0003566882,0.000474805,0.0045601497,0.7244524,0.04560904,0.0008381886,0.00020457366,0.00035625647,0.00060220907,0.0016723276,0.22081196,0.0000613742],"about_ca_topic_score_codex":0.004519492,"about_ca_topic_score_gemma":0.0099514695,"teacher_disagreement_score":0.0074365693,"about_ca_system_score_codex":0.0027018199,"about_ca_system_score_gemma":0.00649851,"threshold_uncertainty_score":0.039328814},"labels":[],"label_agreement":null},{"id":"W2088286185","doi":"10.1586/14737167.5.2.215","title":"Health insurance, access to prescription medicines and health outcomes in children","year":2005,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Novartis Pharma; RAND Corporation; Novartis","keywords":"Medical prescription; Receipt; Cost sharing; Medicine; Family medicine; Prescription costs; Health care; Pharmacy; Health insurance; Business; Environmental health; Prescription drug; Nursing; Economic growth; Accounting","score_opus":0.14406626420603585,"score_gpt":0.620680893205534,"score_spread":0.47661462899949814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088286185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58514744,0.40034422,0.00024103341,0.0047255214,0.00006413802,0.000042928117,0.0016514498,0.000004291111,0.007779063],"genre_scores_gemma":[0.86269844,0.13510826,0.0005663627,0.0005470163,0.0001031863,0.000035065812,0.00050961244,0.000001897204,0.00043022883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907565,0.0004450964,0.00014339018,0.00006563805,0.0002070472,0.00006321373],"domain_scores_gemma":[0.9924584,0.0049516666,0.0020692053,0.000072867915,0.00028098538,0.00016680601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022662522,0.000115984134,0.00038852234,0.0017166237,0.000183152,0.00051521044,0.00018481593,0.00044976623,0.0025542704],"category_scores_gemma":[0.008629382,0.00011248042,0.0006763741,0.0021300653,0.0003125437,0.0004397461,0.00028904894,0.00036620218,0.00010506216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023525872,0.000060975428,0.9433376,0.002159627,0.0009493901,0.00027139645,0.0003950294,0.00012643864,0.00008053755,0.00049250614,0.0008716174,0.05101956],"study_design_scores_gemma":[0.00002412705,0.00016013994,0.9907981,0.0021375115,0.0008590185,0.0005292781,0.0004879805,0.000073901465,0.00010855894,0.00029178517,0.004521096,0.000008610216],"about_ca_topic_score_codex":0.00891338,"about_ca_topic_score_gemma":0.017181564,"teacher_disagreement_score":0.00891338,"about_ca_system_score_codex":0.0005109344,"about_ca_system_score_gemma":0.00097157754,"threshold_uncertainty_score":0.017722964},"labels":[],"label_agreement":null},{"id":"W2089095786","doi":"10.1586/14737167.2014.864559","title":"The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22","year":2013,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Reliability (semiconductor); Medicine; Quality of life (healthcare); Cancer; Quality (philosophy); Validity; Medical physics; Family medicine; Oncology; Internal medicine; Psychometrics; Nursing; Clinical psychology","score_opus":0.07534755666028842,"score_gpt":0.4937597669935135,"score_spread":0.41841221033322507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089095786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527234,0.0011166603,0.0011486893,0.00026269234,0.000076186545,0.00013778731,0.00028658166,0.000008484431,0.001690602],"genre_scores_gemma":[0.9976452,0.0003050852,0.001138471,0.00010271906,0.00003827982,0.00014068083,0.00043257867,0.000004086227,0.00019293558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996727,0.0012961659,0.00043563228,0.00029685564,0.0010197365,0.00022467219],"domain_scores_gemma":[0.995095,0.0019502855,0.0012019556,0.0002962865,0.001289937,0.00016655137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068260976,0.00032710776,0.00049691147,0.0009872735,0.00039427012,0.0005088627,0.0003883559,0.0003148078,0.0010533299],"category_scores_gemma":[0.014852028,0.00018140617,0.0006487441,0.00090015936,0.0005910525,0.00040960024,0.00063372584,0.00051854487,0.0002183353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025876838,0.00015656765,0.9561777,0.00010379892,0.00025191755,0.00005102522,0.00082473975,0.00024161742,0.0006444063,0.00016241691,0.00064032053,0.040486757],"study_design_scores_gemma":[0.000061534476,0.00044422143,0.9957437,0.000055519973,0.000082610364,0.00031581623,0.00073552405,0.00060966326,0.0002948853,0.0001764872,0.0014671636,0.000012875234],"about_ca_topic_score_codex":0.0014470649,"about_ca_topic_score_gemma":0.0021750291,"teacher_disagreement_score":0.0068260976,"about_ca_system_score_codex":0.00045116353,"about_ca_system_score_gemma":0.0006479013,"threshold_uncertainty_score":0.036100328},"labels":[],"label_agreement":null},{"id":"W2089572944","doi":"10.1586/14737167.2015.1017563","title":"Cost–effectiveness of therapies for melanoma","year":2015,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University; BC Cancer Agency; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Dabrafenib; Medicine; Vemurafenib; Ipilimumab; Trametinib; Melanoma; Intensive care medicine; Cost effectiveness; Oncology; Disease; Internal medicine; Metastatic melanoma; Immunotherapy; Cancer; Cancer research","score_opus":0.22221636620857801,"score_gpt":0.6187242438974649,"score_spread":0.39650787768888696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089572944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005010538,0.9969627,0.00018517002,0.0007782852,0.000097749486,0.000028945442,0.00012230496,0.0000027821047,0.0013209025],"genre_scores_gemma":[0.012951098,0.98523486,0.000702352,0.00040766608,0.00019629847,0.00006694795,0.0001285313,0.0000031680527,0.00030903268],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976324,0.0010782595,0.00036853898,0.00014241728,0.000680745,0.00009768278],"domain_scores_gemma":[0.9964953,0.0025705583,0.0005957343,0.000037369064,0.00025635702,0.000044718516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029223813,0.00092063064,0.0025055395,0.0033218374,0.00018901468,0.0015358501,0.0009848375,0.001313705,0.008868388],"category_scores_gemma":[0.008093286,0.00031261283,0.0031197502,0.0031959477,0.0003602473,0.0011138889,0.0006660872,0.0013937153,0.0005405381],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004938665,0.00010108006,0.00090603344,0.08574153,0.0043257535,0.00014331273,0.000038985,0.001863736,0.0003189077,0.007396628,0.0110026505,0.88766754],"study_design_scores_gemma":[0.0011919645,0.001255607,0.020469116,0.24677445,0.02151628,0.0045940503,0.00045800803,0.0031350043,0.0019710143,0.024435459,0.67404515,0.00015380915],"about_ca_topic_score_codex":0.0029486022,"about_ca_topic_score_gemma":0.0041602994,"teacher_disagreement_score":0.008868388,"about_ca_system_score_codex":0.0027646245,"about_ca_system_score_gemma":0.0026497596,"threshold_uncertainty_score":0.029667735},"labels":[],"label_agreement":null},{"id":"W2092979623","doi":"10.1586/erp.13.27","title":"Economic evaluations of point of care testing strategies for active tuberculosis","year":2013,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Point-of-care testing; Tuberculosis; Diagnostic test; Medicine; Economic evaluation; Health care; Limited resources; Tuberculosis control; Test (biology); Point of care; Risk analysis (engineering); Control (management); Cost–benefit analysis; Tuberculosis diagnosis; Test strategy; Computer science; Economics; Mycobacterium tuberculosis; Nursing; Economic growth; Pathology","score_opus":0.17302382955536175,"score_gpt":0.6102745936655904,"score_spread":0.4372507641102287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092979623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010649641,0.9943188,0.00080901774,0.0010808889,0.00018447035,0.0002125445,0.0002029474,0.000005955662,0.0021205102],"genre_scores_gemma":[0.026428364,0.96955967,0.0023692534,0.0004853191,0.00018844202,0.00045960266,0.0001815734,0.0000063617376,0.00032141205],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98656344,0.009782382,0.0012943029,0.0003797174,0.0017246653,0.0002554308],"domain_scores_gemma":[0.95761096,0.037302278,0.0028993639,0.00031981146,0.0016399374,0.00022758561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018007213,0.0018791793,0.004588762,0.004704385,0.00032027505,0.002238114,0.0021714196,0.002407307,0.0074047516],"category_scores_gemma":[0.060413383,0.000534869,0.0052367444,0.0043770014,0.0006204563,0.0020244266,0.0011330034,0.0018835793,0.0004344584],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001855564,0.00029671457,0.0012101879,0.17411603,0.009363263,0.0001492425,0.000064832224,0.007430411,0.0001934752,0.013446232,0.009090773,0.7827834],"study_design_scores_gemma":[0.0039008025,0.0035863244,0.013970286,0.5753929,0.058074944,0.0020208997,0.0006535534,0.01107537,0.0024764475,0.046644658,0.28191537,0.0002884439],"about_ca_topic_score_codex":0.002968631,"about_ca_topic_score_gemma":0.003610779,"teacher_disagreement_score":0.018007213,"about_ca_system_score_codex":0.0041354485,"about_ca_system_score_gemma":0.00521889,"threshold_uncertainty_score":0.09523243},"labels":[],"label_agreement":null},{"id":"W2095717568","doi":"10.1586/14737167.4.2.135","title":"Economic benefits of pioglitazone for treating patients with Type 2 diabetes","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"Eli Lilly Canada; Eli Lilly and Company","keywords":"Pioglitazone; Metformin; Type 2 diabetes; Medicine; Sulfonylurea; Diabetes mellitus; Insulin resistance; Intensive care medicine; Insulin; Internal medicine; Endocrinology","score_opus":0.03182937887154053,"score_gpt":0.4519257589841406,"score_spread":0.4200963801126001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095717568","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18656796,0.42433122,0.016423535,0.12958471,0.002175975,0.0005617211,0.0016476336,0.00018879172,0.23851848],"genre_scores_gemma":[0.88919973,0.09744329,0.0052360957,0.0027687892,0.0011115593,0.00016151783,0.00033171853,0.000012860136,0.0037345286],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970842,0.0019524174,0.00009765042,0.000049144302,0.0007340249,0.0000826164],"domain_scores_gemma":[0.99621034,0.0027833027,0.00047910202,0.00007295828,0.0002482109,0.00020611464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003303752,0.00034179274,0.00059903663,0.0013157655,0.00039097492,0.0012723446,0.00033465165,0.0010610673,0.005472886],"category_scores_gemma":[0.015587743,0.00010163807,0.000743649,0.0015274436,0.00027965422,0.00063338043,0.00060048286,0.00081978366,0.00028383546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00444496,0.0004933478,0.015559385,0.0016079935,0.0012156934,0.000611633,0.00013219472,0.01945729,0.00047890385,0.023932442,0.03173447,0.9003317],"study_design_scores_gemma":[0.0061481316,0.006969361,0.18644747,0.014186902,0.011100045,0.008681574,0.0025576255,0.0918228,0.0025438885,0.19233453,0.47682366,0.0003839756],"about_ca_topic_score_codex":0.0026229175,"about_ca_topic_score_gemma":0.004258595,"teacher_disagreement_score":0.005472886,"about_ca_system_score_codex":0.0014422003,"about_ca_system_score_gemma":0.0021546697,"threshold_uncertainty_score":0.0183087},"labels":[],"label_agreement":null},{"id":"W2098391174","doi":"10.1586/erp.10.24","title":"QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique","year":2010,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"Centers for Disease Control and Prevention; Kaiser Permanente","keywords":"Psychological intervention; Quality-adjusted life year; Medicine; Robustness (evolution); Health economics; Quality of life (healthcare); Intellectual disability; Cost effectiveness; Pediatrics; Public health; Psychiatry","score_opus":0.45680108102391076,"score_gpt":0.6910804809478953,"score_spread":0.23427939992398455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098391174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007759636,0.4574206,0.34627965,0.13779135,0.005776252,0.0014668757,0.0020410945,0.00052173046,0.04094288],"genre_scores_gemma":[0.30802038,0.25724733,0.3356694,0.0700419,0.0118669765,0.008917673,0.0013416386,0.0013519317,0.005542777],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.7012099,0.23124455,0.02144408,0.005473734,0.03942052,0.001207077],"domain_scores_gemma":[0.38245445,0.57573676,0.010890921,0.010147669,0.020329442,0.00044078162],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.31657735,0.0027071428,0.006451317,0.009670782,0.0010243049,0.008841457,0.008716088,0.0063361796,0.003545464],"category_scores_gemma":[0.622958,0.0027326103,0.005023554,0.014584257,0.0072029303,0.009701245,0.0052802493,0.015673297,0.0009527285],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047825003,0.00010025741,0.0028616474,0.011421314,0.0019805094,0.00019054874,0.0012161596,0.016134208,0.00012677145,0.47773457,0.051586125,0.43616965],"study_design_scores_gemma":[0.00067982083,0.0003634085,0.0059691854,0.05850491,0.0014448577,0.0010518522,0.00078956323,0.03326068,0.0008802974,0.706537,0.19020206,0.00031637287],"about_ca_topic_score_codex":0.007995687,"about_ca_topic_score_gemma":0.0037819436,"teacher_disagreement_score":0.6834227,"about_ca_system_score_codex":0.009505922,"about_ca_system_score_gemma":0.005520941,"threshold_uncertainty_score":0.8427818},"labels":[],"label_agreement":null},{"id":"W2099796042","doi":"10.1586/14737167.8.1.27","title":"Delays for coronary artery bypass surgery: how long is too long?","year":2008,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bypass grafting; Coronary artery bypass surgery; Revascularization; Artery; Bypass surgery; Intensive care medicine; Surgery; Cardiology; Myocardial infarction","score_opus":0.19916105074320234,"score_gpt":0.5949175870227084,"score_spread":0.395756536279506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099796042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5541077,0.13317896,0.12757973,0.16906092,0.0022433377,0.00043279794,0.0040002977,0.00020698294,0.009189264],"genre_scores_gemma":[0.9146145,0.03589478,0.04165988,0.0044701137,0.0017570839,0.00016031924,0.00070298836,0.00005465486,0.0006856691],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9948591,0.00273284,0.00074048736,0.0004685307,0.0010319873,0.0001669482],"domain_scores_gemma":[0.92148674,0.05130703,0.019431742,0.0011802921,0.005312571,0.001281655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0155573925,0.00044409282,0.0011314239,0.0030981794,0.00083277636,0.0031368886,0.00092808326,0.0011236035,0.0011598344],"category_scores_gemma":[0.08167123,0.0002550677,0.00074389635,0.0057789697,0.0012777811,0.0040568765,0.00084834505,0.0015179927,0.00015715144],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001275591,0.00019468674,0.3609036,0.0035097797,0.0010498741,0.0002703633,0.0045197327,0.010405334,0.0014252181,0.026347365,0.00970667,0.58039176],"study_design_scores_gemma":[0.0004683897,0.0026880754,0.57810545,0.005781522,0.0032149185,0.0018308526,0.0398509,0.058558647,0.0037939404,0.24537073,0.05968728,0.00064937933],"about_ca_topic_score_codex":0.014936515,"about_ca_topic_score_gemma":0.028218668,"teacher_disagreement_score":0.0155573925,"about_ca_system_score_codex":0.0031867293,"about_ca_system_score_gemma":0.0044331043,"threshold_uncertainty_score":0.082276344},"labels":[],"label_agreement":null},{"id":"W2099819548","doi":"10.1586/14737167.6.1.37","title":"Acquiring an evidence base in palliative care: challenges and future directions","year":2006,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Palliative care; Extant taxon; Nursing; Medicine; Critical appraisal; Evidence-based practice; Psychology; Alternative medicine","score_opus":0.22884390701034202,"score_gpt":0.6001447633468874,"score_spread":0.37130085633654536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099819548","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023782693,0.1518722,0.01997854,0.8135206,0.007076143,0.0011159434,0.00028952424,0.00016934828,0.0035993888],"genre_scores_gemma":[0.14180408,0.22695552,0.4097983,0.19290899,0.017515223,0.008399994,0.0009092,0.00020025075,0.0015084688],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.56690013,0.31697372,0.062655665,0.008077247,0.040581394,0.004811952],"domain_scores_gemma":[0.089173414,0.80496174,0.019915354,0.013647841,0.06292826,0.009373339],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.57410175,0.0028581412,0.011464608,0.017825983,0.007155156,0.033238403,0.011478256,0.023909908,0.01002373],"category_scores_gemma":[0.7085988,0.002691516,0.0050535304,0.015926505,0.023997558,0.05308995,0.018255671,0.02697769,0.002515551],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011642566,0.0009104954,0.008465855,0.068797,0.0020170866,0.0009079193,0.006827052,0.003836606,0.00067280006,0.16698402,0.08233667,0.6570803],"study_design_scores_gemma":[0.0011578188,0.0015165951,0.006821484,0.20523825,0.0013102726,0.0010741766,0.028745916,0.0070587783,0.0006586837,0.60850626,0.1372115,0.0007003065],"about_ca_topic_score_codex":0.01089115,"about_ca_topic_score_gemma":0.017297314,"teacher_disagreement_score":0.42589825,"about_ca_system_score_codex":0.01827655,"about_ca_system_score_gemma":0.08701427,"threshold_uncertainty_score":0.5252084},"labels":[],"label_agreement":null},{"id":"W2101955909","doi":"10.1586/erp.12.45","title":"A review of cost–effectiveness of palivizumab for respiratory syncytial virus","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; McMaster University; Sunnybrook Hospital","funders":"","keywords":"Palivizumab; Medicine; Cost effectiveness; Intensive care medicine; Pediatrics; Cost–utility analysis; Respiratory system; Risk analysis (engineering); Internal medicine","score_opus":0.24262883967038143,"score_gpt":0.6329369047018628,"score_spread":0.3903080650314814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101955909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003863048,0.9989936,0.00005608507,0.00018152545,0.000047300124,0.000032867363,0.00009554887,0.0000022843753,0.00020458484],"genre_scores_gemma":[0.004606647,0.99482006,0.00022826206,0.00014600276,0.00003213565,0.000048688587,0.000054992848,0.0000012854921,0.000061954655],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724954,0.0009840274,0.0008029567,0.00016273944,0.00070981815,0.000090956244],"domain_scores_gemma":[0.9920141,0.0060865427,0.0010661666,0.00007119212,0.0006893695,0.000072671486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042120647,0.0012057367,0.004782343,0.0053842817,0.00026982493,0.00159633,0.0012156363,0.0012842163,0.00431834],"category_scores_gemma":[0.016074583,0.0005712555,0.00527732,0.0069647515,0.000320605,0.001041257,0.0005584049,0.00077257503,0.00029411918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057049806,0.00004304298,0.00045158222,0.72926533,0.008918552,0.00015756198,0.00006486392,0.0006873924,0.0003006577,0.00080691243,0.004676507,0.25405708],"study_design_scores_gemma":[0.0007018314,0.0007894275,0.009509486,0.75977004,0.09473075,0.0014303277,0.00022904652,0.0005591146,0.0007550787,0.0015901066,0.12987171,0.00006309728],"about_ca_topic_score_codex":0.005001786,"about_ca_topic_score_gemma":0.009016866,"teacher_disagreement_score":0.0053842817,"about_ca_system_score_codex":0.002935196,"about_ca_system_score_gemma":0.004928075,"threshold_uncertainty_score":0.022275805},"labels":[],"label_agreement":null},{"id":"W2104769168","doi":"10.1586/14737167.2013.814962","title":"Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences","year":2013,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Harmonization; Reimbursement; Restructuring; Process (computing); Business; Risk analysis (engineering); Process management; Management science; Public economics; Health care; Computer science; Economics; Political science; Finance; Law","score_opus":0.34823755418425967,"score_gpt":0.6178948080118515,"score_spread":0.2696572538275918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104769168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011982211,0.9956808,0.0009362179,0.0007635754,0.00009189582,0.0003485116,0.00030367024,0.000009963754,0.00066712836],"genre_scores_gemma":[0.014092797,0.98157126,0.0028419485,0.0005578494,0.000053583524,0.00047711655,0.00028495595,0.0000120991235,0.00010842705],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9568813,0.018607287,0.014213643,0.0021685043,0.007597379,0.0005318945],"domain_scores_gemma":[0.8634707,0.098930046,0.020151496,0.002732458,0.013824709,0.0008905687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.060469557,0.0010476046,0.004627831,0.0148826735,0.0007285821,0.003198236,0.0026942552,0.0017077812,0.0026976755],"category_scores_gemma":[0.1268403,0.00090707204,0.004068864,0.020454185,0.0015832018,0.004027303,0.0021638544,0.0015386004,0.00036787632],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003193597,0.00006538444,0.002059862,0.6240766,0.0037576465,0.00020343365,0.0014135565,0.00046882665,0.00051026436,0.0031403678,0.0072464733,0.35673824],"study_design_scores_gemma":[0.00020826804,0.00025951728,0.008642119,0.846546,0.016413875,0.0009916043,0.0016909423,0.00028887368,0.00069562177,0.0018180687,0.12236393,0.00008115695],"about_ca_topic_score_codex":0.006598165,"about_ca_topic_score_gemma":0.018940307,"teacher_disagreement_score":0.060469557,"about_ca_system_score_codex":0.005475246,"about_ca_system_score_gemma":0.025287261,"threshold_uncertainty_score":0.3197974},"labels":[],"label_agreement":null},{"id":"W2106412009","doi":"10.1586/erp.12.4","title":"Projected referral to other healthcare services in an outpatient palliative radiotherapy clinic","year":2012,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Referral; Palliative care; Psychosocial; Quality of life (healthcare); Multidisciplinary approach; Hospital Anxiety and Depression Scale; Anxiety; Depression (economics); Radiation therapy; Health care; Family medicine; Nursing; Psychiatry; Internal medicine","score_opus":0.14003833544910868,"score_gpt":0.5940839871988549,"score_spread":0.4540456517497462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106412009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945102,0.0005824563,0.00014587892,0.0014109409,0.000030205447,0.000043913475,0.0008692207,0.000018536291,0.0023886354],"genre_scores_gemma":[0.99815035,0.00041062152,0.00018647348,0.0003144162,0.00003686649,0.000031348965,0.00048825803,0.000003961575,0.0003776587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981123,0.0006765597,0.00024025443,0.00019196961,0.0004753335,0.0003035731],"domain_scores_gemma":[0.99442047,0.000903294,0.0031515167,0.00006658812,0.00047721362,0.0009809271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071114465,0.00013406659,0.00020848852,0.0006562121,0.00063326483,0.00082095317,0.00050694897,0.00071447965,0.005084454],"category_scores_gemma":[0.0053166766,0.00018389658,0.0005412068,0.0008808622,0.00023124769,0.0005509628,0.00076679717,0.000911831,0.00055421225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089313966,0.00009068983,0.99025565,0.000053666347,0.0000360945,0.0007177681,0.00033845764,0.00017738402,0.0002494635,0.000038309045,0.0012650845,0.006688086],"study_design_scores_gemma":[0.000010201829,0.0001609821,0.9949292,0.000071153605,0.00002096356,0.002179057,0.0012359975,0.00047041982,0.000079506695,0.000022431686,0.00081048306,0.000009755918],"about_ca_topic_score_codex":0.011767773,"about_ca_topic_score_gemma":0.024640262,"teacher_disagreement_score":0.011767773,"about_ca_system_score_codex":0.0011726565,"about_ca_system_score_gemma":0.0010299732,"threshold_uncertainty_score":0.023398578},"labels":[],"label_agreement":null},{"id":"W2106819379","doi":"10.1586/14737167.8.4.329","title":"Using economic evidence as a support tool for policy decisions: Herculean or Sisyphean effort?","year":2008,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Public economics; Economics; Business; Management science","score_opus":0.35965030458066927,"score_gpt":0.6008521816639829,"score_spread":0.24120187708331364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106819379","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022134539,0.0773687,0.017011277,0.8871968,0.0047681965,0.0001661569,0.0003127465,0.000057743535,0.010904929],"genre_scores_gemma":[0.3015915,0.23475689,0.11818096,0.3126507,0.025259204,0.0015700433,0.00045855955,0.00021500626,0.0053171753],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.81939644,0.15335153,0.007652979,0.0042134523,0.01349781,0.0018878062],"domain_scores_gemma":[0.34765682,0.58313614,0.020047143,0.018089814,0.027140196,0.003929895],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.26509258,0.0020760095,0.0069275936,0.011730286,0.0019066157,0.02171757,0.005167665,0.018246084,0.010479925],"category_scores_gemma":[0.4989794,0.00135501,0.0019880286,0.009940777,0.015538212,0.04294044,0.0068744645,0.01829147,0.002010698],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044830283,0.00032897684,0.004552282,0.010034424,0.0021370777,0.00043472246,0.0011646837,0.0048715747,0.00017385016,0.62438166,0.12751392,0.22395849],"study_design_scores_gemma":[0.00035413945,0.00010658658,0.0015750725,0.025574267,0.00043130323,0.00013553257,0.0018251378,0.006195088,0.00021068327,0.8464154,0.117010705,0.00016614526],"about_ca_topic_score_codex":0.0075329714,"about_ca_topic_score_gemma":0.007004505,"teacher_disagreement_score":0.7349074,"about_ca_system_score_codex":0.009240562,"about_ca_system_score_gemma":0.018782906,"threshold_uncertainty_score":0.9062717},"labels":[],"label_agreement":null},{"id":"W2108849668","doi":"10.1586/14737167.5.5.519","title":"A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritis","year":2005,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital","funders":"","keywords":"Adalimumab; Rheumatoid arthritis; Medicine; Quality of life (healthcare); Intensive care medicine; Biologic Agents; Psychological intervention; Health care; Pharmacoeconomics; Indirect costs; Physical therapy; Internal medicine; Nursing; Business","score_opus":0.06979611566228061,"score_gpt":0.5343854698473723,"score_spread":0.46458935418509173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108849668","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006154216,0.9988576,0.000047612004,0.0003514793,0.00016254655,0.000011039058,0.000015903599,0.0000021210624,0.00049007026],"genre_scores_gemma":[0.00038514513,0.9988187,0.00015216517,0.00028292718,0.00010558544,0.000010035212,0.000018761355,5.9435376e-7,0.00022607855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901545,0.0003143141,0.00014866429,0.00007810171,0.00040388067,0.000039694372],"domain_scores_gemma":[0.9985623,0.0007856985,0.00022058922,0.000023665825,0.00035439766,0.000053432665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001993628,0.0008213792,0.0022545808,0.004053495,0.00031162877,0.00094278075,0.0009851387,0.0013334996,0.00469942],"category_scores_gemma":[0.0030040774,0.0004002637,0.0010855218,0.0060509513,0.00035542727,0.0010009496,0.0004478009,0.0010975542,0.0011717745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016684766,0.0000940797,0.0001389533,0.071276,0.0004244182,0.00028201996,0.000054105294,0.00040358581,0.000576985,0.0025650566,0.052788507,0.8712294],"study_design_scores_gemma":[0.00017222975,0.00032937052,0.0028009955,0.06484299,0.0013334902,0.0015109754,0.00009653292,0.00024103203,0.00035421478,0.001925206,0.92636013,0.000032776963],"about_ca_topic_score_codex":0.0034059645,"about_ca_topic_score_gemma":0.010912636,"teacher_disagreement_score":0.00469942,"about_ca_system_score_codex":0.0015665232,"about_ca_system_score_gemma":0.002779636,"threshold_uncertainty_score":0.015721083},"labels":[],"label_agreement":null},{"id":"W2109380539","doi":"10.1586/14737167.6.5.563","title":"Systemic lupus erythematosus: clinical manifestations, treatment and economics","year":2006,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Systemic lupus erythematosus; Population; Multisystem disease; Immunology; Internal medicine","score_opus":0.06626511842310975,"score_gpt":0.523687288272031,"score_spread":0.45742216984892126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109380539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010609949,0.8721408,0.0016253513,0.07200363,0.00067152095,0.00006760959,0.00019363278,0.000035008623,0.042652488],"genre_scores_gemma":[0.15815663,0.81083864,0.0032597827,0.011180947,0.004216451,0.000100357494,0.00019754843,0.000014807248,0.012034828],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985759,0.0005523331,0.0001016343,0.000057327903,0.00065484917,0.00005796861],"domain_scores_gemma":[0.99880695,0.00044689837,0.00025178964,0.00002464379,0.0003153587,0.00015428421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017444339,0.00022194373,0.00063253014,0.00088889094,0.00023022403,0.0016330485,0.00029103606,0.00094509614,0.004534728],"category_scores_gemma":[0.0036498518,0.0000942571,0.00020492755,0.0010543253,0.0005226232,0.0006117952,0.00042052066,0.0008182118,0.001100245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023463873,0.00024486796,0.008267258,0.0019512412,0.00007795655,0.0009209323,0.0000683941,0.0009539816,0.0010675114,0.014892699,0.05864441,0.9126762],"study_design_scores_gemma":[0.000326504,0.00090749585,0.05739752,0.007296655,0.00016390409,0.017969618,0.0005544592,0.0014909398,0.0008083075,0.0343045,0.87870884,0.00007130755],"about_ca_topic_score_codex":0.0015406748,"about_ca_topic_score_gemma":0.0017831712,"teacher_disagreement_score":0.004534728,"about_ca_system_score_codex":0.0015768837,"about_ca_system_score_gemma":0.0016272771,"threshold_uncertainty_score":0.015170157},"labels":[],"label_agreement":null},{"id":"W2109650194","doi":"10.1586/erp.10.41","title":"General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals","year":2010,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Population; Event (particle physics); Reimbursement; Activity-based costing; Actuarial science; Estimation; Medicine; Econometrics; Demography; Statistics; Economics; Environmental health; Health care; Mathematics; Accounting","score_opus":0.5367290743000347,"score_gpt":0.6540591500758738,"score_spread":0.1173300757758391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109650194","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010146556,0.82500297,0.119108826,0.0158669,0.0046757273,0.007421751,0.004274433,0.00023259102,0.013270287],"genre_scores_gemma":[0.356581,0.41206196,0.17016287,0.017759936,0.007197626,0.0279617,0.0035712477,0.00041409128,0.0042896373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.5218247,0.35707664,0.07446592,0.009649412,0.03586356,0.0011197688],"domain_scores_gemma":[0.20060393,0.72091603,0.044821404,0.01488917,0.018256253,0.0005132476],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.43590102,0.0022501564,0.0113021275,0.012745266,0.0006934128,0.0081802,0.0038577742,0.0040759095,0.007894348],"category_scores_gemma":[0.7115021,0.0013822162,0.008457591,0.015709296,0.0029935248,0.006244247,0.0034328112,0.004754855,0.0011615559],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026905069,0.00015659606,0.020196365,0.15927388,0.035893187,0.0003673014,0.0018433337,0.005340442,0.0002992029,0.06387384,0.020343428,0.68972194],"study_design_scores_gemma":[0.004181255,0.0014186173,0.072837345,0.26808226,0.054643683,0.0032391408,0.0017651273,0.022210311,0.0024287035,0.35020027,0.2181121,0.0008812449],"about_ca_topic_score_codex":0.002403707,"about_ca_topic_score_gemma":0.0023272042,"teacher_disagreement_score":0.56409895,"about_ca_system_score_codex":0.005944799,"about_ca_system_score_gemma":0.004773616,"threshold_uncertainty_score":0.6956345},"labels":[],"label_agreement":null},{"id":"W2110004318","doi":"10.1586/erp.10.21","title":"Integrating patient-reported outcomes in healthcare policy, research and practice","year":2010,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Health care; Quality (philosophy); Clinical Practice; Outcomes research; Medicine; Family medicine; Nursing; Alternative medicine; Economics; Economic growth","score_opus":0.35824559176272935,"score_gpt":0.6711628898195108,"score_spread":0.3129172980567814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110004318","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021283846,0.025353976,0.000587279,0.0716682,0.9014389,0.00002730019,0.00006788355,0.000042635314,0.00079260935],"genre_scores_gemma":[0.000548036,0.021722827,0.0008265806,0.025918534,0.94806325,0.000059757047,0.000033591707,0.00005619606,0.0027711391],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95399904,0.017349156,0.008330173,0.0024088894,0.016870983,0.0010418189],"domain_scores_gemma":[0.6278225,0.2650285,0.009866973,0.0063820137,0.08416093,0.006738986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08144121,0.0042928057,0.009212264,0.007812525,0.003936744,0.01439097,0.0062352996,0.026061988,0.0094604865],"category_scores_gemma":[0.21093063,0.002464023,0.0042414702,0.0066243988,0.009853759,0.009957447,0.0041113603,0.051883057,0.007096277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039210598,0.000015492269,0.000041909105,0.0010223694,0.000098433586,0.000059316837,0.00005163868,0.00006432356,0.000026940057,0.0020800785,0.9782382,0.018262126],"study_design_scores_gemma":[0.00024379873,0.00004088563,0.00053408917,0.0069114068,0.0004252607,0.0002373055,0.00014898101,0.00044993524,0.00016616247,0.011195571,0.9795457,0.00010083243],"about_ca_topic_score_codex":0.0062622386,"about_ca_topic_score_gemma":0.015512834,"teacher_disagreement_score":0.08144121,"about_ca_system_score_codex":0.0092444355,"about_ca_system_score_gemma":0.013291275,"threshold_uncertainty_score":0.43070745},"labels":[],"label_agreement":null},{"id":"W2110007186","doi":"10.1586/erp.10.5","title":"Should all patients with uncomplicated bone metastases be treated with a single 8-Gy fraction?","year":2010,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Ohio State University","keywords":"Medicine; Fraction (chemistry); Urology; Internal medicine; Oncology; Surgery; Chemistry","score_opus":0.06230524441576476,"score_gpt":0.5007124570304285,"score_spread":0.4384072126146638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110007186","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001573597,0.06274062,0.00030970882,0.20239331,0.7316198,0.000030586438,0.000113956376,0.000054665237,0.002580032],"genre_scores_gemma":[0.001462601,0.04148792,0.0005875991,0.1139649,0.8364832,0.00004800724,0.00006665692,0.000031498035,0.0058676503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721247,0.00069292245,0.0005786454,0.0002609057,0.0010751918,0.00017972961],"domain_scores_gemma":[0.98201996,0.010587579,0.0011125678,0.000286784,0.0048378073,0.0011552204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075350213,0.0018447383,0.0045286356,0.0011993855,0.0013161214,0.003238045,0.002442039,0.017777426,0.004124562],"category_scores_gemma":[0.023864789,0.0008670213,0.0021722307,0.0010195514,0.0016259567,0.0028586239,0.00069272483,0.029112032,0.00393531],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013871813,0.000026720685,0.00008120624,0.0009646691,0.00008409324,0.00018067994,0.00001788885,0.00007606877,0.00011606749,0.00065894186,0.96598387,0.03167107],"study_design_scores_gemma":[0.0003509969,0.00009261486,0.0008736101,0.0020800214,0.00032858847,0.0005697161,0.00006919104,0.00025054472,0.00022032254,0.0017456553,0.99336916,0.000049684244],"about_ca_topic_score_codex":0.0027015153,"about_ca_topic_score_gemma":0.009065175,"teacher_disagreement_score":0.017777426,"about_ca_system_score_codex":0.0021709092,"about_ca_system_score_gemma":0.003180808,"threshold_uncertainty_score":0.03984952},"labels":[],"label_agreement":null},{"id":"W2111946751","doi":"10.1586/14737167.4.2.189","title":"Principles of good modeling practice in healthcare cost-effectiveness studies","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Ontario Ministry of Health and Long-Term Care; GlaxoSmithKline","keywords":"Interpretability; Computer science; Management science; Risk analysis (engineering); Process (computing); Interpretation (philosophy); Quality (philosophy); Health care; Presentation (obstetrics); Data science; Quality assurance; Process management; Medicine; Artificial intelligence; Operations management; Engineering","score_opus":0.6070815731599783,"score_gpt":0.6887313461827933,"score_spread":0.08164977302281495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111946751","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014059198,0.006950648,0.9363486,0.037525084,0.0007817409,0.0022657916,0.00040962268,0.0002925697,0.014020021],"genre_scores_gemma":[0.058859434,0.007197516,0.9159422,0.006656929,0.0008867478,0.008926017,0.00028766843,0.00020605631,0.0010374202],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.61598283,0.31973913,0.021233065,0.008313508,0.032645624,0.0020859144],"domain_scores_gemma":[0.55712354,0.36905164,0.014517656,0.02812514,0.029446756,0.001735254],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3387624,0.0035572639,0.0077347187,0.007863791,0.0039719623,0.016145842,0.012058555,0.013891519,0.0035189895],"category_scores_gemma":[0.40298492,0.003513137,0.0060499986,0.008436504,0.021480946,0.010234106,0.010013868,0.0193021,0.003017047],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108190354,0.00020712777,0.0013961946,0.0043058963,0.0007504894,0.0002745942,0.0032833784,0.064827695,0.00020380749,0.8565063,0.0154158985,0.052720483],"study_design_scores_gemma":[0.00023324335,0.00016425549,0.00034041243,0.0046217856,0.0002328573,0.0001438616,0.00046223257,0.019062743,0.0003357974,0.92097086,0.053326584,0.00010543203],"about_ca_topic_score_codex":0.0051791575,"about_ca_topic_score_gemma":0.004241289,"teacher_disagreement_score":0.6612376,"about_ca_system_score_codex":0.009015481,"about_ca_system_score_gemma":0.025497993,"threshold_uncertainty_score":0.81542367},"labels":[],"label_agreement":null},{"id":"W2112625260","doi":"10.1586/erp.11.56","title":"Symptom clusters in patients with lung cancer: a literature review","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"CINAHL; Lung cancer; Medicine; Nausea; Cluster (spacecraft); MEDLINE; Vomiting; Population; Intensive care medicine; Cancer; Internal medicine; Psychiatry; Environmental health; Psychological intervention","score_opus":0.03951982324808489,"score_gpt":0.5146885318127733,"score_spread":0.4751687085646884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112625260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009904989,0.99836534,0.000052912852,0.00016671496,0.000050715167,0.000056870434,0.00010542685,0.0000029865057,0.000208546],"genre_scores_gemma":[0.00808852,0.9911137,0.00034739138,0.00016896574,0.000039634127,0.000084948835,0.00010656729,0.0000012894544,0.000049002792],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971533,0.00081349915,0.0011383004,0.00024234576,0.0005612376,0.000091328846],"domain_scores_gemma":[0.98867923,0.008139465,0.0020579004,0.00009834898,0.0009092382,0.00011567982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031419399,0.0009860576,0.003347236,0.012845916,0.0005899998,0.0016497242,0.001419883,0.0011706109,0.002563691],"category_scores_gemma":[0.014353164,0.00056780037,0.0025712019,0.015817063,0.0006134125,0.0019668925,0.0009457105,0.0006269693,0.00024124821],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018882837,0.00004210535,0.0033350126,0.70200396,0.002233611,0.0004333208,0.00077022833,0.0002036638,0.00022990504,0.00042131357,0.0063846293,0.28375345],"study_design_scores_gemma":[0.00018640066,0.00039052384,0.03765151,0.8570495,0.017821467,0.0045708385,0.0027527236,0.0001968496,0.00033915616,0.00086663483,0.07807681,0.00009757604],"about_ca_topic_score_codex":0.007134502,"about_ca_topic_score_gemma":0.016613912,"teacher_disagreement_score":0.012845916,"about_ca_system_score_codex":0.0022766492,"about_ca_system_score_gemma":0.00654026,"threshold_uncertainty_score":0.016616344},"labels":[],"label_agreement":null},{"id":"W2112899529","doi":"10.1586/14737167.2.2.99","title":"Health utility estimation","year":2002,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University","funders":"","keywords":"Preference; Estimation; Measure (data warehouse); Scale (ratio); Quality (philosophy); Index (typography); Actuarial science; Quality-adjusted life year; Computer science; EQ-5D; Economics; Operations management; Microeconomics; MEDLINE; Cost effectiveness; Data mining; Health related quality of life; Political science; Management","score_opus":0.4892947962156367,"score_gpt":0.6522368886425373,"score_spread":0.16294209242690055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112899529","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009203413,0.009734689,0.8903932,0.004215758,0.0006888969,0.0012884431,0.009644569,0.0013312278,0.07349978],"genre_scores_gemma":[0.5073453,0.01609295,0.38463473,0.0019612445,0.0010136743,0.0034311628,0.022378292,0.0007238255,0.0624188],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9959447,0.0025223433,0.00022768737,0.00041111285,0.00066076004,0.00023346303],"domain_scores_gemma":[0.99443144,0.0039269184,0.00026218273,0.0004565371,0.0008411814,0.00008163968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005848369,0.0011749957,0.0014997113,0.0031571458,0.00030538504,0.0026253324,0.0013723784,0.0015236768,0.051960535],"category_scores_gemma":[0.038537756,0.00037908106,0.0019044253,0.0032740966,0.00038157534,0.0016254026,0.001227974,0.0017371626,0.0104066795],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002722966,0.00016090002,0.0072431364,0.0008573845,0.00053932884,0.00019872613,0.00012464257,0.08308534,0.00020164839,0.14738576,0.0937766,0.66615415],"study_design_scores_gemma":[0.00020053136,0.0003117315,0.0068543274,0.0014337515,0.00047529844,0.0008487062,0.00034744936,0.43793297,0.0012222079,0.40193272,0.14833614,0.000104194754],"about_ca_topic_score_codex":0.004325111,"about_ca_topic_score_gemma":0.0016668513,"teacher_disagreement_score":0.051960535,"about_ca_system_score_codex":0.0014137486,"about_ca_system_score_gemma":0.0016275917,"threshold_uncertainty_score":0.17382526},"labels":[],"label_agreement":null},{"id":"W2113308225","doi":"10.1586/erp.11.58","title":"Are economic evaluations an important tool in vaccine policy decisions?","year":2011,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Health economics; Public economics; Economics; Health policy; Politics; Political science; Economic growth; Health care; Law","score_opus":0.49969434992854705,"score_gpt":0.6606018222334664,"score_spread":0.16090747230491936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113308225","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031709734,0.36671644,0.08105185,0.49444655,0.011091681,0.00053242076,0.001111415,0.00016504874,0.041713692],"genre_scores_gemma":[0.27912155,0.44404623,0.14073414,0.1015244,0.025131335,0.0017728667,0.00078656455,0.00039757584,0.0064853043],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.771034,0.19725527,0.009921415,0.002529197,0.017847778,0.0014123716],"domain_scores_gemma":[0.264065,0.6789198,0.019612303,0.009772752,0.025520902,0.0021093257],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.29298735,0.0018645313,0.008187689,0.011356194,0.0014049575,0.015056978,0.0034958974,0.010449779,0.009436816],"category_scores_gemma":[0.6053181,0.0015608037,0.002315319,0.011734361,0.010214221,0.028962802,0.0036819112,0.012440095,0.0018648736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000900331,0.00027096143,0.0042014094,0.0088279,0.001547968,0.00025328487,0.00056341704,0.012497624,0.00010506525,0.4888142,0.1267779,0.35523987],"study_design_scores_gemma":[0.00038290262,0.00021961454,0.0026457862,0.0149208335,0.00052269944,0.0001768615,0.00087321847,0.009124211,0.00027638488,0.84099525,0.12965667,0.00020551033],"about_ca_topic_score_codex":0.004612886,"about_ca_topic_score_gemma":0.0032771372,"teacher_disagreement_score":0.29298735,"about_ca_system_score_codex":0.008116305,"about_ca_system_score_gemma":0.011649036,"threshold_uncertainty_score":0.8718725},"labels":[],"label_agreement":null},{"id":"W2119080426","doi":"10.1586/erp.09.62","title":"Reimbursement agency requirements for health related quality-of-life data: a case study","year":2009,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Generalizability theory; Reimbursement; Nice; Health technology; Agency (philosophy); Actuarial science; Comparability; Quality-adjusted life year; Medicine; Quality (philosophy); Estimation; Business; Public economics; Health care; Cost effectiveness; Risk analysis (engineering); Economic growth; Economics; Computer science; Psychology","score_opus":0.8048848477919793,"score_gpt":0.7382181904057402,"score_spread":0.06666665738623911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119080426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25315458,0.4329765,0.12278264,0.08171231,0.0013050532,0.015555582,0.01164647,0.00016335819,0.08070348],"genre_scores_gemma":[0.77085793,0.10988133,0.09485503,0.0075457348,0.0004435299,0.010924704,0.0032018502,0.000094977215,0.0021948735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.86298484,0.09604399,0.019197391,0.0019186593,0.01792686,0.0019283632],"domain_scores_gemma":[0.56070566,0.3843449,0.01888989,0.0070336084,0.028051298,0.0009746483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13865414,0.00055172405,0.0022439214,0.0065989494,0.0016599772,0.0043420335,0.0017833996,0.0046242345,0.005722802],"category_scores_gemma":[0.29368868,0.0006313391,0.0039177607,0.01415574,0.0011343592,0.00430156,0.002400945,0.0023463203,0.0006623176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002341658,0.00095926155,0.09010099,0.0667621,0.0020125662,0.012844307,0.008847947,0.007328528,0.0008385935,0.10823983,0.03524559,0.6644786],"study_design_scores_gemma":[0.0021050023,0.003613158,0.12371151,0.14270519,0.008192245,0.051639102,0.021869218,0.01959263,0.0045280117,0.05808492,0.5632065,0.0007524623],"about_ca_topic_score_codex":0.009489478,"about_ca_topic_score_gemma":0.0120992735,"teacher_disagreement_score":0.13865414,"about_ca_system_score_codex":0.008124447,"about_ca_system_score_gemma":0.013419748,"threshold_uncertainty_score":0.73328197},"labels":[],"label_agreement":null},{"id":"W2119361956","doi":"10.1586/erp.10.9","title":"Cancer prevention: major initiatives and looking into the future","year":2010,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer prevention; Cancer; Medicine; Cancer incidence; Optimism; Causes of cancer; Environmental health; Incidence (geometry); Intervention (counseling); Tobacco control; Public health; Internal medicine; Pathology; Psychology","score_opus":0.06891056378515197,"score_gpt":0.5845167964852631,"score_spread":0.5156062327001112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119361956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052034316,0.99234605,0.0001657204,0.0058674007,0.00068213244,0.000008170567,0.00001067882,0.0000142273975,0.000853565],"genre_scores_gemma":[0.00053106644,0.9959079,0.0006521884,0.001894899,0.0005213579,0.000013324652,0.000018155326,0.0000025037139,0.00045860754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985802,0.0004965203,0.00018375317,0.00016257691,0.000479317,0.000097523305],"domain_scores_gemma":[0.9975752,0.0010949832,0.00027977978,0.000097539974,0.00069599296,0.000256422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047420417,0.0014895485,0.0022498276,0.002257073,0.0006736237,0.0021307536,0.0015824059,0.0033403658,0.0050264103],"category_scores_gemma":[0.0029814693,0.00040276523,0.0009620058,0.0036559869,0.0014279376,0.0042328695,0.0015256599,0.004089334,0.0025591017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000778563,0.000113162765,0.00026701883,0.02535589,0.00011675773,0.0001410729,0.00017625923,0.00025062505,0.00068239117,0.0101421,0.057119813,0.9055571],"study_design_scores_gemma":[0.000038129696,0.00013869908,0.0010495902,0.023038756,0.00018550821,0.00078698253,0.0005206906,0.00012924847,0.000185505,0.008482358,0.96541923,0.000025288287],"about_ca_topic_score_codex":0.0027726751,"about_ca_topic_score_gemma":0.0041609122,"teacher_disagreement_score":0.0050264103,"about_ca_system_score_codex":0.0021026344,"about_ca_system_score_gemma":0.0067673405,"threshold_uncertainty_score":0.025078595},"labels":[],"label_agreement":null},{"id":"W2120100340","doi":"10.1586/erp.10.15","title":"Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG","year":2010,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Clinical trial; Quality of life (healthcare); Cancer; Health related quality of life; Intensive care medicine; Physical therapy; Internal medicine; Disease; Nursing","score_opus":0.8521365921051185,"score_gpt":0.7445000144577951,"score_spread":0.10763657764732337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120100340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005340992,0.9797738,0.0024185642,0.013815462,0.00076064543,0.00019999355,0.00012609357,0.000023573033,0.002347709],"genre_scores_gemma":[0.021016724,0.9520469,0.015427893,0.0073457877,0.0025800935,0.00074266095,0.00014387078,0.00004619938,0.00064980035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.81375223,0.13950059,0.013273563,0.0029018782,0.029911913,0.0006598276],"domain_scores_gemma":[0.2910661,0.66795063,0.013872843,0.0061148447,0.020064091,0.0009314808],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21593268,0.0015567184,0.0085880505,0.009993397,0.0006294334,0.008980194,0.0028302236,0.004684839,0.003808637],"category_scores_gemma":[0.41593322,0.00091464026,0.0045868806,0.012865787,0.003233597,0.0060171383,0.003424217,0.009401525,0.00052129803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053191104,0.000040196013,0.0011516429,0.03173995,0.0022586456,0.00009087271,0.00021147105,0.0015784325,0.00014771198,0.022405157,0.018569622,0.9212744],"study_design_scores_gemma":[0.0015226597,0.0012478088,0.012081223,0.2977658,0.015243126,0.001987474,0.00052206725,0.00890821,0.0011721302,0.11556351,0.5436234,0.00036267086],"about_ca_topic_score_codex":0.004696125,"about_ca_topic_score_gemma":0.006405839,"teacher_disagreement_score":0.21593268,"about_ca_system_score_codex":0.01088662,"about_ca_system_score_gemma":0.0123954825,"threshold_uncertainty_score":0.96689457},"labels":[],"label_agreement":null},{"id":"W2120920974","doi":"10.1586/14737167.2014.912562","title":"Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?","year":2014,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; Utilities Kingston (Canada); University of Alberta","funders":"","keywords":"Comparability; Time-trade-off; Time horizon; Quality-adjusted life year; Nice; EQ-5D; Health economics; Actuarial science; Preference; Excellence; Economic evaluation; Public economics; Medicine; Health care; Economics; MEDLINE; Quality of life (healthcare); Cost effectiveness; Computer science; Risk analysis (engineering); Economic growth; Political science; Mathematics; Microeconomics; Health related quality of life; Nursing","score_opus":0.7797505926709365,"score_gpt":0.7038089061160802,"score_spread":0.07594168655485634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120920974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026088783,0.468103,0.41525507,0.098844975,0.0051073804,0.0012138111,0.0010971419,0.0003175713,0.0074521527],"genre_scores_gemma":[0.10365687,0.29949564,0.5394889,0.03608818,0.00854136,0.007752708,0.001148511,0.0006864969,0.0031413354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7861584,0.17941394,0.014084292,0.004385859,0.0152180465,0.0007394671],"domain_scores_gemma":[0.4796084,0.47638622,0.0127025945,0.008185529,0.022252496,0.00086467713],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25642136,0.002251298,0.0071395943,0.005741233,0.0009321607,0.009159612,0.007879875,0.0045557525,0.0065820157],"category_scores_gemma":[0.4637468,0.0013183464,0.005362907,0.008922277,0.0046957685,0.009566274,0.004697066,0.013383597,0.0017435936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043198906,0.00012806397,0.00344715,0.017911984,0.003369753,0.00016485176,0.001624681,0.0057949736,0.0001290204,0.110934295,0.037462953,0.8186003],"study_design_scores_gemma":[0.00052738667,0.00041966245,0.0064972285,0.061884724,0.0021643937,0.001009275,0.002973916,0.023709822,0.0005231777,0.65494996,0.2448257,0.000514836],"about_ca_topic_score_codex":0.0069436836,"about_ca_topic_score_gemma":0.00786131,"teacher_disagreement_score":0.7435787,"about_ca_system_score_codex":0.0039352933,"about_ca_system_score_gemma":0.0062721544,"threshold_uncertainty_score":0.9169648},"labels":[],"label_agreement":null},{"id":"W2121035436","doi":"10.1586/erp.10.80","title":"Medical and employment-related costs of epilepsy in the USA","year":2010,"lang":"en","type":"letter","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epilepsy; Medicine; Business; Actuarial science; Economics; Public economics; Psychiatry","score_opus":0.048423007801154716,"score_gpt":0.5126385932062446,"score_spread":0.4642155854050899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121035436","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11473821,0.018200869,0.00013980662,0.82671314,0.004209619,0.000059665388,0.0060229716,0.00004376923,0.029871909],"genre_scores_gemma":[0.69263643,0.025444552,0.0005904907,0.252168,0.01467749,0.0001712907,0.0037124038,0.000016899112,0.0105824135],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99903667,0.00030330586,0.00017226872,0.00005765076,0.00033651918,0.000093630864],"domain_scores_gemma":[0.99653095,0.0012553291,0.0006873426,0.00005491606,0.0012125766,0.00025896254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088265724,0.00012190379,0.00025963085,0.0009064599,0.0003700132,0.0005836725,0.00025967692,0.002479013,0.002187193],"category_scores_gemma":[0.009168111,0.00014238895,0.00026619932,0.0012995803,0.00016930838,0.00040137046,0.00020657173,0.0011536832,0.0005453037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027922576,0.00016746348,0.1479481,0.00034513054,0.0001386433,0.0035345564,0.0002055415,0.0004241635,0.0002808045,0.0011838711,0.76269144,0.08280103],"study_design_scores_gemma":[0.00040136706,0.00026682173,0.6943086,0.0017248021,0.00031381738,0.012608456,0.0009911981,0.006542089,0.0006791482,0.0026212789,0.27943492,0.00010744065],"about_ca_topic_score_codex":0.030859888,"about_ca_topic_score_gemma":0.0712736,"teacher_disagreement_score":0.030859888,"about_ca_system_score_codex":0.0027160123,"about_ca_system_score_gemma":0.0019401669,"threshold_uncertainty_score":0.061360538},"labels":[],"label_agreement":null},{"id":"W2123504518","doi":"10.1586/14737167.2014.950233","title":"Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?","year":2014,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international; European Commission","keywords":"Health technology; Risk analysis (engineering); Order (exchange); Value (mathematics); Business; Medicine; Computer science; Health care; Economics","score_opus":0.581421447728661,"score_gpt":0.7115769387593235,"score_spread":0.13015549103066248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123504518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004220384,0.82912064,0.04955918,0.0915532,0.002249039,0.0023208738,0.0048928657,0.00009303206,0.015990777],"genre_scores_gemma":[0.15184155,0.70494324,0.08553248,0.03820672,0.0033659174,0.010802559,0.0041889222,0.00018516007,0.0009334313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.62659365,0.2675474,0.047205657,0.0075147133,0.04943283,0.001705757],"domain_scores_gemma":[0.22460844,0.69011706,0.03915426,0.016045328,0.029312827,0.00076216046],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.32400423,0.0013090757,0.008754897,0.008868303,0.0011361528,0.010826274,0.0052848873,0.008048766,0.0057674716],"category_scores_gemma":[0.5560661,0.0013413841,0.0052594775,0.013468098,0.006616001,0.014528695,0.00469383,0.0071116113,0.0013569206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004948974,0.00021802448,0.0068605985,0.17190127,0.0035396344,0.00020014874,0.0014300311,0.0028917214,0.00039031243,0.12156479,0.026325522,0.664183],"study_design_scores_gemma":[0.001114314,0.00039521023,0.01255816,0.5366355,0.004904183,0.0006077812,0.0017273223,0.0026329856,0.0015551068,0.15987352,0.27773532,0.00026061945],"about_ca_topic_score_codex":0.005132696,"about_ca_topic_score_gemma":0.004922814,"teacher_disagreement_score":0.32400423,"about_ca_system_score_codex":0.006420162,"about_ca_system_score_gemma":0.031090703,"threshold_uncertainty_score":0.8336232},"labels":[],"label_agreement":null},{"id":"W2125072836","doi":"10.1586/14737167.9.1.49","title":"Sleep disorders: impact on daytime functioning and quality of life","year":2009,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Magyar Tudományos Akadémia; Fonds National de la Recherche Luxembourg","keywords":"Insomnia; Quality of life (healthcare); Obstructive sleep apnea; Sleep (system call); Sleep disorder; Excessive daytime sleepiness; Psychiatry; Medicine; Sleep apnea; Psychology; Clinical psychology; Psychotherapist","score_opus":0.1624279677925731,"score_gpt":0.6152126075520499,"score_spread":0.4527846397594768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125072836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004179141,0.99864835,0.00004201878,0.00017627665,0.000044893975,0.0000056383406,0.000044614713,0.0000023365071,0.0006180574],"genre_scores_gemma":[0.0060143485,0.9932909,0.00016205169,0.00012153316,0.00008636338,0.000013474032,0.000054076223,8.7314095e-7,0.0002563623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999453,0.00016156546,0.00011392815,0.00004564283,0.00019798812,0.000027856371],"domain_scores_gemma":[0.9992416,0.0004461721,0.00016994393,0.000010829003,0.00010952323,0.000022022276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083866605,0.0006725932,0.0019544826,0.0017281735,0.00015653588,0.00083299173,0.0005406227,0.0006827162,0.0036120964],"category_scores_gemma":[0.0014174546,0.00015570507,0.00088653056,0.001917564,0.00023419005,0.0005354158,0.00044165397,0.0006491461,0.0005156956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016184937,0.000086483386,0.001969272,0.05526697,0.0013537526,0.0001383463,0.00009062725,0.0002570505,0.00084530894,0.0008921795,0.008516553,0.93042153],"study_design_scores_gemma":[0.00033725216,0.0013878742,0.10216603,0.13955759,0.008370328,0.0068984614,0.0010304889,0.0006655271,0.0021403641,0.0048871976,0.73242813,0.00013074186],"about_ca_topic_score_codex":0.00210862,"about_ca_topic_score_gemma":0.0040853526,"teacher_disagreement_score":0.0036120964,"about_ca_system_score_codex":0.00061440753,"about_ca_system_score_gemma":0.0009127363,"threshold_uncertainty_score":0.012083709},"labels":[],"label_agreement":null},{"id":"W2125344185","doi":"10.1586/14737167.4.2.227","title":"Use of the Greek McGill Pain Questionnaire in cancer patients","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"McGill Pain Questionnaire; Cancer pain; Medicine; Reliability (semiconductor); Palliative care; Physical therapy; Cancer; Pain assessment; Pain management; Visual analogue scale; Nursing; Internal medicine","score_opus":0.06827429764328337,"score_gpt":0.49623038925092094,"score_spread":0.4279560916076376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125344185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661135,0.010012786,0.0012307776,0.0021495686,0.0001829787,0.0014559599,0.0034851483,0.000047914138,0.015321278],"genre_scores_gemma":[0.9912348,0.0024190594,0.0021466953,0.0009036456,0.000051759343,0.00095243135,0.0013131794,0.0000056802373,0.00097277923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821824,0.0007929514,0.0003050992,0.00014031587,0.0004418771,0.00010147096],"domain_scores_gemma":[0.9975358,0.0008193763,0.0010769307,0.00006941258,0.00034723373,0.00015130494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020652805,0.00014872044,0.0006466641,0.0010092417,0.0002496923,0.00034271402,0.0002646796,0.00045655062,0.002014139],"category_scores_gemma":[0.006833657,0.00008292481,0.0005059557,0.0013439308,0.00024405032,0.00037746158,0.0004051292,0.00052871165,0.00028662718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010194937,0.0006178402,0.86166894,0.001437234,0.00036355606,0.00094855326,0.0019517863,0.0005794456,0.0019835476,0.00049006334,0.010562649,0.11837692],"study_design_scores_gemma":[0.000085795305,0.00078447536,0.9907742,0.0001764737,0.000063657106,0.0014416351,0.0005472281,0.00039158505,0.00021964603,0.0001967706,0.0052894875,0.000028963854],"about_ca_topic_score_codex":0.0015848797,"about_ca_topic_score_gemma":0.0017655309,"teacher_disagreement_score":0.0020652805,"about_ca_system_score_codex":0.00055840093,"about_ca_system_score_gemma":0.00047161497,"threshold_uncertainty_score":0.010922432},"labels":[],"label_agreement":null},{"id":"W2125789790","doi":"10.1586/14737167.2014.894463","title":"Burden of schizophrenia on selected comorbidity costs","year":2014,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Comorbidity; Schizophrenia (object-oriented programming); Medicine; Medicaid; Psychiatry; Diabetes mellitus; Substance abuse; Health care","score_opus":0.044155074586706776,"score_gpt":0.4934844209583143,"score_spread":0.44932934637160754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125789790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97470254,0.006931778,0.00028033665,0.0012261885,0.000042713735,0.00004455653,0.010915576,0.000010790139,0.005845524],"genre_scores_gemma":[0.9927866,0.0030931341,0.00026547216,0.00008269977,0.0000362659,0.000017811668,0.003434119,0.0000030053866,0.00028100295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987878,0.00038012175,0.00018402956,0.00007470593,0.0003879037,0.00018539156],"domain_scores_gemma":[0.99804866,0.00039925726,0.001031904,0.000046315974,0.0003125391,0.0001613609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075282465,0.00027186857,0.0004731035,0.0019190265,0.0003019949,0.00095351395,0.00020319299,0.00025526815,0.0025266898],"category_scores_gemma":[0.0054434557,0.00015413643,0.0012249098,0.002285284,0.00015993862,0.00042172824,0.0008269811,0.0004692703,0.000109962304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029507594,0.00004177259,0.97009605,0.00018887759,0.00080103165,0.00022130916,0.000074346644,0.0018675162,0.00017085846,0.0008107623,0.0016848281,0.02374747],"study_design_scores_gemma":[0.00001163885,0.000034829896,0.9960077,0.00015404767,0.00021591476,0.0004009459,0.00020615409,0.0013915965,0.000052578387,0.00025750516,0.0012572537,0.000009921315],"about_ca_topic_score_codex":0.045547504,"about_ca_topic_score_gemma":0.07283037,"teacher_disagreement_score":0.045547504,"about_ca_system_score_codex":0.0025382012,"about_ca_system_score_gemma":0.00180292,"threshold_uncertainty_score":0.09056479},"labels":[],"label_agreement":null},{"id":"W2128180508","doi":"10.1586/erp.11.99","title":"Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases","year":2012,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Palliative care; Cancer; Reliability (semiconductor); Consistency (knowledge bases); Internal consistency; Construct validity; Physical therapy; Medical physics; Internal medicine; Surgery; Patient satisfaction; Nursing; Computer science","score_opus":0.1562678481951936,"score_gpt":0.6085159587682488,"score_spread":0.45224811057305525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128180508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98369527,0.010155571,0.0010292095,0.0004585507,0.00010922521,0.0007048694,0.0014006797,0.000007821193,0.0024388344],"genre_scores_gemma":[0.9944352,0.0015041375,0.0013967529,0.00015920878,0.000044206172,0.0010328434,0.0012095973,0.0000053606336,0.00021270385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895051,0.0071782283,0.0010572419,0.00041273297,0.0015609415,0.0002856529],"domain_scores_gemma":[0.97229904,0.018175514,0.0048734313,0.00050507643,0.0033901837,0.0007567636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014201476,0.00043756564,0.0009218301,0.0022842805,0.00023440631,0.0008882149,0.0005920917,0.0007331099,0.0014774265],"category_scores_gemma":[0.04297059,0.0002447881,0.0015113256,0.0024944618,0.00037606456,0.001244167,0.00096511847,0.0007105556,0.00025505602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017687485,0.001570345,0.843009,0.0017444592,0.0032973967,0.00017942952,0.0019351259,0.001331762,0.00058621925,0.0006066915,0.002202958,0.12584914],"study_design_scores_gemma":[0.0018481865,0.009180753,0.97909224,0.0006958436,0.0009115968,0.00059500214,0.001446682,0.0018260449,0.00023785008,0.00028919874,0.003822832,0.000053654523],"about_ca_topic_score_codex":0.0017834574,"about_ca_topic_score_gemma":0.0024879186,"teacher_disagreement_score":0.014201476,"about_ca_system_score_codex":0.0011236961,"about_ca_system_score_gemma":0.001248151,"threshold_uncertainty_score":0.07510549},"labels":[],"label_agreement":null},{"id":"W2128957789","doi":"10.1586/erp.10.8","title":"One-year treatment costs of trauma care in the USA","year":2010,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"U.S. Public Health Service; Centers for Disease Control and Prevention; National Institute on Aging; Kaiser Permanente","keywords":"Medicine; Emergency medicine; Population; Total cost; Health care; Medical emergency; Environmental health","score_opus":0.08651194521049145,"score_gpt":0.5424378248767435,"score_spread":0.4559258796662521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128957789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8841304,0.057491228,0.0014891851,0.0035741925,0.00018501976,0.00015071234,0.033223774,0.000050452716,0.01970501],"genre_scores_gemma":[0.9657949,0.018344408,0.00097587676,0.0006826571,0.00014913025,0.00009502413,0.012417133,0.00000624567,0.0015346052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998665,0.0004860116,0.00021568176,0.00009877588,0.00046287398,0.00007160991],"domain_scores_gemma":[0.9972011,0.0007024617,0.0013818995,0.00004500939,0.0005603735,0.00010914509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076914707,0.00020745165,0.00043141228,0.0019462503,0.00017148748,0.00075959775,0.00035442892,0.0003597164,0.001061088],"category_scores_gemma":[0.005516335,0.00013238617,0.0008915115,0.0033241576,0.00012557665,0.00052688946,0.0002551623,0.00057835574,0.00020659594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039208893,0.00026025463,0.8565739,0.0010341681,0.0029216474,0.00036663373,0.00018157891,0.0066345786,0.00021787726,0.0023883255,0.017497482,0.11153148],"study_design_scores_gemma":[0.000028124037,0.00020495836,0.9813083,0.00034214385,0.00079651875,0.0011188341,0.00021612848,0.0036059981,0.00022116333,0.0005401039,0.011592773,0.000024854384],"about_ca_topic_score_codex":0.026673203,"about_ca_topic_score_gemma":0.049159363,"teacher_disagreement_score":0.026673203,"about_ca_system_score_codex":0.0022130946,"about_ca_system_score_gemma":0.00088390114,"threshold_uncertainty_score":0.053035855},"labels":[],"label_agreement":null},{"id":"W2131199597","doi":"10.1586/erp.10.61","title":"Health outcome and economic measurement in breast cancer surgery: challenges and opportunities","year":2010,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Breast cancer; Medicine; Scrutiny; Health care; Quality of life (healthcare); Outcome (game theory); Breast surgery; Family medicine; Cancer; Nursing; Internal medicine; Political science","score_opus":0.7351564296115329,"score_gpt":0.6533131831694065,"score_spread":0.08184324644212648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131199597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023560803,0.48816308,0.0855479,0.37500337,0.005556043,0.00074712443,0.0016981,0.00009600841,0.019627498],"genre_scores_gemma":[0.559268,0.24514967,0.12942427,0.042449467,0.01677606,0.0034211888,0.0017435603,0.00021870396,0.0015490889],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6967323,0.2654411,0.012273514,0.004566933,0.019400027,0.0015861816],"domain_scores_gemma":[0.42558432,0.5024373,0.027212039,0.012952504,0.02782514,0.0039887466],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.26465657,0.0018731306,0.0044647353,0.0068329223,0.001701999,0.010540419,0.0040970934,0.0053249924,0.0027000217],"category_scores_gemma":[0.41412637,0.00077293697,0.0020006124,0.015883502,0.011503588,0.01391701,0.0073878192,0.008895744,0.0005436531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006067431,0.0006911919,0.051017694,0.0142331645,0.0015495192,0.00020567543,0.0030706222,0.0075805257,0.00018950886,0.26645198,0.03234598,0.6220574],"study_design_scores_gemma":[0.00022393005,0.0012637427,0.08145391,0.039250597,0.0008242834,0.00070313393,0.0068080015,0.023086686,0.00057940296,0.73516864,0.110045314,0.00059239776],"about_ca_topic_score_codex":0.008752683,"about_ca_topic_score_gemma":0.0054278728,"teacher_disagreement_score":0.26465657,"about_ca_system_score_codex":0.0078087263,"about_ca_system_score_gemma":0.011287089,"threshold_uncertainty_score":0.90680933},"labels":[],"label_agreement":null},{"id":"W2131241212","doi":"10.1586/erp.12.50","title":"A ‘year in the life’ of health services research in oncology","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Health care; MEDLINE; Family medicine; Oncology; Nursing; Political science","score_opus":0.2500173400769087,"score_gpt":0.594136557912106,"score_spread":0.3441192178351973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131241212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004623259,0.950703,0.0006491159,0.03377503,0.010347154,0.000087596294,0.00029159724,0.000026678315,0.0036575485],"genre_scores_gemma":[0.011683853,0.9437636,0.0038058504,0.026771465,0.009838495,0.00039956716,0.0004447006,0.00003966791,0.0032527205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9604852,0.01808522,0.010187948,0.0017696418,0.00801693,0.0014549632],"domain_scores_gemma":[0.8623321,0.08686607,0.021153187,0.005028336,0.015637644,0.008982694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047495756,0.000950663,0.004069575,0.012678301,0.0017219203,0.011546143,0.001554806,0.0049492912,0.010175159],"category_scores_gemma":[0.10229429,0.001039522,0.0022868698,0.022785569,0.005122808,0.01613042,0.0054195155,0.006546725,0.002041382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033676645,0.00007134205,0.002762026,0.094613984,0.0008801107,0.0001992903,0.0018974774,0.0001651665,0.0006482979,0.03780936,0.27584895,0.5847673],"study_design_scores_gemma":[0.00007314376,0.00015337742,0.007813092,0.077341095,0.00037836685,0.00060344354,0.0014937579,0.00005996879,0.00009141506,0.008834951,0.9031069,0.00005049069],"about_ca_topic_score_codex":0.0038708048,"about_ca_topic_score_gemma":0.009744687,"teacher_disagreement_score":0.047495756,"about_ca_system_score_codex":0.0077559766,"about_ca_system_score_gemma":0.016164972,"threshold_uncertainty_score":0.25118452},"labels":[],"label_agreement":null},{"id":"W2132932769","doi":"10.1586/14737167.4.2.143","title":"Levetiracetam: an innovative and cost-effective add-on drug for refractory partial epilepsy","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Levetiracetam; Tolerability; Medicine; Epilepsy; Quality of life (healthcare); Intensive care medicine; Regimen; Adverse effect; Pediatrics; Psychiatry; Pharmacology; Internal medicine","score_opus":0.07345537034517131,"score_gpt":0.5465840953544802,"score_spread":0.47312872500930886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132932769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76066476,0.15410998,0.019488238,0.013436707,0.0011185168,0.000952226,0.0018161216,0.0018521136,0.04656138],"genre_scores_gemma":[0.93283206,0.042185824,0.010038701,0.0017978953,0.0005706122,0.00016138285,0.0010520724,0.000053629774,0.011307813],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99992573,0.000013811907,0.000006659247,0.000010057877,0.000031714517,0.000011975812],"domain_scores_gemma":[0.9999578,0.0000050056033,0.000010029302,0.0000031822892,0.000005401916,0.000018673038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009682182,0.0003664917,0.00032946476,0.00043155355,0.00011872739,0.00030981997,0.0004052225,0.00047758425,0.0024135031],"category_scores_gemma":[0.00014904,0.000062062034,0.0003404219,0.0002774521,0.000143808,0.00031546727,0.00027054801,0.00048370176,0.0009115339],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036117798,0.0010447083,0.0016519523,0.0007580332,0.0000993219,0.0040990785,0.00006105807,0.0009212238,0.08612925,0.0014494999,0.009288994,0.890885],"study_design_scores_gemma":[0.016041579,0.046379007,0.088015065,0.000703626,0.001411492,0.081904,0.00023868943,0.012645223,0.14209367,0.0042192847,0.6060638,0.00028460394],"about_ca_topic_score_codex":0.000638749,"about_ca_topic_score_gemma":0.0024403054,"teacher_disagreement_score":0.0024135031,"about_ca_system_score_codex":0.00045018728,"about_ca_system_score_gemma":0.0002941691,"threshold_uncertainty_score":0.008073986},"labels":[],"label_agreement":null},{"id":"W2133504690","doi":"10.1586/erp.13.4","title":"Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?","year":2013,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Context (archaeology); Internal medicine; Chemotherapy; Cancer; Endocrine system; Gynecology; Hormone; Biology","score_opus":0.0682867311333272,"score_gpt":0.5211553308540013,"score_spread":0.45286859972067417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133504690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002284972,0.9983839,0.000080317455,0.00074783294,0.00006617833,0.000006609768,0.000035175177,0.0000013199908,0.0004500909],"genre_scores_gemma":[0.003309911,0.9956489,0.00029421598,0.00040794507,0.00012148638,0.000017928522,0.000039903294,0.0000014104846,0.00015826205],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99904007,0.0004317748,0.00014372049,0.00008955002,0.00025459708,0.000040250612],"domain_scores_gemma":[0.99656904,0.002755362,0.00031748187,0.000029748118,0.00028957933,0.00003882307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031113545,0.0005270701,0.0025884642,0.0016668648,0.00013127479,0.0012730331,0.0009871193,0.0012731161,0.0039617755],"category_scores_gemma":[0.0071174316,0.0002566472,0.0014858922,0.0021966929,0.00045764976,0.0009639238,0.0003720788,0.0013990493,0.0006762326],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038455467,0.000060453927,0.0005679351,0.028731572,0.00088808866,0.00009965058,0.000019395067,0.00043115157,0.00022705848,0.0026287127,0.010463748,0.95549774],"study_design_scores_gemma":[0.0011076804,0.0013442445,0.013764918,0.110998094,0.010132018,0.0040385756,0.0004000055,0.0012966811,0.0017292857,0.0130415065,0.8419765,0.00017044811],"about_ca_topic_score_codex":0.0018815786,"about_ca_topic_score_gemma":0.003946162,"teacher_disagreement_score":0.0039617755,"about_ca_system_score_codex":0.0011018609,"about_ca_system_score_gemma":0.0015913259,"threshold_uncertainty_score":0.016454577},"labels":[],"label_agreement":null},{"id":"W2140281139","doi":"10.1586/erp.11.60","title":"Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective","year":2011,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University","funders":"","keywords":"Health technology; Multidisciplinary approach; Perspective (graphical); Technology assessment; Health care; Economic evaluation; Engineering ethics; Management science; Political science; Medicine; Sociology; Engineering; Computer science; Social science","score_opus":0.6859030105099432,"score_gpt":0.6972228750913135,"score_spread":0.011319864581370354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140281139","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037360825,0.076694384,0.029518072,0.63610166,0.0011389868,0.0013202301,0.001275676,0.00027516155,0.21631499],"genre_scores_gemma":[0.8368627,0.067171134,0.06848628,0.020198619,0.00081981416,0.0004735977,0.00053745526,0.00008333106,0.005367123],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8970412,0.053996507,0.006508548,0.0022112215,0.032913383,0.007329155],"domain_scores_gemma":[0.7387331,0.14989929,0.011330561,0.004376406,0.08344199,0.01221861],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.094026655,0.0010052755,0.0020141322,0.013917389,0.0079408,0.02531437,0.0044784476,0.005346176,0.0025624547],"category_scores_gemma":[0.21062694,0.00083141454,0.0012273074,0.02034422,0.01059135,0.006463511,0.005998137,0.0074452073,0.00023922294],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00024851775,0.0004610413,0.034733336,0.0047926926,0.00079348177,0.0010741953,0.00807605,0.03132617,0.0005784121,0.51555777,0.059821885,0.34253645],"study_design_scores_gemma":[0.00060640794,0.00041439178,0.09128406,0.021024281,0.0009701898,0.00047552725,0.022387393,0.073734894,0.0025066785,0.32623357,0.4593293,0.0010333287],"about_ca_topic_score_codex":0.9764864,"about_ca_topic_score_gemma":0.97294474,"teacher_disagreement_score":0.9059733,"about_ca_system_score_codex":0.22630894,"about_ca_system_score_gemma":0.5120357,"threshold_uncertainty_score":0.89737195},"labels":[],"label_agreement":null},{"id":"W2141506913","doi":"10.1586/14737167.8.5.433","title":"Is trastuzumab a cost-effective treatment for breast cancer?","year":2008,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Trastuzumab; Breast cancer; Medicine; Oncology; Cost effectiveness; Internal medicine; Cancer; Intensive care medicine; Risk analysis (engineering)","score_opus":0.14571005024597344,"score_gpt":0.6090204262930101,"score_spread":0.4633103760470367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141506913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045775026,0.5414797,0.0017113999,0.43109336,0.003921287,0.00003017086,0.00020100438,0.000024031564,0.016961481],"genre_scores_gemma":[0.118444964,0.7720255,0.0024454661,0.08496517,0.015391257,0.00008299932,0.0002052927,0.00003379803,0.0064055305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738246,0.0010664475,0.00014656922,0.00017160566,0.0010843972,0.00014846942],"domain_scores_gemma":[0.99313873,0.0043654423,0.0008517888,0.00014709444,0.0011928937,0.00030397257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003972368,0.00039528357,0.0013986443,0.0011741483,0.00031896235,0.002994813,0.0007200632,0.0029365988,0.009914077],"category_scores_gemma":[0.021267317,0.00018319723,0.0005881083,0.0017208741,0.0014895244,0.0029668405,0.00045016772,0.0022888146,0.001546382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009063222,0.00017936445,0.0030321449,0.0038147238,0.0006561229,0.0005061557,0.000092831106,0.001246857,0.0009159734,0.057952426,0.14558718,0.7851099],"study_design_scores_gemma":[0.0006746868,0.0006182843,0.011245055,0.00971702,0.0009908075,0.002285128,0.00066448847,0.0016992678,0.0010167469,0.12865552,0.84232384,0.00010911627],"about_ca_topic_score_codex":0.0024405315,"about_ca_topic_score_gemma":0.0022206954,"teacher_disagreement_score":0.009914077,"about_ca_system_score_codex":0.0026134667,"about_ca_system_score_gemma":0.0019862584,"threshold_uncertainty_score":0.033165872},"labels":[],"label_agreement":null},{"id":"W2143519608","doi":"10.1586/14737167.2015.965155","title":"Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion","year":2014,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"Florida Agricultural and Mechanical University","keywords":"Multiple-criteria decision analysis; Health technology; Decision analysis; Management science; Health economics; Health care; Political science; Medicine; Operations research; Engineering; Economics","score_opus":0.3636857210830116,"score_gpt":0.638950156221162,"score_spread":0.2752644351381504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143519608","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11851829,0.04185079,0.08847065,0.5367807,0.0018091027,0.0028711155,0.0022207473,0.000107119624,0.20737146],"genre_scores_gemma":[0.7975795,0.02198845,0.1317003,0.032582056,0.00069019344,0.0012026303,0.00093116687,0.0001015904,0.013224098],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.92873085,0.036685135,0.0030906613,0.0021525095,0.023700392,0.00564046],"domain_scores_gemma":[0.8165022,0.11251293,0.002412899,0.0018112471,0.06325123,0.00350943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13058805,0.0008625465,0.0015091677,0.0043004313,0.009867931,0.011865268,0.0039082114,0.00662336,0.003202835],"category_scores_gemma":[0.1255736,0.0006603546,0.0023881395,0.0070617693,0.0041138055,0.0032860085,0.0034016247,0.0059592044,0.0002867917],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040250435,0.00040167282,0.014850739,0.003927554,0.00072128145,0.0031399776,0.054284804,0.08134588,0.001523149,0.38270608,0.19499277,0.26170364],"study_design_scores_gemma":[0.00026586893,0.00017391246,0.025854586,0.011432783,0.000628333,0.00044238486,0.047913432,0.08790255,0.0020158305,0.18665619,0.6358856,0.00082857034],"about_ca_topic_score_codex":0.8479713,"about_ca_topic_score_gemma":0.8655681,"teacher_disagreement_score":0.9009341,"about_ca_system_score_codex":0.099065885,"about_ca_system_score_gemma":0.18960655,"threshold_uncertainty_score":0.7187767},"labels":[],"label_agreement":null},{"id":"W2143632656","doi":"10.1586/erp.12.34","title":"Meaningful change in oncology quality-of-life instruments: a systematic literature review","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; MEDLINE; Optimism; Systematic review; Clinical trial; Quality of life (healthcare); Medical physics; Intensive care medicine; Publication bias; Meta-analysis; Oncology; Internal medicine; Psychology","score_opus":0.22632404913979168,"score_gpt":0.6133978644091834,"score_spread":0.3870738152693918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143632656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007593638,0.9982274,0.00015378202,0.00015555217,0.00005691335,0.00034086098,0.00014651092,0.0000049504006,0.00015465093],"genre_scores_gemma":[0.0118082445,0.9857248,0.001094719,0.00033695658,0.000056775923,0.0007659361,0.00014495087,0.0000038897997,0.00006372073],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9878049,0.0043826173,0.004292295,0.00065098685,0.0026540437,0.0002150973],"domain_scores_gemma":[0.9471625,0.04068525,0.007703623,0.00055518624,0.0035233763,0.00037000488],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017122978,0.0013032313,0.0084061185,0.012683339,0.0006608482,0.0024136696,0.0016155266,0.0016076565,0.0030808714],"category_scores_gemma":[0.06007076,0.0008698062,0.006320696,0.013264292,0.0009875562,0.0024661957,0.0015863843,0.0012266069,0.0002431167],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019028463,0.00002987923,0.00077808864,0.9206841,0.0062838322,0.00006273737,0.00014276106,0.00008456747,0.00009482614,0.0001938734,0.0011920508,0.07026294],"study_design_scores_gemma":[0.00032261515,0.00029432066,0.006450728,0.91223973,0.06348151,0.0003997159,0.00030560582,0.00014545994,0.00022352378,0.00038784253,0.015700456,0.000048432412],"about_ca_topic_score_codex":0.0048641274,"about_ca_topic_score_gemma":0.017713934,"teacher_disagreement_score":0.982877,"about_ca_system_score_codex":0.0048144497,"about_ca_system_score_gemma":0.012146305,"threshold_uncertainty_score":0.090556085},"labels":[],"label_agreement":null},{"id":"W2144031459","doi":"10.1586/erp.11.37","title":"Measuring voice outcomes following treatment for laryngeal cancer","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Voice and Speech Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University","funders":"","keywords":"Medicine; Quality of life (healthcare); Malignancy; Cancer; Laryngeal Neoplasm; Modalities; Stage (stratigraphy); Larynx; Radiation therapy; Disease; Rehabilitation; Head and neck cancer; Voice therapy; Intensive care medicine; Surgery; Physical therapy; Internal medicine","score_opus":0.247943614929226,"score_gpt":0.5907586055630331,"score_spread":0.34281499063380705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144031459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005535009,0.99829334,0.00012604428,0.00024611477,0.000063039064,0.00001581926,0.00004292426,0.0000028698312,0.0006563464],"genre_scores_gemma":[0.00363597,0.9955095,0.00036810475,0.0001454404,0.00008159587,0.000025177187,0.000052066403,0.0000010445341,0.00018120384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916995,0.00026004182,0.00014047763,0.00010317818,0.00029908775,0.000027362112],"domain_scores_gemma":[0.998425,0.001003563,0.0003279033,0.000017624287,0.00020298387,0.00002299366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019522207,0.0005426239,0.0020735126,0.0017404701,0.00015944055,0.00090641325,0.0007123713,0.00084404706,0.0018678344],"category_scores_gemma":[0.0032910754,0.00013689112,0.00091137976,0.0020196098,0.00029387197,0.0007293824,0.00051095756,0.00076542934,0.0005410157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007545847,0.00006093756,0.0010842632,0.027881956,0.00033364436,0.000074817224,0.000054754884,0.00015605045,0.00047287744,0.0005302498,0.0031765676,0.9660985],"study_design_scores_gemma":[0.00032885277,0.0020085399,0.09045499,0.16394542,0.00551286,0.009047667,0.0015714713,0.00094309595,0.004788729,0.0074051036,0.7137694,0.00022393584],"about_ca_topic_score_codex":0.0013428017,"about_ca_topic_score_gemma":0.0026566628,"teacher_disagreement_score":0.0020735126,"about_ca_system_score_codex":0.0006283281,"about_ca_system_score_gemma":0.0010837498,"threshold_uncertainty_score":0.010324419},"labels":[],"label_agreement":null},{"id":"W2145345262","doi":"10.1586/erp.11.80","title":"Adherence to long-term adjuvant hormonal therapy for breast cancer","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Aromatase; Adjuvant; Oncology; Hormonal therapy; Internal medicine; Gynecology; Intensive care medicine; Cancer","score_opus":0.24212172369096427,"score_gpt":0.6156297505928514,"score_spread":0.3735080269018871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145345262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00078344665,0.99810815,0.00008227361,0.00027559118,0.00006190157,0.0000091808015,0.0000206506,0.0000034789114,0.0006553881],"genre_scores_gemma":[0.005190958,0.99402326,0.0001857216,0.00015528576,0.0001020121,0.000016252923,0.00004108589,6.2380155e-7,0.00028478602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922144,0.00025152467,0.00012936705,0.00006416274,0.00030076847,0.00003269327],"domain_scores_gemma":[0.99900657,0.0004914244,0.000316936,0.000018901728,0.00013857598,0.000027608756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001290638,0.00036516905,0.001408043,0.0008979765,0.00019070803,0.0004877634,0.00054947525,0.0007354005,0.0016382018],"category_scores_gemma":[0.0027534557,0.00012350181,0.0005821344,0.0016302374,0.00016058914,0.00039126334,0.00031649362,0.00060843624,0.00033804614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004881561,0.00008732268,0.0011084267,0.025445335,0.00031926873,0.000087596934,0.000067472654,0.000101013626,0.00039042006,0.0003543358,0.0057918252,0.9661982],"study_design_scores_gemma":[0.00026654045,0.0015186155,0.08658802,0.13383722,0.0038258322,0.008309475,0.00075671717,0.0008344766,0.002096326,0.002659155,0.759221,0.000086571396],"about_ca_topic_score_codex":0.0016773448,"about_ca_topic_score_gemma":0.0033757172,"teacher_disagreement_score":0.0016773448,"about_ca_system_score_codex":0.00030375196,"about_ca_system_score_gemma":0.00093812356,"threshold_uncertainty_score":0.006825626},"labels":[],"label_agreement":null},{"id":"W2152341689","doi":"10.1586/erp.11.64","title":"Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer","year":2011,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Quality of life (healthcare); Cancer; Medicine; Quality (philosophy); Gerontology; Oncology; Family medicine; Internal medicine; Nursing","score_opus":0.13458928638245818,"score_gpt":0.5818670540567401,"score_spread":0.44727776767428196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152341689","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15469623,0.8353709,0.0021959806,0.0009777801,0.00027743718,0.00088271534,0.0012785598,0.000011764251,0.0043086833],"genre_scores_gemma":[0.740953,0.24550644,0.007820657,0.001038484,0.0002569932,0.001799181,0.0021612276,0.000017475377,0.00044639452],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9888859,0.006420005,0.002046899,0.00062370533,0.0018785746,0.00014492948],"domain_scores_gemma":[0.9853276,0.0107030105,0.0017097826,0.00015591236,0.001953159,0.00015056694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012313776,0.0003984132,0.0016283697,0.0038964788,0.00020149675,0.00096223137,0.00056645845,0.00050531444,0.0009594415],"category_scores_gemma":[0.02247539,0.00019328835,0.0022426504,0.0045069014,0.00030890477,0.0012460237,0.0006665775,0.00070928264,0.00012395463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068030814,0.00036502047,0.16457479,0.059564408,0.011049065,0.00026137749,0.0019257143,0.0010902367,0.0013039438,0.0015166964,0.0032500334,0.7482956],"study_design_scores_gemma":[0.0022510902,0.013631296,0.8442934,0.04463305,0.017836085,0.0032934553,0.005120592,0.003161485,0.001161606,0.0017028514,0.062719956,0.00019510808],"about_ca_topic_score_codex":0.0015194721,"about_ca_topic_score_gemma":0.003803365,"teacher_disagreement_score":0.012313776,"about_ca_system_score_codex":0.0012921669,"about_ca_system_score_gemma":0.0013604162,"threshold_uncertainty_score":0.06512219},"labels":[],"label_agreement":null},{"id":"W2153821960","doi":"10.1586/erp.09.50","title":"Understanding the EORTC QLQ-BM22, the module for patients with bone metastases","year":2009,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Clinical trial; Palliative care; Cancer; Psychological intervention; Intensive care medicine; Physical therapy; Internal medicine; Nursing","score_opus":0.11411693489052487,"score_gpt":0.5082855620888818,"score_spread":0.3941686271983569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153821960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38624933,0.032857187,0.12753652,0.076286785,0.0032372023,0.026301522,0.13631195,0.0027991654,0.20842034],"genre_scores_gemma":[0.6541015,0.012963442,0.13199055,0.025724161,0.0011260947,0.031439863,0.10344389,0.0005690494,0.03864148],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978568,0.0011105625,0.00021173939,0.0001267159,0.00046364075,0.00023052121],"domain_scores_gemma":[0.9976724,0.0005354512,0.0004635036,0.00011693852,0.00093420607,0.00027754667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028412072,0.0005612003,0.0005496801,0.000876689,0.00036847458,0.00078238157,0.0006720168,0.00075866026,0.00909927],"category_scores_gemma":[0.01159604,0.000109412766,0.00086538336,0.0013939131,0.00030088704,0.0009232915,0.0014111982,0.000966671,0.0027498584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004208375,0.000467799,0.09398389,0.0021622248,0.0002383827,0.00032750124,0.0010013059,0.0028050733,0.0027141878,0.0067598047,0.28517863,0.6039403],"study_design_scores_gemma":[0.0003835981,0.0011077445,0.31167454,0.0017215433,0.00016600313,0.0019359845,0.0007264711,0.0043137944,0.0017923141,0.011920404,0.66414344,0.000114132],"about_ca_topic_score_codex":0.003852694,"about_ca_topic_score_gemma":0.0050252085,"teacher_disagreement_score":0.00909927,"about_ca_system_score_codex":0.0010473103,"about_ca_system_score_gemma":0.0027900098,"threshold_uncertainty_score":0.030440092},"labels":[],"label_agreement":null},{"id":"W2154636208","doi":"10.1586/14737167.3.3.273","title":"Costs of dyslipidemia","year":2003,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Dyslipidemia; Medicine; Intensive care medicine; Cost effectiveness; Population; Cost–benefit analysis; Disease; Risk analysis (engineering); Environmental health; Internal medicine","score_opus":0.05206509620023147,"score_gpt":0.5243368935090683,"score_spread":0.47227179730883684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154636208","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25047535,0.20075749,0.021363027,0.1403758,0.003967858,0.00066539604,0.019509463,0.0004661568,0.3624195],"genre_scores_gemma":[0.8577837,0.089400895,0.0064673545,0.006531083,0.001485305,0.00028623507,0.004628075,0.000056627185,0.03336073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804544,0.00071098784,0.00015561565,0.0001060013,0.0007383225,0.00024354632],"domain_scores_gemma":[0.99677026,0.0010903169,0.0007544914,0.00010976314,0.0008504684,0.00042471968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012485564,0.0004011551,0.00057411386,0.0013184902,0.0005663705,0.001964324,0.0005548087,0.001014744,0.010233087],"category_scores_gemma":[0.00941959,0.00022826584,0.0008932235,0.0014680465,0.00036892327,0.0007588985,0.0008630584,0.0012558163,0.0010158143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007635432,0.00027542948,0.048175868,0.0021851296,0.0014082293,0.0018180098,0.00034451674,0.010021971,0.0013894531,0.08603587,0.09940401,0.74817795],"study_design_scores_gemma":[0.00032913257,0.001017358,0.27722424,0.006238555,0.0024739928,0.02039839,0.0021743155,0.018732237,0.0021542872,0.105463654,0.5635996,0.00019426795],"about_ca_topic_score_codex":0.0130563555,"about_ca_topic_score_gemma":0.010584886,"teacher_disagreement_score":0.0130563555,"about_ca_system_score_codex":0.004153937,"about_ca_system_score_gemma":0.0033942596,"threshold_uncertainty_score":0.034233034},"labels":[],"label_agreement":null},{"id":"W2155126456","doi":"10.1586/erp.09.34","title":"How should we support pharmaceutical innovation?","year":2009,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Incentive; Subsidy; Business; Productivity; Pharmaceutical industry; Risk analysis (engineering); Industrial organization; Marketing; Economics; Medicine; Pharmacology; Economic growth","score_opus":0.21842768923524403,"score_gpt":0.557909442245123,"score_spread":0.33948175300987893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155126456","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051634545,0.015425442,0.00660711,0.92445743,0.0018552573,0.000034069388,0.00010961567,0.00010822409,0.046239465],"genre_scores_gemma":[0.67674136,0.04649731,0.010471602,0.23184447,0.013606952,0.0002553123,0.00010475647,0.00009939685,0.020378841],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897198,0.004933428,0.00034292194,0.00080999616,0.0026942973,0.0014994523],"domain_scores_gemma":[0.9612858,0.024490284,0.004900958,0.0016943251,0.0044713784,0.0031572082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012886019,0.0005166811,0.0010397047,0.0020475597,0.002342585,0.010548921,0.0011020693,0.01206916,0.012591356],"category_scores_gemma":[0.067815654,0.00033610966,0.000624826,0.0021126834,0.009640697,0.01729806,0.0031890175,0.0073965974,0.003010658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042906293,0.00009742521,0.0014222712,0.0002952141,0.000052740827,0.00008947942,0.00022457376,0.0017468602,0.00013369675,0.9016223,0.054991126,0.03928139],"study_design_scores_gemma":[0.000071217924,0.000035467005,0.0010345636,0.0002972495,0.000016768292,0.00005224685,0.00027463882,0.0010026001,0.00013089764,0.84127253,0.15578905,0.000022753584],"about_ca_topic_score_codex":0.0052756276,"about_ca_topic_score_gemma":0.002284686,"teacher_disagreement_score":0.012886019,"about_ca_system_score_codex":0.005462043,"about_ca_system_score_gemma":0.012130719,"threshold_uncertainty_score":0.06814861},"labels":[],"label_agreement":null},{"id":"W2155943491","doi":"10.1586/14737167.2015.1012069","title":"Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease","year":2015,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Seven Oaks General Hospital","funders":"","keywords":"Medicine; Kidney disease; Intensive care medicine; Peritoneal dialysis; Nephrology; Hemodialysis; Referral; Dialysis; Quality of life (healthcare); Kidney transplantation; Renal replacement therapy; Internal medicine; Transplantation; Family medicine","score_opus":0.14911446132999018,"score_gpt":0.5581059795801654,"score_spread":0.4089915182501752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155943491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015480447,0.998543,0.00008973264,0.000463738,0.00009037581,0.000011255365,0.000048115373,0.0000037466054,0.00059519336],"genre_scores_gemma":[0.0012873021,0.99799275,0.0002539443,0.00018209625,0.00009272951,0.000013478052,0.00004251244,0.0000010560049,0.00013421928],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99935216,0.00019283783,0.00012589504,0.00006809323,0.0002233411,0.000037667323],"domain_scores_gemma":[0.99897826,0.0006470252,0.00015468476,0.0000200061,0.00017224353,0.000027883529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012659271,0.000766016,0.0016851921,0.002523932,0.00024930312,0.0009623304,0.0010569566,0.0010760864,0.006907324],"category_scores_gemma":[0.003256623,0.00018839358,0.0015215932,0.0024028737,0.00028237308,0.0007899337,0.00061638205,0.0011433461,0.0009829613],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074266965,0.000105118655,0.00037817913,0.058035534,0.00085536286,0.000068950336,0.000046964382,0.00040542686,0.0003240215,0.003602217,0.019047398,0.91705644],"study_design_scores_gemma":[0.0001437162,0.0002956166,0.0058220862,0.101512454,0.003555126,0.0013203039,0.00022110043,0.0004288098,0.0006341672,0.0057675764,0.8802389,0.000060174483],"about_ca_topic_score_codex":0.001838842,"about_ca_topic_score_gemma":0.0033727202,"teacher_disagreement_score":0.006907324,"about_ca_system_score_codex":0.0006935314,"about_ca_system_score_gemma":0.0017531693,"threshold_uncertainty_score":0.02310729},"labels":[],"label_agreement":null},{"id":"W2156328434","doi":"10.1586/14737167.2013.850420","title":"Mapping utilities from cancer-specific health-related quality of life instruments: a review of the literature","year":2013,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Quality (philosophy); Quality-adjusted life year; Quality of life (healthcare); Management science; Sample (material); Economic evaluation; Clinical trial; Computer science; Medicine; Risk analysis (engineering); Actuarial science; Operations research; Cost effectiveness; Business; Economics; Mathematics; Pathology","score_opus":0.5207712268768203,"score_gpt":0.6286184462871409,"score_spread":0.1078472194103206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156328434","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009108698,0.9925729,0.003898574,0.0010138855,0.00009340217,0.000056919183,0.00023428649,0.00001380656,0.0012053889],"genre_scores_gemma":[0.019427795,0.9743584,0.005194399,0.00026489387,0.00011965019,0.00021929771,0.00027251287,0.0000139543545,0.00012904787],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9879744,0.006721586,0.0016651886,0.00071459665,0.0027528198,0.0001714215],"domain_scores_gemma":[0.92869514,0.0648618,0.0031329575,0.0006493855,0.0025418277,0.00011881293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019353993,0.0015664233,0.0036688661,0.012380437,0.00033571577,0.0034265462,0.0019717314,0.001390844,0.004520818],"category_scores_gemma":[0.07924462,0.00076870306,0.0047729956,0.016458593,0.00096785463,0.003892315,0.0015747853,0.0022852481,0.0005544992],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010887652,0.00005225796,0.0027088101,0.07137946,0.0015641808,0.000072433046,0.00015748259,0.0036666386,0.00006989807,0.010035553,0.005511714,0.90467274],"study_design_scores_gemma":[0.00028356214,0.00064496236,0.051226474,0.45646256,0.014145829,0.002583262,0.0020910958,0.018007843,0.0016822964,0.1116031,0.3407996,0.00046938032],"about_ca_topic_score_codex":0.0037808463,"about_ca_topic_score_gemma":0.0040611075,"teacher_disagreement_score":0.019353993,"about_ca_system_score_codex":0.0030091656,"about_ca_system_score_gemma":0.0034712052,"threshold_uncertainty_score":0.102354944},"labels":[],"label_agreement":null},{"id":"W2158408499","doi":"10.1586/erp.11.11","title":"Inventory of Cancer Guidelines: a tool to advance the guideline enterprise and improve the uptake of evidence","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Partnership Against Cancer","funders":"Health Research Board; Cancer Care Ontario; Hamilton Health Sciences","keywords":"Guideline; Psychological intervention; Medicine; Audit; Leverage (statistics); Process management; Quality (philosophy); Traceability; Breast cancer; Business; Cancer; Computer science; Nursing; Accounting; Pathology","score_opus":0.5089455112329556,"score_gpt":0.702869191668811,"score_spread":0.1939236804358554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158408499","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02070342,0.23708856,0.34875673,0.19668533,0.008491352,0.06717805,0.020832295,0.022387356,0.07787684],"genre_scores_gemma":[0.015436596,0.03956146,0.92113835,0.0041797105,0.0005502736,0.012788646,0.0040929304,0.0003058172,0.0019462195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.84613824,0.08241509,0.037980583,0.0026899164,0.029543333,0.001232862],"domain_scores_gemma":[0.5198186,0.2708726,0.07405735,0.023195742,0.098619506,0.013436198],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22142158,0.0024120351,0.0051356847,0.04261586,0.0021309198,0.013432286,0.004833303,0.0029942435,0.010148637],"category_scores_gemma":[0.3836478,0.0035886457,0.0043489058,0.038298935,0.0017285584,0.017132988,0.011072406,0.0073466576,0.003917463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011827017,0.0002015715,0.00314339,0.024436947,0.0005569106,0.00008706793,0.0016920218,0.00059776544,0.0003033443,0.007943477,0.09479483,0.8661245],"study_design_scores_gemma":[0.0012928536,0.0007536939,0.025196606,0.09461399,0.00275331,0.0008564185,0.0036041196,0.005031831,0.0013378037,0.020433076,0.84349376,0.0006325068],"about_ca_topic_score_codex":0.0089220535,"about_ca_topic_score_gemma":0.021939171,"teacher_disagreement_score":0.7785784,"about_ca_system_score_codex":0.008520237,"about_ca_system_score_gemma":0.060547967,"threshold_uncertainty_score":0.9601258},"labels":[],"label_agreement":null},{"id":"W2159012420","doi":"10.1586/14737167.8.2.179","title":"Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation","year":2008,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"","keywords":"Medicine; Quality of life (healthcare); Clinical trial; Health related quality of life; Cancer; Oncology; Intensive care medicine; Internal medicine; Disease","score_opus":0.8570624245254256,"score_gpt":0.7311085065718395,"score_spread":0.12595391795358613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159012420","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010415489,0.028302275,0.9475539,0.004219599,0.00067776913,0.006732048,0.0008207017,0.00023162733,0.0010466466],"genre_scores_gemma":[0.18549973,0.010033829,0.7733925,0.0011880972,0.00068674755,0.027532933,0.0010738365,0.00021233624,0.0003800642],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.2631755,0.6643297,0.035733312,0.004771826,0.031424485,0.00056517095],"domain_scores_gemma":[0.12491765,0.80318856,0.019867083,0.031703155,0.019823512,0.00050008245],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.62438804,0.0024812946,0.006580997,0.010431522,0.001545899,0.0051073143,0.003857485,0.0029516222,0.0027804915],"category_scores_gemma":[0.7821145,0.0013237655,0.009624944,0.021986319,0.0060054655,0.0043679215,0.005400429,0.0049481806,0.00040767764],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00584553,0.00048631773,0.08911923,0.021390507,0.03265523,0.000292313,0.0019832938,0.041486934,0.00094988965,0.117310114,0.008670059,0.6798106],"study_design_scores_gemma":[0.005030097,0.009896044,0.06999392,0.02260752,0.027778557,0.0019894892,0.0021998978,0.37841296,0.0056230603,0.409246,0.06613334,0.001089234],"about_ca_topic_score_codex":0.002613024,"about_ca_topic_score_gemma":0.0017738002,"teacher_disagreement_score":0.62438804,"about_ca_system_score_codex":0.0045766137,"about_ca_system_score_gemma":0.005930305,"threshold_uncertainty_score":0.46319646},"labels":[],"label_agreement":null},{"id":"W2159099688","doi":"10.1586/14737167.2014.868313","title":"Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor","year":2013,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Economics; Ticagrelor; Set (abstract data type); Frontier; Efficient frontier; Microeconomics; Actuarial science; Public economics; Econometrics; Financial economics; Medicine; Computer science; Internal medicine","score_opus":0.1267396604495972,"score_gpt":0.5269130122506183,"score_spread":0.4001733518010211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159099688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57655877,0.016708257,0.33235812,0.0073183137,0.00042057913,0.0007749575,0.0028314642,0.00021442048,0.06281519],"genre_scores_gemma":[0.94166714,0.0020775523,0.052730158,0.00038628856,0.000063359104,0.00023163116,0.000931264,0.000044924567,0.0018677966],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99028945,0.006573017,0.0002935938,0.0005523074,0.0018160075,0.00047565447],"domain_scores_gemma":[0.9842308,0.013714254,0.0006947086,0.00059027266,0.0006863293,0.000083566425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014947428,0.0006545453,0.0010077356,0.0025124957,0.00052613317,0.0032377802,0.0010093258,0.0018732705,0.0020228117],"category_scores_gemma":[0.035383753,0.0002825772,0.0011626508,0.0029505235,0.0014546134,0.0031133962,0.0017592921,0.0016597006,0.00018370942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010606975,0.00015207031,0.008811821,0.0008006007,0.00027033512,0.0004288148,0.00045107055,0.30495235,0.00065274176,0.503693,0.008011506,0.17071499],"study_design_scores_gemma":[0.0005134972,0.0009581938,0.04764071,0.0007668482,0.0004089736,0.0004077986,0.0016788208,0.6762391,0.0032892057,0.23965655,0.028202198,0.00023814666],"about_ca_topic_score_codex":0.0170618,"about_ca_topic_score_gemma":0.007402863,"teacher_disagreement_score":0.0170618,"about_ca_system_score_codex":0.00724663,"about_ca_system_score_gemma":0.002558801,"threshold_uncertainty_score":0.07905048},"labels":[],"label_agreement":null},{"id":"W2159729171","doi":"10.1586/14737167.5.6.661","title":"Ethical economics and cost–effectiveness analysis: is it ethical to ignore opportunity costs?","year":2005,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Economics; Health economics; Ethical issues; Opportunity cost; Public economics; Cost–benefit analysis; Actuarial science; Cost effectiveness; Medicine; Positive economics; Psychology; Engineering ethics; Microeconomics; Political science; Operations management; Health care; Law; Economic growth; Engineering","score_opus":0.37724344231516993,"score_gpt":0.6545457216448355,"score_spread":0.27730227932966556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159729171","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046042773,0.07277023,0.0011631482,0.16131955,0.7630948,0.000029330382,0.00007526738,0.000049822956,0.0014517545],"genre_scores_gemma":[0.0012079383,0.03206614,0.0010580053,0.06245989,0.89994764,0.00006353383,0.00003232959,0.000067999914,0.0030965938],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9704863,0.01287651,0.0046892734,0.0013073168,0.010068335,0.0005722323],"domain_scores_gemma":[0.65420276,0.2814061,0.006942301,0.004274852,0.049048077,0.0041257977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051833984,0.0029453533,0.0074226228,0.005798525,0.0026312396,0.010129805,0.0057092546,0.030494636,0.0063697817],"category_scores_gemma":[0.18353856,0.0019165293,0.00318714,0.004163873,0.009503772,0.006406965,0.001546904,0.04055209,0.004623098],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027932163,0.000011718116,0.000024391764,0.0007025662,0.00008942828,0.00007047236,0.00003706199,0.000046271718,0.000019901008,0.0020767471,0.9853601,0.011533227],"study_design_scores_gemma":[0.00026699548,0.00003840977,0.0004285937,0.005263692,0.00043184482,0.0004878004,0.00017883466,0.00056448474,0.00015880632,0.021689966,0.9703963,0.00009427205],"about_ca_topic_score_codex":0.0037289327,"about_ca_topic_score_gemma":0.00911713,"teacher_disagreement_score":0.051833984,"about_ca_system_score_codex":0.004483027,"about_ca_system_score_gemma":0.0068068644,"threshold_uncertainty_score":0.2741276},"labels":[],"label_agreement":null},{"id":"W2160194973","doi":"10.1586/14737167.8.3.273","title":"Systematic review of economic evaluations of Alzheimer’s disease medications","year":2008,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Pharmacoeconomics; Medicine; Disease; Economic evaluation; Intensive care medicine; Cost effectiveness; Health economics; Actuarial science; Economics; Risk analysis (engineering); Public health; Pathology","score_opus":0.3929277369869546,"score_gpt":0.6398002024196178,"score_spread":0.24687246543266317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160194973","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030395084,0.9920123,0.00074202183,0.0005717064,0.000229173,0.0009876495,0.0013445682,0.000016103657,0.0010568689],"genre_scores_gemma":[0.05019211,0.94431514,0.0023411806,0.0005062719,0.00015001536,0.0016035276,0.0006373652,0.000012421471,0.00024186914],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9647645,0.020011837,0.008156206,0.0009779605,0.0055312403,0.0005582988],"domain_scores_gemma":[0.91256773,0.07044881,0.0103192,0.0009244546,0.0052621574,0.0004777952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026150348,0.0022710098,0.0111964345,0.015851995,0.00062538334,0.0032996156,0.0017477126,0.0018862466,0.00637399],"category_scores_gemma":[0.13757251,0.0012276828,0.009837596,0.01430091,0.00092910475,0.0020382535,0.0014726537,0.0015303245,0.0003462472],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008272488,0.000037913855,0.0009584629,0.90750486,0.0377332,0.00016810834,0.000092179405,0.0008292879,0.000083130755,0.0008192001,0.0020925642,0.04885379],"study_design_scores_gemma":[0.0016383672,0.0005416903,0.0071939235,0.7880786,0.17517579,0.0005458473,0.00023316414,0.000787268,0.00030101454,0.0018713498,0.023566077,0.0000668551],"about_ca_topic_score_codex":0.0075987424,"about_ca_topic_score_gemma":0.019426337,"teacher_disagreement_score":0.026150348,"about_ca_system_score_codex":0.007515929,"about_ca_system_score_gemma":0.011966447,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":["metaepi_broad"],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":["metaepi_broad"],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2160983891","doi":"10.1586/14737167.2015.965153","title":"Utility values for pre-menopausal women suffering from symptomatic uterine fibroids","year":2014,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Uterine fibroids; Menstrual bleeding; Gynecology; Pelvic pain; Quality of life (healthcare); Obstetrics; Surgery","score_opus":0.04434877439909115,"score_gpt":0.5187737843774758,"score_spread":0.47442500997838466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160983891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597058,0.020720126,0.004146051,0.0014399271,0.00005822441,0.00030699658,0.0040973336,0.00004519002,0.009480346],"genre_scores_gemma":[0.9956143,0.0015057164,0.0018031913,0.00007298803,0.000009284335,0.000046298148,0.00073212717,0.0000019998213,0.00021417848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981558,0.00085758144,0.00018700199,0.00008630181,0.0006330505,0.00008020099],"domain_scores_gemma":[0.99335796,0.0042598112,0.0011694903,0.00014250242,0.0008712718,0.00019886537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051901187,0.0002813779,0.00060856494,0.0011823355,0.00022748388,0.000609134,0.00037892678,0.00036097405,0.0018011488],"category_scores_gemma":[0.01823029,0.00008698146,0.0011880486,0.001305734,0.00037780608,0.00030338616,0.00036491954,0.0005525445,0.00012610403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016955255,0.00023805157,0.8445053,0.0016194787,0.0014563957,0.00013424235,0.0011248124,0.003378407,0.0003780401,0.000869637,0.002528507,0.14207157],"study_design_scores_gemma":[0.000111285524,0.0010701781,0.98578864,0.0005810985,0.0008194353,0.0003949872,0.0011219146,0.00466066,0.00050619897,0.0014765662,0.0034256852,0.00004331378],"about_ca_topic_score_codex":0.025279095,"about_ca_topic_score_gemma":0.03741649,"teacher_disagreement_score":0.025279095,"about_ca_system_score_codex":0.0018282892,"about_ca_system_score_gemma":0.0011645156,"threshold_uncertainty_score":0.05026394},"labels":[],"label_agreement":null},{"id":"W2161342117","doi":"10.1586/erp.11.32","title":"Better guidelines for better care: enhancing the implementability of clinical practice guidelines","year":2011,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Guideline; Clinical Practice; Context (archaeology); Intervention (counseling); Action (physics); Process management; Management science; Medicine; Knowledge management; Computer science; Nursing; Business; Engineering","score_opus":0.6619902706323569,"score_gpt":0.7630638663695358,"score_spread":0.10107359573717889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161342117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012233604,0.53424865,0.081489086,0.32725322,0.0037566684,0.004917344,0.00019613227,0.0005026635,0.03540258],"genre_scores_gemma":[0.13952905,0.36828205,0.4463446,0.038052723,0.0017031982,0.004036263,0.000298868,0.00012012094,0.001633119],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.6969286,0.23943336,0.020983282,0.0037695114,0.036883943,0.0020012811],"domain_scores_gemma":[0.58997685,0.3283686,0.036153387,0.014324419,0.027374044,0.003802752],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21083593,0.0014374048,0.0024235223,0.0073046624,0.0015045538,0.0074400823,0.0039201416,0.007360797,0.003800008],"category_scores_gemma":[0.42670462,0.0015517671,0.0026984338,0.0063201147,0.004278808,0.014270882,0.0068701906,0.010144403,0.0009613136],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050798917,0.00030825898,0.0016637408,0.032628767,0.0005762162,0.00014836524,0.008291838,0.0011765779,0.0004431198,0.032389447,0.014474572,0.9078483],"study_design_scores_gemma":[0.00082335126,0.0011538953,0.016625734,0.33039826,0.0018828193,0.00146617,0.013866417,0.0024508853,0.0020172002,0.10427703,0.5246415,0.00039683125],"about_ca_topic_score_codex":0.008564903,"about_ca_topic_score_gemma":0.010251563,"teacher_disagreement_score":0.78916407,"about_ca_system_score_codex":0.006961326,"about_ca_system_score_gemma":0.04087464,"threshold_uncertainty_score":0.9731798},"labels":[],"label_agreement":null},{"id":"W2161800579","doi":"10.1586/14737167.2013.842127","title":"Risk equalization in The Netherlands: an empirical evaluation","year":2013,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Equalization (audio); Incentive; Actuarial science; Selection (genetic algorithm); Computer science; Population; Economics; Econometrics; Risk analysis (engineering); Environmental health; Medicine; Telecommunications; Microeconomics","score_opus":0.22744797561720198,"score_gpt":0.5931156316683976,"score_spread":0.36566765605119567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161800579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799064,0.0030264389,0.010033636,0.0005291335,0.00003588033,0.00019964822,0.0019894964,0.000046200345,0.004233235],"genre_scores_gemma":[0.9919035,0.00087011064,0.003238057,0.000082715385,0.000029042421,0.00013291537,0.0027995,0.00002752688,0.0009165858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99394387,0.0039372374,0.00036185273,0.00079752324,0.0006692087,0.00029033015],"domain_scores_gemma":[0.91324335,0.075146064,0.005459859,0.0031350194,0.0024451916,0.0005705076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01649061,0.0006618681,0.0013171792,0.0015156463,0.00043663543,0.0018529252,0.0025464902,0.0010432578,0.0037653279],"category_scores_gemma":[0.06626412,0.0005447927,0.0017856668,0.0024568627,0.0008266526,0.0023380572,0.0015439844,0.0012285683,0.0004360456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001729215,0.0018698779,0.54926133,0.0012416637,0.0026104108,0.0013285,0.0017365782,0.3269969,0.00023341009,0.027394105,0.010778353,0.07481964],"study_design_scores_gemma":[0.00045271762,0.0007491683,0.25062117,0.00048754984,0.0009966658,0.00063393544,0.0025111616,0.71623415,0.0005738537,0.01327201,0.013326895,0.00014075045],"about_ca_topic_score_codex":0.0882478,"about_ca_topic_score_gemma":0.03142693,"teacher_disagreement_score":0.0882478,"about_ca_system_score_codex":0.0032984335,"about_ca_system_score_gemma":0.0015878653,"threshold_uncertainty_score":0.17546827},"labels":[],"label_agreement":null},{"id":"W2167761647","doi":"10.1586/14737167.8.2.111","title":"Pharmacoeconomics of adalimumab for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn’s disease","year":2008,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Adalimumab; Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis; Pharmacoeconomics; Crohn's disease; Infliximab; Biosimilar; Spondylitis; Dermatology; Psoriasis; Internal medicine; Disease; Intensive care medicine","score_opus":0.02317900869786747,"score_gpt":0.42501132709663614,"score_spread":0.40183231839876865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167761647","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11231163,0.6334163,0.009116019,0.15590738,0.0014066469,0.00089341163,0.017127834,0.00016270088,0.06965813],"genre_scores_gemma":[0.74929076,0.21572389,0.006353443,0.016253265,0.002121968,0.0009147854,0.005130309,0.00007009312,0.0041415133],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98944104,0.0070229643,0.00048661456,0.0002257947,0.0026367696,0.00018676172],"domain_scores_gemma":[0.9817992,0.013856972,0.0020807143,0.00029094264,0.0015270532,0.00044510936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007120013,0.00038287108,0.001565674,0.0027620175,0.00021815905,0.0018740044,0.0005061583,0.0010397681,0.00690858],"category_scores_gemma":[0.03078265,0.00018574287,0.0015757963,0.005254508,0.00034913424,0.00071021373,0.0005388326,0.0010638746,0.00034509902],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047295345,0.0005008607,0.0504222,0.0056847637,0.0056629954,0.00044122103,0.00011328944,0.018241018,0.00048482366,0.02430227,0.0442503,0.84516674],"study_design_scores_gemma":[0.0057287756,0.0041777636,0.5587316,0.013088635,0.014970916,0.0040183617,0.00061909645,0.055301778,0.0017178372,0.06544427,0.27587202,0.0003288912],"about_ca_topic_score_codex":0.011972504,"about_ca_topic_score_gemma":0.015436469,"teacher_disagreement_score":0.011972504,"about_ca_system_score_codex":0.004788461,"about_ca_system_score_gemma":0.004276596,"threshold_uncertainty_score":0.037654698},"labels":[],"label_agreement":null},{"id":"W2169804509","doi":"10.1586/14737167.2014.933671","title":"The economic burden of psoriasis: a systematic literature review","year":2014,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriasis; Indirect costs; Medicine; Systematic review; Economic cost; MEDLINE; Business; Economics; Political science; Dermatology; Accounting","score_opus":0.04387184782459543,"score_gpt":0.47216852535200154,"score_spread":0.42829667752740613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169804509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048172538,0.9983412,0.00010116584,0.00026211308,0.00008243782,0.0001296819,0.00031984196,0.0000045752013,0.00027721463],"genre_scores_gemma":[0.004037034,0.9951513,0.00023966965,0.00022187602,0.000049551065,0.000110172296,0.00012033064,0.0000020518219,0.000067971705],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960414,0.001117401,0.00140483,0.0002930662,0.0009967848,0.00014651165],"domain_scores_gemma":[0.98535943,0.010213584,0.002773519,0.00017498278,0.0012968687,0.00018156227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049589053,0.0015803206,0.006118047,0.014122461,0.0006591556,0.0026694885,0.001453004,0.0016465229,0.007234038],"category_scores_gemma":[0.022900827,0.00086332526,0.005956697,0.012770255,0.00056223304,0.0020846832,0.0014369395,0.0011045382,0.00044749843],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015436675,0.000019874886,0.00062411063,0.9265209,0.00713443,0.00018277441,0.00009360236,0.0001458858,0.00010462363,0.00040682228,0.0032276683,0.061384905],"study_design_scores_gemma":[0.00015517393,0.00013151682,0.0038653947,0.90414,0.053333152,0.00089173636,0.00021282544,0.00010801155,0.00013988682,0.00065408845,0.03632892,0.000039327017],"about_ca_topic_score_codex":0.006778426,"about_ca_topic_score_gemma":0.017373914,"teacher_disagreement_score":0.014122461,"about_ca_system_score_codex":0.0036705518,"about_ca_system_score_gemma":0.010292439,"threshold_uncertainty_score":0.026631892},"labels":[],"label_agreement":null},{"id":"W2222802110","doi":"10.1586/14737167.2016.1135740","title":"A systematic review and mixed treatment comparison of monotherapy in early Parkinson’s disease: implications for Latin America","year":2016,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rasagiline; Selegiline; Levodopa; Medicine; Placebo; Parkinson's disease; Pramipexole; Rating scale; Clinical trial; Randomized controlled trial; Disease; Internal medicine; Psychology; Alternative medicine","score_opus":0.09809309373557436,"score_gpt":0.5476245594910921,"score_spread":0.4495314657555178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2222802110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007742703,0.99783605,0.00016140993,0.0002601503,0.00012411494,0.00033226132,0.0002079264,0.0000053391127,0.00029855972],"genre_scores_gemma":[0.027433382,0.96839744,0.0012421068,0.001131852,0.000138927,0.0011735021,0.0002638796,0.000008328698,0.0002106305],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9835186,0.009194279,0.004323173,0.00091254956,0.0017386144,0.0003127735],"domain_scores_gemma":[0.966407,0.027138991,0.003646129,0.00045453795,0.002119665,0.00023369801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020060977,0.0017737597,0.011386626,0.006171603,0.0006110557,0.0032056738,0.0015391822,0.0018900343,0.0057156216],"category_scores_gemma":[0.051490393,0.0007479941,0.011584028,0.006997501,0.00094730535,0.00208397,0.0013826296,0.0011656132,0.00031361435],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006414651,0.000021604961,0.00056187424,0.9322825,0.033703398,0.00008020459,0.00011869296,0.00010606257,0.00013388005,0.00045380706,0.0009827173,0.030913955],"study_design_scores_gemma":[0.0013356708,0.00043471283,0.0041977917,0.66604763,0.30502677,0.00027313206,0.0002547169,0.00016286022,0.00019872753,0.00094667374,0.02108056,0.00004082727],"about_ca_topic_score_codex":0.0074306196,"about_ca_topic_score_gemma":0.023855455,"teacher_disagreement_score":0.020060977,"about_ca_system_score_codex":0.004619406,"about_ca_system_score_gemma":0.010269184,"threshold_uncertainty_score":0.106093824},"labels":[],"label_agreement":null},{"id":"W2259186441","doi":"10.1586/14737167.2016.1133301","title":"Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis","year":2015,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Secukinumab; Ustekinumab; Medicine; Etanercept; Psoriasis; Plaque psoriasis; Dermatology; Quality of life (healthcare); Cost effectiveness; Intensive care medicine; Internal medicine; Psoriatic arthritis; Adalimumab; Tumor necrosis factor alpha","score_opus":0.125425104094077,"score_gpt":0.5415789431220314,"score_spread":0.41615383902795433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259186441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007046625,0.9993685,0.000028351316,0.00021784165,0.000049047547,0.00000874963,0.000021483924,9.959733e-7,0.00023460902],"genre_scores_gemma":[0.0011128271,0.9984743,0.000091470945,0.0001337062,0.00005703448,0.000013154473,0.000024127266,7.165238e-7,0.00009259561],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99908257,0.0003470492,0.00018271839,0.00006723661,0.00027836658,0.000042133335],"domain_scores_gemma":[0.9973894,0.0018054005,0.00038568338,0.000028359358,0.00033493034,0.000056231645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002511466,0.00072846963,0.002230407,0.0033487345,0.00023417019,0.0011311964,0.0011751205,0.001133696,0.005938541],"category_scores_gemma":[0.005655844,0.00037284647,0.0017014358,0.004110261,0.00029408917,0.0007303711,0.00048346596,0.00089898973,0.0006048226],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032728855,0.00009432987,0.00021974833,0.1957401,0.0014732102,0.00016558536,0.000059383077,0.0005993527,0.00027381172,0.0036784993,0.03142309,0.7659457],"study_design_scores_gemma":[0.00035974145,0.0004573789,0.0037560388,0.2213748,0.006749075,0.0013204623,0.00014955066,0.00050581986,0.000423328,0.0051605906,0.759685,0.00005820074],"about_ca_topic_score_codex":0.002554489,"about_ca_topic_score_gemma":0.00502698,"teacher_disagreement_score":0.005938541,"about_ca_system_score_codex":0.0012372513,"about_ca_system_score_gemma":0.0027850973,"threshold_uncertainty_score":0.019866347},"labels":[],"label_agreement":null},{"id":"W2296617749","doi":"10.1586/14737167.2016.1159514","title":"Endocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations","year":2016,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Breast cancer; Clinical trial; Selective estrogen receptor modulator; Aromatase; Intensive care medicine; Gynecology; Tamoxifen; Oncology; Cancer; Cost effectiveness; Internal medicine; Risk analysis (engineering)","score_opus":0.07188749332857211,"score_gpt":0.5697167154446845,"score_spread":0.49782922211611236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296617749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001088817,0.99636877,0.0001033743,0.0023354962,0.0001021488,0.0000056495296,0.000026548056,0.0000020823495,0.00094702956],"genre_scores_gemma":[0.0012700971,0.9974215,0.00024133235,0.0006324702,0.00017781822,0.000010603748,0.00001767036,0.000001127135,0.00022733842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999311,0.00028000903,0.00009666099,0.000065497035,0.00020924342,0.00003773329],"domain_scores_gemma":[0.99741757,0.001995322,0.00021258157,0.000035005298,0.00029100128,0.000048573813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002058924,0.00044424232,0.0016117524,0.0014942695,0.00020575791,0.0014458122,0.00087692,0.0016161766,0.0054607117],"category_scores_gemma":[0.0037127256,0.00018843183,0.000956859,0.0020196857,0.00049597304,0.0011122529,0.0004950711,0.0019781007,0.00096227624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096803786,0.000059727085,0.00026505033,0.020838577,0.0002602475,0.0001638667,0.000044106357,0.00042863144,0.00028547592,0.009409033,0.023708409,0.9444401],"study_design_scores_gemma":[0.00009928195,0.00018061482,0.0019387698,0.036017776,0.0006913203,0.0019466225,0.00018263113,0.00029620278,0.00029620362,0.0131640155,0.94515055,0.000035996756],"about_ca_topic_score_codex":0.0015956068,"about_ca_topic_score_gemma":0.0040053194,"teacher_disagreement_score":0.0054607117,"about_ca_system_score_codex":0.000915917,"about_ca_system_score_gemma":0.0020747494,"threshold_uncertainty_score":0.01826787},"labels":[],"label_agreement":null},{"id":"W2299509180","doi":"10.1586/14737167.2016.1167600","title":"Variations in costs and use of provincially-funded testosterone replacement therapy across Canada: a population-based study","year":2016,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information; Sunnybrook Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; St. Michael's Hospital","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Reimbursement; Testosterone replacement; Demography; Listing (finance); Medicine; Population; Environmental health; Geography; Health care; Business; Economic growth; Economics; Finance","score_opus":0.07820718193682295,"score_gpt":0.5059071232565997,"score_spread":0.42769994131977673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299509180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98443615,0.0028708577,0.00021299781,0.0006445234,0.000011496536,0.00006388661,0.010199028,0.000014758099,0.0015462285],"genre_scores_gemma":[0.996201,0.0011144818,0.00021719262,0.00010962588,0.000005747569,0.000018259883,0.002096983,0.000004939334,0.00023186672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980058,0.00019883063,0.00020328852,0.0002815392,0.0008875036,0.00042299367],"domain_scores_gemma":[0.99590874,0.00035741602,0.001388346,0.00016961183,0.0016341725,0.0005416833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013044736,0.00025178192,0.00054178335,0.0021078126,0.001370612,0.0012354872,0.0012704936,0.00039405838,0.0013150465],"category_scores_gemma":[0.004432029,0.00034452853,0.0008648168,0.008450328,0.0007349191,0.00034074316,0.00063336623,0.0005533155,0.00012731565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054634325,0.0000150393635,0.99515545,0.00006952016,0.000174336,0.000034517427,0.0002801465,0.00016205703,0.000056751793,0.00008603518,0.0008058283,0.0031057198],"study_design_scores_gemma":[0.000005065429,0.0000089494115,0.99902546,0.000033939137,0.000039214843,0.000033411623,0.00024637041,0.00018551422,0.000022520564,0.000013284091,0.00037998418,0.0000062333056],"about_ca_topic_score_codex":0.99061567,"about_ca_topic_score_gemma":0.9917623,"teacher_disagreement_score":0.026717229,"about_ca_system_score_codex":0.026717229,"about_ca_system_score_gemma":0.02845217,"threshold_uncertainty_score":0.19384795},"labels":[],"label_agreement":null},{"id":"W2299937594","doi":"10.1586/14737167.2016.1165608","title":"Advantages and disadvantages of discrete-event simulation for health economic analyses","year":2016,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Health technology; Discrete event simulation; Economic evaluation; Event (particle physics); Health economics; Actuarial science; Intervention (counseling); Carry (investment); Public economics; Risk analysis (engineering); Management science; Environmental economics; Medicine; Computer science; Economics; Health care; Economic growth; Nursing; Simulation; Microeconomics; Finance","score_opus":0.3024852049675816,"score_gpt":0.7057749390583502,"score_spread":0.4032897340907686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299937594","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080396456,0.1790637,0.20191242,0.20834513,0.39704344,0.0001863239,0.0011797267,0.0011431305,0.010322234],"genre_scores_gemma":[0.04373423,0.19631091,0.1515463,0.12724802,0.4606204,0.0013882574,0.00092779245,0.0017822153,0.016441906],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9342333,0.045018874,0.00560676,0.0026634962,0.012114892,0.00036264092],"domain_scores_gemma":[0.46217778,0.5158037,0.0037914624,0.0053704726,0.011834792,0.0010217369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.068305746,0.001859717,0.0034986292,0.0023408507,0.000845641,0.00784899,0.0043927804,0.009687333,0.00900125],"category_scores_gemma":[0.28208703,0.0010695303,0.0048439796,0.0025988966,0.00472367,0.004903772,0.00197674,0.021497693,0.003836436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066076114,0.000085772685,0.00044589426,0.006852228,0.0018167994,0.00033728682,0.00026791354,0.021969937,0.00016404112,0.17909764,0.59252995,0.19577178],"study_design_scores_gemma":[0.00082061044,0.0001129129,0.00037872026,0.005474335,0.000530959,0.0003899061,0.000059893577,0.041537963,0.0002792447,0.2817732,0.6684825,0.00015974119],"about_ca_topic_score_codex":0.0020014464,"about_ca_topic_score_gemma":0.0017873436,"teacher_disagreement_score":0.068305746,"about_ca_system_score_codex":0.0024226822,"about_ca_system_score_gemma":0.0038068802,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2343721711","doi":"10.1080/14737167.2016.1182865","title":"A further examination of the problem of double-counting in incremental cost-utility analyses","year":2016,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"McMaster University","keywords":"Cost–utility analysis; Productivity; Operations management; Economics; Econometrics; Actuarial science; Operations research; Computer science; Cost effectiveness; Mathematics","score_opus":0.38475998268930706,"score_gpt":0.6370176872461477,"score_spread":0.25225770455684066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343721711","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026161343,0.14731482,0.019809818,0.36306524,0.46249008,0.000106655236,0.0004194494,0.00023196351,0.006300442],"genre_scores_gemma":[0.0063558063,0.059986085,0.011528927,0.18259008,0.7320839,0.00019881224,0.00009347915,0.00047675075,0.006686094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9399213,0.032100577,0.0065788976,0.004202437,0.016714882,0.00048189564],"domain_scores_gemma":[0.4870177,0.4639467,0.0071843294,0.008419839,0.03173677,0.0016946974],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09519388,0.002640446,0.004384603,0.0034676641,0.0021841773,0.008109387,0.0054673296,0.015186872,0.008937402],"category_scores_gemma":[0.32072386,0.0010590713,0.0047780536,0.0038194312,0.008767295,0.00875332,0.0024119066,0.037716765,0.00400477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012688512,0.000020217629,0.00015053789,0.002485579,0.00029183755,0.000196657,0.00024638712,0.00047116727,0.00010984249,0.042085413,0.87003773,0.08377779],"study_design_scores_gemma":[0.00013808713,0.00007544423,0.00041140607,0.0065431795,0.0002979819,0.00075875636,0.00010876699,0.0014145995,0.0002896442,0.06421362,0.9256501,0.00009836114],"about_ca_topic_score_codex":0.002596543,"about_ca_topic_score_gemma":0.0038338604,"teacher_disagreement_score":0.90480614,"about_ca_system_score_codex":0.004927474,"about_ca_system_score_gemma":0.0056353454,"threshold_uncertainty_score":0.50343937},"labels":[],"label_agreement":null},{"id":"W2469634066","doi":"10.1080/14737167.2016.1203258","title":"Persistence with medication and overactive bladder: an ongoing challenge","year":2016,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Overactive bladder; Persistence (discontinuity); Disease; Medicine; Intensive care medicine; Narrative review; Alternative medicine; Internal medicine; Pathology","score_opus":0.12493976069138231,"score_gpt":0.5667339729519317,"score_spread":0.44179421226054943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469634066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026640837,0.98115325,0.00015209922,0.017308516,0.0005784201,0.000006921346,0.00004267419,0.000003127464,0.00048865814],"genre_scores_gemma":[0.0058993483,0.98552763,0.00038029582,0.0062763444,0.0015731803,0.000025137815,0.00003871494,0.0000038022342,0.00027562416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928544,0.0033890684,0.0011541065,0.0006001921,0.001745413,0.00025682288],"domain_scores_gemma":[0.96856,0.0249215,0.0033730813,0.00032723343,0.0024532387,0.00036499716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008480924,0.00048212902,0.0028241714,0.0015128807,0.000751827,0.0028441644,0.0012872933,0.0034956334,0.0047496245],"category_scores_gemma":[0.021905942,0.00034722232,0.001732204,0.0029681765,0.00204855,0.0041707987,0.0014038038,0.0036938637,0.0006062606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001627509,0.000034229415,0.0019494288,0.16040088,0.00090712856,0.0007802825,0.002001584,0.00035480244,0.00036582546,0.017486388,0.069184,0.7463727],"study_design_scores_gemma":[0.000054015913,0.00016962587,0.007200295,0.30910504,0.0012824938,0.005095245,0.004500611,0.00021155305,0.00023127338,0.016574906,0.6554653,0.00010965968],"about_ca_topic_score_codex":0.006428858,"about_ca_topic_score_gemma":0.012398647,"teacher_disagreement_score":0.008480924,"about_ca_system_score_codex":0.0021414775,"about_ca_system_score_gemma":0.009216078,"threshold_uncertainty_score":0.04485196},"labels":[],"label_agreement":null},{"id":"W2547467223","doi":"10.1080/14737167.2017.1256775","title":"Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa","year":2016,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Alternative medicine; Family medicine; Political science; Traditional medicine","score_opus":0.18886071628508216,"score_gpt":0.4957692279024389,"score_spread":0.3069085116173567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547467223","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.090942875,0.013707222,0.006307312,0.6557345,0.14494073,0.005230104,0.010231218,0.0002509703,0.07265509],"genre_scores_gemma":[0.40155932,0.018437719,0.017267324,0.1893282,0.0535852,0.010592534,0.011748917,0.00051574997,0.296965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965592,0.0013961354,0.00009888452,0.00020049883,0.00080608315,0.0009392556],"domain_scores_gemma":[0.9863651,0.0022302894,0.000670611,0.00022303798,0.0037169594,0.0067940047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02205124,0.0010220021,0.00055562344,0.00078455155,0.0021066542,0.0038419613,0.0008555517,0.005247656,0.012733397],"category_scores_gemma":[0.017688546,0.0003297155,0.0011077578,0.0005069857,0.00049844297,0.0013250792,0.003876634,0.005744881,0.0029341215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017442802,0.0010731851,0.0053240047,0.0017028784,0.00013147817,0.0016187358,0.004686219,0.0004844865,0.0037524847,0.0033423766,0.92201453,0.054125417],"study_design_scores_gemma":[0.0005883032,0.00092584506,0.03609019,0.0011825669,0.0001183488,0.00022785715,0.007436633,0.0003588236,0.003059822,0.0020135026,0.9479136,0.00008441085],"about_ca_topic_score_codex":0.005364258,"about_ca_topic_score_gemma":0.010005675,"teacher_disagreement_score":0.02205124,"about_ca_system_score_codex":0.0034811012,"about_ca_system_score_gemma":0.011328773,"threshold_uncertainty_score":0.11661953},"labels":[],"label_agreement":null},{"id":"W2556969995","doi":"10.1080/14737167.2016.1259573","title":"Reply: Letter to the Editor: About the advantages and disadvantages of discrete-event simulation for health economic analyses","year":2016,"lang":"en","type":"letter","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Discrete event simulation; Event (particle physics); Operations research; Computer science; Management science; Actuarial science; Economics; Engineering; Simulation","score_opus":0.30611077186823754,"score_gpt":0.6609729736570953,"score_spread":0.35486220178885775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556969995","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008366098,0.00069307705,0.00009567669,0.97629195,0.022131216,0.000013104275,0.00013710791,0.000034667402,0.0005194668],"genre_scores_gemma":[0.00087531883,0.00053796923,0.00020865191,0.97130585,0.024706567,0.000049997194,0.00004186467,0.000030370504,0.002243507],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910103,0.0033005395,0.0016955542,0.0009236987,0.0024238615,0.0006460854],"domain_scores_gemma":[0.9599006,0.024278732,0.0029730164,0.00086011575,0.009481863,0.0025057243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01405298,0.001078974,0.0024349438,0.0011442292,0.0030014194,0.0048784446,0.003204062,0.05199388,0.009421445],"category_scores_gemma":[0.089279436,0.0011615498,0.0028953748,0.0013048999,0.003035163,0.005308417,0.0020607165,0.05151691,0.011185364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004003064,0.000008051065,0.00014515674,0.00004387304,0.000010862156,0.0001132342,0.000031330495,0.00004019713,0.000026720481,0.00054874475,0.9969716,0.0020201788],"study_design_scores_gemma":[0.00023097139,0.00006057415,0.0010177706,0.00072129496,0.00007120654,0.00068244454,0.00023780375,0.00078918005,0.00029143883,0.0066148955,0.9891719,0.00011052132],"about_ca_topic_score_codex":0.0075042993,"about_ca_topic_score_gemma":0.0077916244,"teacher_disagreement_score":0.05199388,"about_ca_system_score_codex":0.0052718436,"about_ca_system_score_gemma":0.009549594,"threshold_uncertainty_score":0.07432014},"labels":[],"label_agreement":null},{"id":"W2613930366","doi":"10.1080/14737167.2017.1330152","title":"Recent amendments to NICE’s value-based assessment of health technologies: implicitly inequitable?","year":2017,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nice; Value (mathematics); Health technology; Medicine; Public economics; Political science; Environmental economics; Economics; Computer science; Economic growth; Health care; Mathematics; Statistics","score_opus":0.36754775048736343,"score_gpt":0.6718588689455758,"score_spread":0.30431111845821235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613930366","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029089275,0.018090978,0.00045044083,0.23088837,0.7477021,0.000040685747,0.0001914628,0.000059969687,0.0025467705],"genre_scores_gemma":[0.00072578964,0.014811227,0.00069910294,0.13064604,0.8459256,0.00010861131,0.00010723176,0.0001464575,0.0068299063],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9424425,0.015170329,0.009859545,0.0034759955,0.027407294,0.0016443988],"domain_scores_gemma":[0.7074817,0.21683942,0.0105844075,0.0056924177,0.053618178,0.0057838755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0629332,0.0031819178,0.0060692467,0.006099363,0.0041149464,0.012342138,0.0079365,0.031269956,0.009674994],"category_scores_gemma":[0.2471879,0.002020894,0.005151672,0.0049223867,0.009878638,0.0076508285,0.0036697309,0.046959955,0.008407422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018196328,0.0000060289103,0.0000108563445,0.00039852696,0.000029417712,0.000035084606,0.000042664975,0.000027595113,0.000014265389,0.001831246,0.99305254,0.004533562],"study_design_scores_gemma":[0.00008577406,0.000017475668,0.00013240613,0.00212659,0.00010895816,0.000113504364,0.000062968145,0.00011190258,0.00007386532,0.0054623056,0.9916631,0.000041191954],"about_ca_topic_score_codex":0.005559837,"about_ca_topic_score_gemma":0.012918241,"teacher_disagreement_score":0.0629332,"about_ca_system_score_codex":0.007545134,"about_ca_system_score_gemma":0.013947931,"threshold_uncertainty_score":0.3328265},"labels":[],"label_agreement":null},{"id":"W2944222080","doi":"10.1080/14737167.2019.1612242","title":"The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management","year":2019,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Preference; Health care; Stakeholder; Medicine; Drug development; Drug; Public relations; Political science","score_opus":0.584630819039588,"score_gpt":0.706413443861426,"score_spread":0.12178262482183799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944222080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013985154,0.939861,0.007398637,0.04562862,0.0015739565,0.00014824887,0.00025927532,0.000017347269,0.0037144893],"genre_scores_gemma":[0.06442478,0.8855989,0.017520292,0.026755845,0.0040510804,0.0008914519,0.00021741343,0.000032237684,0.00050802744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.79807454,0.17506868,0.008473748,0.0036316626,0.013763895,0.0009874899],"domain_scores_gemma":[0.3693931,0.5992434,0.012404176,0.004257782,0.013276936,0.0014246817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15428784,0.0011509696,0.0051106806,0.005058796,0.0009965678,0.008435534,0.0029866616,0.0049021435,0.007836475],"category_scores_gemma":[0.25695676,0.0007601293,0.003450179,0.009628717,0.0071346913,0.009678129,0.0042311316,0.008260407,0.00069000234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047046982,0.00009934362,0.0023698302,0.092236795,0.0014690654,0.00015830282,0.0031905917,0.0012652691,0.00010022078,0.095178135,0.024494193,0.77896774],"study_design_scores_gemma":[0.00040413474,0.0008031164,0.009048555,0.3990193,0.0018415243,0.0015908683,0.0070134588,0.0033271175,0.00046381136,0.3030947,0.27292004,0.00047334863],"about_ca_topic_score_codex":0.005104175,"about_ca_topic_score_gemma":0.0070814965,"teacher_disagreement_score":0.15428784,"about_ca_system_score_codex":0.007053288,"about_ca_system_score_gemma":0.01265244,"threshold_uncertainty_score":0.81596184},"labels":[],"label_agreement":null},{"id":"W3008489692","doi":"10.1080/14737167.2020.1734455","title":"Effectiveness of non-pharmacological COPD management on health-related quality of life - a systematic review","year":2020,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Gemeinsame Bundesausschuss","keywords":"Medicine; COPD; Quality of life (healthcare); Physical therapy; Pulmonary rehabilitation; Psychological intervention; Randomized controlled trial; Intensive care medicine; Rehabilitation; MEDLINE; Systematic review; Intervention (counseling); Internal medicine; Nursing","score_opus":0.09918586841478204,"score_gpt":0.5623960061897446,"score_spread":0.46321013777496256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008489692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007042433,0.9984835,0.00005787045,0.000106685264,0.00005479618,0.000164798,0.00023568589,0.0000060476837,0.000186405],"genre_scores_gemma":[0.016762046,0.98185354,0.0003335116,0.00029358888,0.00007143441,0.00041299878,0.00017938309,0.0000041173544,0.00008944055],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99481994,0.0020935787,0.0014723896,0.00047082416,0.0009765514,0.00016664942],"domain_scores_gemma":[0.9821976,0.013757064,0.0026494924,0.0001775796,0.0010276523,0.00019062741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056608263,0.0013773777,0.01028599,0.005380231,0.00045312633,0.0021011082,0.0014783075,0.0014954432,0.0063791983],"category_scores_gemma":[0.02398495,0.0007312908,0.0076334267,0.005550483,0.00072047644,0.0013577085,0.0009362458,0.0011300688,0.00030668953],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022818196,0.000020428863,0.00046081012,0.9550527,0.01218959,0.000037763024,0.00005549016,0.00008646969,0.00008035203,0.00011493663,0.00094674906,0.030726483],"study_design_scores_gemma":[0.00067346357,0.0004306619,0.0070796963,0.83375084,0.1417751,0.00027064836,0.00015366511,0.00015538663,0.00020459479,0.00031882158,0.015145224,0.00004198347],"about_ca_topic_score_codex":0.007930484,"about_ca_topic_score_gemma":0.020753976,"teacher_disagreement_score":0.01028599,"about_ca_system_score_codex":0.0031732407,"about_ca_system_score_gemma":0.0064249844,"threshold_uncertainty_score":0.029937685},"labels":[],"label_agreement":null},{"id":"W3015429864","doi":"10.1080/14737167.2020.1755261","title":"Predicting SF-6Dv2 utility scores for chronic low back pain using the Oswestry Disability Index and Roland-Morris Disability Questionnaire","year":2020,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Hospitalier Universitaire de Sherbrooke; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"","keywords":"Oswestry Disability Index; Physical therapy; Medicine; Index (typography); Chronic pain; Low back pain; Health Utilities Index; Physical medicine and rehabilitation; Alternative medicine; Health related quality of life; Internal medicine","score_opus":0.054209813661163946,"score_gpt":0.48238320368118603,"score_spread":0.4281733900200221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015429864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779665,0.00018591776,0.0009758875,0.000068390036,0.000007462065,0.000018222556,0.0006288647,0.000013354366,0.0003053161],"genre_scores_gemma":[0.99864084,0.000043014043,0.00051458046,0.000008540868,0.00000574524,0.000012597319,0.0006919687,0.000002349214,0.00008037752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992023,0.00036042923,0.000068329486,0.000112560476,0.00016548853,0.0000909515],"domain_scores_gemma":[0.99774796,0.0010905929,0.0005638966,0.00011562073,0.00027493844,0.00020687364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025144373,0.00073398126,0.00041913334,0.0012132175,0.00017553421,0.0006325449,0.00031010248,0.0004976516,0.001554615],"category_scores_gemma":[0.0069403406,0.00021212045,0.00092759484,0.00069943914,0.00021003523,0.00038883527,0.00050613924,0.000602705,0.0004973713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010060547,0.000051623356,0.99676466,0.000010708973,0.000050564893,0.000019417188,0.000023637194,0.00066048006,0.000089815934,0.00001756289,0.00016663174,0.0020442773],"study_design_scores_gemma":[0.000037885402,0.00023112229,0.9837023,0.000015814598,0.00003549615,0.00014774823,0.000079924466,0.015307811,0.00011990478,0.00014815402,0.00016405992,0.000009796534],"about_ca_topic_score_codex":0.003646167,"about_ca_topic_score_gemma":0.004297031,"teacher_disagreement_score":0.003646167,"about_ca_system_score_codex":0.0003775112,"about_ca_system_score_gemma":0.00032553513,"threshold_uncertainty_score":0.013297796},"labels":[],"label_agreement":null},{"id":"W3047784207","doi":"10.1080/14737167.2020.1804873","title":"Health equity and the usage of atypical antipsychotics within the Brazilian national health system: findings and implications","year":2020,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Psychiatry; Medicine; Public health; Health care; Equity (law); Atypical antipsychotic; Antipsychotic; Environmental health; Psychology; Schizophrenia (object-oriented programming); Nursing; Political science","score_opus":0.10126124903362918,"score_gpt":0.559261377525504,"score_spread":0.45800012849187477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047784207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8414357,0.06127729,0.0014092933,0.08018509,0.00027041737,0.000109585846,0.0032438159,0.000019884246,0.012048876],"genre_scores_gemma":[0.9939697,0.0041108406,0.0002524112,0.0013295246,0.000074475836,0.000020026633,0.00015637692,0.0000021554222,0.00008449091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653155,0.0017525458,0.00031483267,0.00040591837,0.0005847293,0.00041043677],"domain_scores_gemma":[0.9805149,0.009899595,0.0062535987,0.0006290924,0.0017890617,0.00091380294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005920028,0.00015984592,0.0004365241,0.0012938743,0.0005592057,0.0008969483,0.000812353,0.0006703722,0.002313117],"category_scores_gemma":[0.022146702,0.00012317662,0.0007011079,0.0024245083,0.0010627072,0.001226892,0.0010781212,0.0007370144,0.00007844941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063871434,0.000042632597,0.94970524,0.0014747771,0.00024623892,0.00022235248,0.0035059291,0.00016689666,0.000102750004,0.0036016311,0.0026391607,0.03822853],"study_design_scores_gemma":[0.000012724514,0.000053153475,0.98295146,0.0033371693,0.0001962292,0.00032532268,0.0056016864,0.0004978083,0.00005952027,0.0020718318,0.004873165,0.000020039137],"about_ca_topic_score_codex":0.12944116,"about_ca_topic_score_gemma":0.13400137,"teacher_disagreement_score":0.12944116,"about_ca_system_score_codex":0.002349328,"about_ca_system_score_gemma":0.0054584723,"threshold_uncertainty_score":0.25737542},"labels":[],"label_agreement":null},{"id":"W3083345798","doi":"10.1080/14737167.2020.1819794","title":"Burden of depression among Canadian adults with cancer; results from a national survey","year":2020,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Suicidal ideation; Depression (economics); Patient Health Questionnaire; Logistic regression; Mental health; Context (archaeology); Psychiatry; Suicide prevention; Poison control; Occupational safety and health; Clinical psychology; Internal medicine; Environmental health; Anxiety; Pathology; Depressive symptoms","score_opus":0.06838418910474976,"score_gpt":0.48471051926123526,"score_spread":0.4163263301564855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083345798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931564,0.0038339852,0.00022584289,0.0014213873,0.000052125783,0.00015561738,0.053737275,0.000044495366,0.008965249],"genre_scores_gemma":[0.9884992,0.0017667401,0.00039184713,0.0002346634,0.000019585546,0.00005170686,0.008070306,0.0000050641775,0.0009608055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993193,0.000043510463,0.00004708274,0.000064634696,0.0003837722,0.00014163813],"domain_scores_gemma":[0.99894875,0.0000318504,0.00023173924,0.000022603068,0.00056465896,0.00020039374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075298856,0.00024174117,0.0002920197,0.0014577578,0.0013578791,0.000747141,0.00058834965,0.00027301407,0.001687386],"category_scores_gemma":[0.0020708938,0.00017564103,0.00053428527,0.0031405706,0.00023189196,0.00026874535,0.0005983268,0.00042727633,0.00022405206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044773642,0.000016401049,0.99210006,0.00006689078,0.000051377217,0.000019620538,0.00016094741,0.000046135032,0.000059876056,0.000036913167,0.003049808,0.004347222],"study_design_scores_gemma":[0.0000045947972,0.000008330741,0.9985044,0.000028729068,0.000024789942,0.00002916877,0.00022505803,0.000096149466,0.000017007487,0.000007551275,0.0010501519,0.0000039575716],"about_ca_topic_score_codex":0.9881095,"about_ca_topic_score_gemma":0.99031013,"teacher_disagreement_score":0.013350958,"about_ca_system_score_codex":0.013350958,"about_ca_system_score_gemma":0.016785089,"threshold_uncertainty_score":0.096868396},"labels":[],"label_agreement":null},{"id":"W3094266949","doi":"10.1080/14737167.2021.1842734","title":"Exploring the consistency of the SF-6Dv2 in a breast cancer population","year":2020,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Breast cancer; Spearman's rank correlation coefficient; Medicine; Statistics; Consistency (knowledge bases); Correlation; SF-36; Population; Gynecology; Mathematics; Cancer; Internal medicine; Health related quality of life; Disease","score_opus":0.5669469787216883,"score_gpt":0.6030223118004292,"score_spread":0.03607533307874089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094266949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988103,0.0001497878,0.0005391602,0.00005204828,0.00000869304,0.000015944135,0.00012081155,0.0000039214488,0.00029933098],"genre_scores_gemma":[0.99937767,0.000038769234,0.00033401494,0.000010903417,0.0000050324006,0.000013933398,0.00019089512,0.0000018504994,0.00002699167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99418736,0.0029548148,0.0006725371,0.00061214855,0.0013113806,0.0002617484],"domain_scores_gemma":[0.98687345,0.0077226977,0.0028070712,0.0008908267,0.0014602473,0.00024568534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013889285,0.00034715363,0.00045319286,0.002198739,0.0004252414,0.0010391467,0.00056827493,0.000475548,0.0005861402],"category_scores_gemma":[0.028829938,0.0002511887,0.0007997185,0.0020839493,0.0008003074,0.0005949351,0.0008697162,0.00066693174,0.000107599015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003194054,0.00002294064,0.9970675,0.000011336432,0.000087744265,0.00001676882,0.0003437524,0.00011363293,0.00007651374,0.000047205955,0.000043696942,0.002136877],"study_design_scores_gemma":[0.0000060591406,0.000115349845,0.9975038,0.000016668844,0.00003398434,0.00014626168,0.00071884156,0.0009801671,0.00014583464,0.000105256644,0.00022145301,0.000006397745],"about_ca_topic_score_codex":0.0026462337,"about_ca_topic_score_gemma":0.0019470619,"teacher_disagreement_score":0.013889285,"about_ca_system_score_codex":0.00057910336,"about_ca_system_score_gemma":0.0007062383,"threshold_uncertainty_score":0.07345444},"labels":[],"label_agreement":null},{"id":"W3098548905","doi":"10.1080/14737167.2021.1851600","title":"A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.","year":2020,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of Northwest Territories","funders":"","keywords":"Azithromycin; Hydroxychloroquine; Medicine; QT interval; Pharmacovigilance; Coronavirus disease 2019 (COVID-19); Torsades de pointes; Intensive care medicine; Drug; Pharmacology; Cardiac arrhythmia; Internal medicine; Atrial fibrillation; Antibiotics","score_opus":0.1273120797751217,"score_gpt":0.5944601966528575,"score_spread":0.46714811687773583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098548905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6855255,0.24753186,0.011450178,0.01151528,0.001206184,0.002507104,0.020980386,0.00024379928,0.019039717],"genre_scores_gemma":[0.97535044,0.008972474,0.0048640245,0.0046034954,0.0003562894,0.0005443816,0.0047755535,0.00003470893,0.0004987201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9862889,0.0076210457,0.0028767698,0.0012456817,0.0016665207,0.0003010371],"domain_scores_gemma":[0.9531347,0.025982602,0.012616197,0.0030203166,0.004449999,0.00079617545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019239126,0.00046571885,0.00149095,0.0016275754,0.00043564758,0.001715249,0.00092882547,0.0017528838,0.0031084453],"category_scores_gemma":[0.0495582,0.00029282767,0.0032031043,0.0029851699,0.00031374083,0.00093410874,0.0008334959,0.0013189304,0.00027838693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018168906,0.00039320928,0.81061745,0.013883707,0.0636465,0.0005713888,0.0004476769,0.00044555112,0.001802923,0.001914894,0.010389764,0.077718005],"study_design_scores_gemma":[0.0053844666,0.0040580686,0.8739445,0.005747028,0.08121715,0.0016561537,0.00032006283,0.0018211376,0.0015278818,0.0021652456,0.02203931,0.00011896517],"about_ca_topic_score_codex":0.0045615667,"about_ca_topic_score_gemma":0.0064900983,"teacher_disagreement_score":0.019239126,"about_ca_system_score_codex":0.00088847644,"about_ca_system_score_gemma":0.0019197554,"threshold_uncertainty_score":0.10174745},"labels":[],"label_agreement":null},{"id":"W3104831071","doi":"10.1080/14737167.2021.1854735","title":"Cannabis use among Canadian adults with cancer (2007–2016): results from a national survey","year":2020,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cannabis; Demography; Logistic regression; Young adult; Cohort; Cancer; Gerontology; Psychiatry; Internal medicine","score_opus":0.06849069524524236,"score_gpt":0.4763952272543149,"score_spread":0.4079045320090725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104831071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8145386,0.008030414,0.00043996001,0.0028529891,0.00012954269,0.00027869715,0.16064948,0.000092172806,0.012988214],"genre_scores_gemma":[0.95936173,0.005704532,0.0007533811,0.00060294574,0.000048175454,0.00011327956,0.031137802,0.000018694525,0.0022595096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900925,0.000040271527,0.000063368214,0.00010032328,0.0005722824,0.00021452425],"domain_scores_gemma":[0.99784625,0.00006124612,0.00036072463,0.000043547538,0.0013489962,0.00033917525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079363195,0.0003156135,0.00034939696,0.002167893,0.001699617,0.0007945789,0.0008512756,0.0003017106,0.0022725458],"category_scores_gemma":[0.0023817942,0.00026150976,0.0008423714,0.0049849935,0.00033791258,0.0003643347,0.00079139014,0.000554879,0.00039993567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062602674,0.00001854429,0.98554385,0.00027784103,0.00009421188,0.000035525245,0.0003496574,0.0000764902,0.00011399975,0.00007682803,0.0074424534,0.0059080054],"study_design_scores_gemma":[0.00000474359,0.00001022746,0.9956117,0.000081222795,0.000042594547,0.000037696966,0.0004370286,0.00008354446,0.000043343247,0.000011652679,0.0036286062,0.000007706328],"about_ca_topic_score_codex":0.9941115,"about_ca_topic_score_gemma":0.99641573,"teacher_disagreement_score":0.018046122,"about_ca_system_score_codex":0.018046122,"about_ca_system_score_gemma":0.031020103,"threshold_uncertainty_score":0.13093442},"labels":[],"label_agreement":null},{"id":"W3108278964","doi":"10.1080/14737167.2021.1857241","title":"Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system","year":2020,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation; Alberta Children's Hospital; University of Calgary","funders":"Canadian Institutes of Health Research; ZonMw; Genome Canada","keywords":"Medicine; Etanercept; Adalimumab; Rheumatoid arthritis; Indirect costs; Emergency medicine; Medical record; Physical therapy; Internal medicine; Pediatrics","score_opus":0.04325283065743128,"score_gpt":0.4439114974889879,"score_spread":0.4006586668315566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108278964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782372,0.0053383936,0.00031773018,0.0006548457,0.000021890164,0.000056514917,0.01308594,0.0000048431302,0.0022824863],"genre_scores_gemma":[0.99201375,0.0018263409,0.00040379594,0.000100540274,0.000029988929,0.000059459395,0.0053295223,0.0000047301723,0.00023175737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960299,0.0015341797,0.0010442175,0.0004010118,0.0006746557,0.00031601035],"domain_scores_gemma":[0.9920529,0.0015446158,0.005605077,0.00012920817,0.0003934511,0.00027475905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013774552,0.0002409889,0.0005057674,0.0017273213,0.00025774603,0.0015087223,0.00046539176,0.00037653142,0.0016803489],"category_scores_gemma":[0.009677256,0.00027282542,0.0010327214,0.004808778,0.00027455177,0.0009094974,0.00065284513,0.0004271525,0.00012951778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015580835,0.00003933382,0.9854754,0.00041796788,0.00082621566,0.00033984712,0.00024080597,0.0012172586,0.000079586716,0.00019376485,0.0010554004,0.009958576],"study_design_scores_gemma":[0.000023685081,0.00005116148,0.9957814,0.0002183299,0.00015561604,0.00052727613,0.0003326775,0.0012710694,0.000045873934,0.00011668894,0.0014622059,0.000013894293],"about_ca_topic_score_codex":0.07229686,"about_ca_topic_score_gemma":0.07039346,"teacher_disagreement_score":0.07229686,"about_ca_system_score_codex":0.0034977517,"about_ca_system_score_gemma":0.0018944336,"threshold_uncertainty_score":0.1437521},"labels":[],"label_agreement":null},{"id":"W3128444525","doi":"10.1080/14737167.2021.1884546","title":"Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications","year":2021,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Organization for Rare Disorders","funders":"","keywords":"Reimbursement; Biosimilar; Transparency (behavior); Business; Sustainability; Health care; Scrutiny; Access to medicines; Actuarial science; Medicine; Economics; Political science; Economic growth; Public health","score_opus":0.31652141479057777,"score_gpt":0.6358728245392732,"score_spread":0.3193514097486954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128444525","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026479432,0.08395471,0.20963933,0.49533358,0.005011444,0.0006353927,0.0014004327,0.00053734495,0.17700832],"genre_scores_gemma":[0.68991953,0.058433384,0.16530266,0.06633552,0.0049295435,0.0010123914,0.0011590323,0.00026992173,0.012638109],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98797613,0.007890583,0.000641138,0.00072569505,0.0021301862,0.00063621055],"domain_scores_gemma":[0.9768861,0.013735305,0.0022182015,0.00140243,0.004636459,0.0011214754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028144965,0.0007131049,0.00084956456,0.0028492769,0.0006865413,0.0077209407,0.0026100767,0.0050089722,0.018368425],"category_scores_gemma":[0.06049691,0.00035581767,0.0024968144,0.0029422713,0.0023364795,0.009745349,0.0045781145,0.0042257947,0.0009881727],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019320892,0.000169701,0.0019141872,0.0009940703,0.0003475501,0.00014021719,0.00015178049,0.03215073,0.00034736673,0.69493234,0.04245752,0.2262013],"study_design_scores_gemma":[0.00027275135,0.00031826887,0.006191972,0.0054840734,0.00021805962,0.00027895637,0.0004468679,0.024563419,0.0005239331,0.74673045,0.21485159,0.000119601165],"about_ca_topic_score_codex":0.00491038,"about_ca_topic_score_gemma":0.0036103176,"teacher_disagreement_score":0.028144965,"about_ca_system_score_codex":0.00604085,"about_ca_system_score_gemma":0.00871222,"threshold_uncertainty_score":0.14884663},"labels":[],"label_agreement":null},{"id":"W3132162779","doi":"10.1080/14737167.2021.1895754","title":"Canadian French translation and linguistic validation of the health-related quality of life utility measure for pre-school children","year":2021,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Université Laval; Université de Sherbrooke; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"","keywords":"Debriefing; Reliability (semiconductor); Cronbach's alpha; Face validity; Quality (philosophy); Psychology; Linguistics; Variety (cybernetics); Psychometrics; Computer science; Artificial intelligence; Clinical psychology; Social psychology","score_opus":0.3580055530930028,"score_gpt":0.5865353498995717,"score_spread":0.22852979680656887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132162779","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4139784,0.052585762,0.07456866,0.037050232,0.0056874244,0.014199408,0.11401154,0.0011504169,0.28676826],"genre_scores_gemma":[0.7734131,0.022299428,0.12373657,0.00323849,0.0003212456,0.012486891,0.039198563,0.00059583836,0.024709914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901938,0.0028948823,0.00095642323,0.00048932177,0.004969407,0.0004961435],"domain_scores_gemma":[0.9600621,0.0052254437,0.0011289689,0.0011631522,0.031650387,0.0007700058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017006174,0.0006503214,0.00059951097,0.0042237546,0.0024321456,0.0021078726,0.0012910671,0.00047507155,0.009766217],"category_scores_gemma":[0.041798014,0.00025670815,0.0011926066,0.0056484314,0.0012477654,0.0005786317,0.001255631,0.0014614676,0.0011200535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006796652,0.0002887715,0.07651695,0.00796422,0.00036672462,0.0012304261,0.019904822,0.0021581554,0.0035763364,0.038554505,0.22134173,0.62741774],"study_design_scores_gemma":[0.00027974363,0.0003216567,0.5332168,0.006373694,0.00030076463,0.0010138964,0.007517431,0.00146972,0.002357362,0.0036939736,0.44324666,0.00020835901],"about_ca_topic_score_codex":0.83451015,"about_ca_topic_score_gemma":0.8344004,"teacher_disagreement_score":0.16548985,"about_ca_system_score_codex":0.024624052,"about_ca_system_score_gemma":0.059096612,"threshold_uncertainty_score":0.3329289},"labels":[],"label_agreement":null},{"id":"W3133497257","doi":"10.1080/14737167.2021.1893167","title":"Will the Markov model and partitioned survival model lead to different results? A review of recent economic evidence of cancer treatments","year":2021,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Markov model; Markov chain; Empirical research; Econometrics; Medicine; Economic model; Expert opinion; Computer science; Actuarial science; Intensive care medicine; Statistics; Economics; Machine learning; Mathematics","score_opus":0.591300319189379,"score_gpt":0.6648543091756798,"score_spread":0.0735539899863008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133497257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014711446,0.99873847,0.00020267672,0.0005088263,0.00007087466,0.000013588132,0.000036022364,0.0000016744709,0.00028071867],"genre_scores_gemma":[0.003852096,0.9951206,0.00039187734,0.00035907587,0.00012813364,0.00003401465,0.000041614658,0.0000033080833,0.000069157664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606895,0.0021715465,0.00072781014,0.00030252084,0.0006185401,0.00011067383],"domain_scores_gemma":[0.9576054,0.038845193,0.001948334,0.00023895867,0.0012442811,0.000117808355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010166649,0.0010636481,0.0045152786,0.0038155196,0.00026686434,0.0018475007,0.0016734798,0.0017399944,0.008196263],"category_scores_gemma":[0.040405355,0.00055715203,0.0047575133,0.004486819,0.00070585683,0.0021603536,0.0006326634,0.0020336418,0.00056239276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070062873,0.00007959579,0.0009112836,0.35619542,0.0063727545,0.00017656926,0.00010683342,0.0022015986,0.00011678186,0.012628332,0.010702677,0.6098075],"study_design_scores_gemma":[0.0006061353,0.0007921109,0.008272607,0.658776,0.04009451,0.0015177384,0.00038977983,0.0035053536,0.00051665,0.032631356,0.25274044,0.00015738702],"about_ca_topic_score_codex":0.0037056643,"about_ca_topic_score_gemma":0.004997338,"teacher_disagreement_score":0.010166649,"about_ca_system_score_codex":0.0023474556,"about_ca_system_score_gemma":0.0036262565,"threshold_uncertainty_score":0.053767025},"labels":[],"label_agreement":null},{"id":"W3174607998","doi":"10.1080/14737167.2021.1945444","title":"Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis","year":2021,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"Biohaven Pharmaceuticals","keywords":"Medicine; Somnolence; Adverse effect; Migraine; Placebo; Randomized controlled trial; Anesthesia; Internal medicine; Alternative medicine","score_opus":0.286205095261552,"score_gpt":0.6206020375326795,"score_spread":0.3343969422711275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174607998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.079075575,0.9038615,0.009051687,0.00093409506,0.0006344227,0.002369922,0.0022814183,0.00019866611,0.0015926738],"genre_scores_gemma":[0.8023109,0.17857747,0.012063314,0.0010793722,0.00036919882,0.0028908665,0.0019896135,0.000085756896,0.00063363527],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.975373,0.017781528,0.0029433297,0.00214195,0.0014191868,0.0003408851],"domain_scores_gemma":[0.9675435,0.026202705,0.0035442451,0.0011587617,0.0012040862,0.0003467337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030103954,0.0034535318,0.01479606,0.0067673754,0.00057701254,0.0037078112,0.0023248387,0.0022762972,0.0033258307],"category_scores_gemma":[0.04881453,0.0016139946,0.052983686,0.005021705,0.00079388416,0.0021008563,0.0019720383,0.00214912,0.00033495965],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056313733,0.00003952165,0.0034285963,0.030318815,0.9552278,0.000048514274,0.00003054541,0.0011100253,0.00016547406,0.000099221914,0.00012090015,0.003779233],"study_design_scores_gemma":[0.0014257027,0.00029466164,0.0019606163,0.0013697356,0.99358976,0.000033497607,0.000014555618,0.00069204555,0.000074072166,0.0002105189,0.00032267207,0.000012198776],"about_ca_topic_score_codex":0.005200009,"about_ca_topic_score_gemma":0.007308567,"teacher_disagreement_score":0.030103954,"about_ca_system_score_codex":0.0025206006,"about_ca_system_score_gemma":0.0021277282,"threshold_uncertainty_score":0.15920681},"labels":[],"label_agreement":null},{"id":"W4220881104","doi":"10.1080/14737167.2022.2055549","title":"Kick-off meeting of the TOWWERS showcase project: 1 <sup>st</sup> collaborative value-based healthcare anchored on real-world data involving the 5P+","year":2022,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; Bristol-Myers Squibb (Canada)","funders":"","keywords":"Health care; Pandemic; Coronavirus disease 2019 (COVID-19); Healthcare system; Value (mathematics); Business; Public relations; Political science; Medicine; Computer science","score_opus":0.4232402734317933,"score_gpt":0.6115093826734787,"score_spread":0.18826910924168533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220881104","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017713208,0.003520979,0.010126773,0.71014416,0.06820121,0.001754643,0.003295984,0.00070478674,0.18453817],"genre_scores_gemma":[0.07724809,0.0023655538,0.009661349,0.07742827,0.0104220845,0.0016697078,0.0029826656,0.0009636039,0.8172587],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99413884,0.002061744,0.00015953943,0.000550926,0.0016980359,0.0013910136],"domain_scores_gemma":[0.98256093,0.0026456693,0.00043601412,0.00057137484,0.0044643707,0.009321677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015440571,0.0009460503,0.0005453289,0.000828623,0.0059844046,0.008106626,0.0017062755,0.0066059176,0.10211338],"category_scores_gemma":[0.014527015,0.0006410543,0.0008316272,0.0005373496,0.0022403414,0.0031095417,0.008876719,0.010006766,0.020883314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009947605,0.00007408721,0.00031254324,0.00007531207,0.000008898918,0.00032464165,0.0004964514,0.0001287721,0.00074040913,0.0056463354,0.9801017,0.011991313],"study_design_scores_gemma":[0.00002056288,0.00004736303,0.00091306167,0.000090554204,0.0000033652088,0.000052522933,0.0011943828,0.00016771583,0.00042260715,0.0013508998,0.9957203,0.000016761613],"about_ca_topic_score_codex":0.017198732,"about_ca_topic_score_gemma":0.043844417,"teacher_disagreement_score":0.10211338,"about_ca_system_score_codex":0.0060997875,"about_ca_system_score_gemma":0.018401477,"threshold_uncertainty_score":0.34160328},"labels":[],"label_agreement":null},{"id":"W4280625667","doi":"10.1080/14737167.2022.2079497","title":"Examining the correlation between treatment effects in clinical trials and economic modeling","year":2022,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina; Centre for Addiction and Mental Health; University of Toronto; Public Health Ontario","funders":"","keywords":"Correlation; Clinical trial; Medicine; Covariance; Econometrics; Statistics; Intensive care medicine; Mathematics; Internal medicine","score_opus":0.7645576136209942,"score_gpt":0.7434989822412623,"score_spread":0.02105863137973185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280625667","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0362408,0.0045346017,0.94784445,0.006283058,0.00020616603,0.0008879573,0.00028484984,0.00012778027,0.0035903724],"genre_scores_gemma":[0.7600334,0.0047470657,0.22829667,0.0014700709,0.00031836858,0.0028338116,0.00028284334,0.00007406577,0.0019437441],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.8318732,0.15526806,0.0032707036,0.003871302,0.0047198646,0.0009969276],"domain_scores_gemma":[0.3672383,0.597217,0.024257742,0.0065469868,0.0038192496,0.0009206844],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16752328,0.0017808895,0.0036958714,0.0030782057,0.0006198546,0.0042077824,0.0026701805,0.0037555508,0.0045590387],"category_scores_gemma":[0.3515881,0.0014165944,0.00332356,0.004036162,0.005346711,0.0044382066,0.002509608,0.004426379,0.0003433069],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032914735,0.00015591666,0.012790926,0.0009521824,0.0012777097,0.00025941085,0.00029480463,0.5815102,0.00023165256,0.3698308,0.001308364,0.031058904],"study_design_scores_gemma":[0.00017405587,0.00028707882,0.0025861242,0.00041203087,0.00034667837,0.00009801237,0.000060246653,0.69319683,0.00031473802,0.3005982,0.0018692685,0.00005665568],"about_ca_topic_score_codex":0.0037242537,"about_ca_topic_score_gemma":0.0021949334,"teacher_disagreement_score":0.83247674,"about_ca_system_score_codex":0.0065171034,"about_ca_system_score_gemma":0.0073547433,"threshold_uncertainty_score":0.8859584},"labels":[],"label_agreement":null},{"id":"W4293554463","doi":"10.1080/14737167.2022.2117691","title":"Consumption of antidepressants and economic austerity in Brazil","year":2022,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Employment and Welfare Studies","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Austerity; Consumption (sociology); Context (archaeology); Gross domestic product; Debt; Pharmacy; Quarter (Canadian coin); Depression (economics); Economics; Business; Economic growth; Medicine; Geography; Finance; Political science; Macroeconomics","score_opus":0.12990745885251773,"score_gpt":0.621527687407669,"score_spread":0.4916202285551512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293554463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93560904,0.040037464,0.00042207347,0.006159615,0.000054267788,0.0000640761,0.0066150962,0.000015300191,0.011022937],"genre_scores_gemma":[0.9830036,0.015128588,0.00031038056,0.00019064288,0.000031711756,0.000024710098,0.0010126121,0.0000047481362,0.0002929896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996145,0.00009807606,0.00006724008,0.00006225021,0.00010526833,0.000052715273],"domain_scores_gemma":[0.99811375,0.0002845151,0.0012398687,0.000042033913,0.00022156643,0.000098380944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007391164,0.00020569455,0.000305519,0.00196002,0.00027030977,0.0007441229,0.00028961446,0.00024512372,0.0015627675],"category_scores_gemma":[0.004331,0.00018793535,0.00048734978,0.003749743,0.000378949,0.00047621073,0.00061474816,0.0003233264,0.00011153008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005687385,0.000031506555,0.9642874,0.0008088254,0.00021808546,0.00030476294,0.0017550193,0.00026738565,0.000290559,0.0012125367,0.0010744313,0.029692601],"study_design_scores_gemma":[0.0000046761456,0.000022257258,0.9923018,0.0005890903,0.000060334056,0.0002934196,0.0013308718,0.000260881,0.000046733614,0.0002396553,0.0048421975,0.000008082013],"about_ca_topic_score_codex":0.09278976,"about_ca_topic_score_gemma":0.1043178,"teacher_disagreement_score":0.09278976,"about_ca_system_score_codex":0.0016126175,"about_ca_system_score_gemma":0.0012722386,"threshold_uncertainty_score":0.18449932},"labels":[],"label_agreement":null},{"id":"W4308294552","doi":"10.1080/14737167.2023.2144838","title":"The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices","year":2022,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Impact; McMaster University; Population Health Research Institute","funders":"","keywords":"Statistics; Econometrics; Medicine; Mathematics; Variance (accounting); Willingness to pay; Time horizon; Economics; Mathematical optimization","score_opus":0.3653814322636475,"score_gpt":0.6068713151230325,"score_spread":0.241489882859385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308294552","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3240485,0.003829582,0.65493727,0.005898953,0.0002569301,0.0009337256,0.0012788607,0.00045261008,0.008363563],"genre_scores_gemma":[0.94942117,0.0003925233,0.048507918,0.0004961117,0.00006355816,0.00049592485,0.0002664345,0.00007654713,0.00027965457],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.91125035,0.07671094,0.0022352752,0.0044560484,0.004241354,0.0011060763],"domain_scores_gemma":[0.41532815,0.5476432,0.018683435,0.012615512,0.00495042,0.00077939284],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14598343,0.0014046384,0.0023389317,0.0012043747,0.00048106472,0.0033449202,0.0021286183,0.001866178,0.002473656],"category_scores_gemma":[0.43288186,0.00084450876,0.0031651258,0.0011622942,0.0032723509,0.005934312,0.0021139795,0.0033276188,0.00024833638],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017874092,0.00020904474,0.04229295,0.00071209716,0.0018995117,0.00023059422,0.00032925798,0.8293116,0.0006846643,0.08389051,0.0011729328,0.037479483],"study_design_scores_gemma":[0.00024375267,0.0010269028,0.011331927,0.00033830447,0.0005744888,0.0002285455,0.00014952032,0.8860815,0.0015964127,0.09718139,0.00111798,0.00012922024],"about_ca_topic_score_codex":0.002910805,"about_ca_topic_score_gemma":0.0012171343,"teacher_disagreement_score":0.85401654,"about_ca_system_score_codex":0.0029150792,"about_ca_system_score_gemma":0.0025366058,"threshold_uncertainty_score":0.7720434},"labels":[],"label_agreement":null},{"id":"W4308774679","doi":"10.1080/14737167.2023.2145946","title":"Exploring the approach to parameter uncertainty in early economic evaluations of surgical technology – a systematic review","year":2022,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Institute of Health Economics; St. Paul's Hospital; University of Calgary; University of British Columbia","funders":"","keywords":"Risk analysis (engineering); Health technology; Investment (military); Technology development; Uncertainty analysis; Computer science; Management science; Medicine; Economics; Engineering; Political science; Simulation","score_opus":0.6039474417750137,"score_gpt":0.6354537802292659,"score_spread":0.031506338454252214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308774679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074678595,0.9841599,0.007904327,0.0036729553,0.00053001894,0.0014318449,0.0004196655,0.000032412696,0.0011020562],"genre_scores_gemma":[0.0583745,0.90245134,0.026356315,0.0048127864,0.0008339037,0.00626192,0.0005199075,0.00004967244,0.000339694],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.74100655,0.19474313,0.03665355,0.0048126876,0.021707514,0.001076493],"domain_scores_gemma":[0.33276308,0.618094,0.027357861,0.006220728,0.01502417,0.0005400605],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17612822,0.0024462268,0.009819609,0.012957049,0.00087094185,0.006901906,0.003476542,0.0036445062,0.005668535],"category_scores_gemma":[0.48886165,0.0018067257,0.010662752,0.009841986,0.0024865298,0.0081139635,0.0036106242,0.0047990326,0.00048557523],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032539273,0.000033329336,0.0011042708,0.80557114,0.020516584,0.00014514431,0.0005136107,0.0020096903,0.00014314543,0.009381961,0.0037122108,0.15654358],"study_design_scores_gemma":[0.00028345722,0.0002104674,0.001648035,0.91387194,0.031692132,0.00023483051,0.00033861017,0.0012641854,0.00032967993,0.015102805,0.034927744,0.000096055854],"about_ca_topic_score_codex":0.004050872,"about_ca_topic_score_gemma":0.009081963,"teacher_disagreement_score":0.8238718,"about_ca_system_score_codex":0.007974245,"about_ca_system_score_gemma":0.021301921,"threshold_uncertainty_score":0.9314662},"labels":[],"label_agreement":null},{"id":"W4315928129","doi":"10.1080/14737167.2023.2166491","title":"Perspectives in prospective comparative economic evaluations: a systematic review","year":2023,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Relevance (law); MEDLINE; Systematic review; Medicine; Quality (philosophy); Family medicine; Political science; Computer science; Law; Epistemology","score_opus":0.6127220712669508,"score_gpt":0.7100279572442373,"score_spread":0.09730588597728651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315928129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006009762,0.99250495,0.00169953,0.0022437058,0.00056812604,0.0011858777,0.00048845785,0.00001469174,0.0006936803],"genre_scores_gemma":[0.028514761,0.94921225,0.010447105,0.0031888608,0.00095200294,0.006773092,0.00071666896,0.000028580807,0.00016668535],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7012887,0.21162781,0.057401285,0.0066485377,0.021739244,0.0012944622],"domain_scores_gemma":[0.3375014,0.5844641,0.0520209,0.00752441,0.017375035,0.0011141762],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18592627,0.0024907864,0.013285529,0.02003867,0.0011442705,0.008592514,0.0030331656,0.0041676867,0.008926017],"category_scores_gemma":[0.47242382,0.0025960798,0.009198952,0.021362057,0.0030923823,0.009590727,0.0035181388,0.0040360643,0.00083555514],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003874282,0.00002705567,0.0010769708,0.9188062,0.010691979,0.00009764292,0.0002778735,0.00031270774,0.00007426206,0.0032011273,0.0029274866,0.06211927],"study_design_scores_gemma":[0.00036001636,0.0001415674,0.0017619987,0.9635205,0.015286948,0.00018992927,0.00030654357,0.00020201462,0.00010416936,0.004012907,0.0140713435,0.00004204009],"about_ca_topic_score_codex":0.0023824195,"about_ca_topic_score_gemma":0.0061617196,"teacher_disagreement_score":0.81407374,"about_ca_system_score_codex":0.008232437,"about_ca_system_score_gemma":0.02112809,"threshold_uncertainty_score":0.9832839},"labels":[],"label_agreement":null},{"id":"W4327547032","doi":"10.1080/14737167.2023.2190514","title":"Estimate of the cost per responder for treatment with biological therapies of moderate-to-severe plaque psoriasis in Colombia for first-year and maintenance periods","year":2023,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Plaque psoriasis; Psoriasis; Medicine; Intensive care medicine; Dermatology","score_opus":0.06564973707451045,"score_gpt":0.4520642311900215,"score_spread":0.38641449411551104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327547032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5995869,0.17897539,0.027952082,0.006216392,0.00048224995,0.0019446881,0.1514662,0.00042155295,0.03295459],"genre_scores_gemma":[0.9581904,0.0140220765,0.00979394,0.0002902369,0.00009751432,0.0006657809,0.015212665,0.00004660623,0.0016806733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726474,0.0014648946,0.00026910228,0.00033919135,0.000556684,0.00010530501],"domain_scores_gemma":[0.99449724,0.0033127228,0.0012185851,0.00020003325,0.0006785983,0.00009277638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003895735,0.00085581216,0.0012646177,0.003360438,0.00018400603,0.0013977155,0.00082815695,0.0005010859,0.0055444906],"category_scores_gemma":[0.0123437075,0.0003553675,0.0044175643,0.0026099999,0.0001902177,0.0004787447,0.00046121218,0.0005577296,0.000282508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009734202,0.00041484198,0.38973725,0.04154689,0.04955458,0.0009217494,0.0004012084,0.21635082,0.0020219684,0.011536957,0.025958674,0.25182095],"study_design_scores_gemma":[0.0028623284,0.0017500359,0.71578974,0.0097603435,0.054707587,0.0021010328,0.0011027912,0.12052294,0.0029931122,0.008020715,0.080044016,0.00034538915],"about_ca_topic_score_codex":0.06318412,"about_ca_topic_score_gemma":0.04113815,"teacher_disagreement_score":0.06318412,"about_ca_system_score_codex":0.006034217,"about_ca_system_score_gemma":0.0022899595,"threshold_uncertainty_score":0.1256327},"labels":[],"label_agreement":null},{"id":"W4362658984","doi":"10.1080/14737167.2023.2200938","title":"Cost-benefit analysis of stroke rehabilitation in Iran","year":2023,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Rehabilitation; Economic evaluation; Stroke (engine); Cost effectiveness; Medicine; Cost–benefit analysis; Multidisciplinary approach; Actuarial science; Business; Physical therapy; Political science; Risk analysis (engineering); Engineering","score_opus":0.07894348941891904,"score_gpt":0.5480638523926816,"score_spread":0.4691203629737626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362658984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5337208,0.3666122,0.045083907,0.012540704,0.00082649256,0.0047420734,0.009588936,0.0001771795,0.026707856],"genre_scores_gemma":[0.95612144,0.031078452,0.008913369,0.00043081277,0.00014637342,0.001203668,0.0012906635,0.000017835759,0.00079742755],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99535275,0.0035196978,0.00022258371,0.0001394072,0.0005688419,0.00019670164],"domain_scores_gemma":[0.99573225,0.0033269092,0.00047611436,0.0000703696,0.00031395946,0.00008046254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074424283,0.0010145179,0.0018561586,0.0022509035,0.00019103455,0.0011719364,0.00077302643,0.00064233463,0.004577454],"category_scores_gemma":[0.015091222,0.00032857584,0.0045864754,0.0017244624,0.00030980902,0.00069574546,0.00064915355,0.0010483364,0.000125473],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013544123,0.0009829765,0.045580372,0.020663086,0.024949422,0.00075037737,0.00016749953,0.54049593,0.00080252386,0.027530707,0.00894062,0.31559238],"study_design_scores_gemma":[0.009053452,0.009679149,0.124554336,0.017133988,0.058581337,0.0028956216,0.0007908621,0.6600044,0.0022378957,0.0701853,0.044552054,0.00033163544],"about_ca_topic_score_codex":0.006655927,"about_ca_topic_score_gemma":0.005257335,"teacher_disagreement_score":0.0074424283,"about_ca_system_score_codex":0.0060383766,"about_ca_system_score_gemma":0.0049659596,"threshold_uncertainty_score":0.04381174},"labels":[],"label_agreement":null},{"id":"W4377245849","doi":"10.1080/14737167.2023.2215430","title":"Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia","year":2023,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Medical Research Council; Ministry of Health, British Columbia","keywords":"EQ-5D; Statistics; Schizophrenia (object-oriented programming); Tobit model; Ordinary least squares; Goodness of fit; Econometrics; Quality of life (healthcare); Quality-adjusted life year; Regression analysis; Regression; Index (typography); Scale (ratio); Mathematics; Psychology; Medicine; Cost effectiveness; Psychiatry; Health related quality of life; Computer science; Cartography; Disease; Internal medicine; Geography","score_opus":0.41389428232893255,"score_gpt":0.5467834205096059,"score_spread":0.13288913818067338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377245849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95637715,0.018512132,0.018800616,0.0012170756,0.000072679926,0.00018611048,0.0022897338,0.000052572123,0.0024920003],"genre_scores_gemma":[0.99026334,0.0050627156,0.003503824,0.000075931974,0.000013482079,0.00008657788,0.00078902306,0.0000075319836,0.00019758599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856913,0.00096348056,0.00011884792,0.00010126124,0.00018608973,0.00006122938],"domain_scores_gemma":[0.99887687,0.0005674269,0.0003096718,0.00007102672,0.00014601115,0.000028972543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040438715,0.00046892618,0.00058268587,0.0013415068,0.000117002215,0.0007701981,0.00036993314,0.00039923194,0.0014134322],"category_scores_gemma":[0.010873914,0.00017843302,0.0014572894,0.001529125,0.00020793662,0.00044768633,0.0005950173,0.0006571706,0.00023393099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012494818,0.0002733642,0.6376196,0.0015736448,0.0020284841,0.00030795016,0.00082372694,0.03786373,0.00075834704,0.0023380418,0.0028656097,0.31229806],"study_design_scores_gemma":[0.00019278927,0.0007332996,0.894335,0.001479376,0.0014573608,0.0006699367,0.0014632287,0.08926211,0.0008290344,0.0055333176,0.0039482205,0.00009633449],"about_ca_topic_score_codex":0.008766454,"about_ca_topic_score_gemma":0.008241572,"teacher_disagreement_score":0.008766454,"about_ca_system_score_codex":0.0006461485,"about_ca_system_score_gemma":0.0010390482,"threshold_uncertainty_score":0.021386325},"labels":[],"label_agreement":null},{"id":"W4379094408","doi":"10.1080/14737167.2023.2221436","title":"Evaluating the correlations of cost and utility parameters from summary statistics for probabilistic analysis in economic evaluations","year":2023,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Hospital for Sick Children; University of Toronto; SickKids Foundation; Institute for Clinical Evaluative Sciences; University of Regina","funders":"","keywords":"Statistics; Correlation; Econometrics; Correlation coefficient; Mathematics; Variance (accounting); Probabilistic logic; Pearson product-moment correlation coefficient; Medicine; Economics","score_opus":0.5241173678745111,"score_gpt":0.6649264171247405,"score_spread":0.1408090492502294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379094408","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055259477,0.013584551,0.91898227,0.0028151025,0.0002692066,0.0015996364,0.0027125464,0.00045590784,0.0043212045],"genre_scores_gemma":[0.70585936,0.006133974,0.27880666,0.0010012998,0.00043317908,0.0042526172,0.0026316072,0.0002593866,0.0006218843],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.6870362,0.27074376,0.015901469,0.007022798,0.018431984,0.00086370675],"domain_scores_gemma":[0.14553112,0.7951595,0.03416191,0.015618752,0.009061091,0.00046759698],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27351418,0.0026618063,0.0037683214,0.0067326473,0.0005524505,0.0058524376,0.0020145818,0.002519433,0.0043825572],"category_scores_gemma":[0.6606967,0.0015173828,0.007214042,0.008385519,0.0028649291,0.007111601,0.0033859855,0.0053978865,0.00056482514],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017127368,0.00037286105,0.12527287,0.006502648,0.019399926,0.000454369,0.0010181383,0.49310765,0.00056782237,0.09772402,0.0072072167,0.24665976],"study_design_scores_gemma":[0.00048081743,0.0016147067,0.04815103,0.005181139,0.0059600887,0.0005403331,0.00038411067,0.66904896,0.0019483155,0.2581624,0.00809348,0.00043464257],"about_ca_topic_score_codex":0.0021419208,"about_ca_topic_score_gemma":0.001941269,"teacher_disagreement_score":0.72648585,"about_ca_system_score_codex":0.003446399,"about_ca_system_score_gemma":0.0047268705,"threshold_uncertainty_score":0.89588636},"labels":[],"label_agreement":null},{"id":"W4379375403","doi":"10.1080/14737167.2023.2219447","title":"The impact of universal health coverage and COVID-19 pandemic on out-of-pocket expenses in Thailand: an analysis of household survey from 1994 to 2021","year":2023,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ministry of Public Health; United Nations; Rockefeller Foundation","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Environmental health; Medicine; Business; Economic growth; Virology; Economics; Outbreak","score_opus":0.21781279444716425,"score_gpt":0.5411057919212812,"score_spread":0.3232929974741169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379375403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667525,0.00029965324,0.00009269095,0.000070832466,0.000004250641,0.000011569844,0.0023756425,0.0000039422416,0.00046607645],"genre_scores_gemma":[0.99785465,0.00019591187,0.000048960126,0.00001886172,0.0000044398316,0.000015266649,0.0016763256,0.0000017989355,0.00018376365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902034,0.00030597227,0.00015687561,0.00013738978,0.00015723809,0.00022225444],"domain_scores_gemma":[0.9957913,0.0008912166,0.0022068704,0.00013552111,0.00046331316,0.0005116702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011234795,0.0002971766,0.00024085426,0.0012169002,0.00028368153,0.00075814466,0.0003467154,0.00032904258,0.0017462999],"category_scores_gemma":[0.003652988,0.00021351466,0.0008849946,0.0021521428,0.00030931173,0.0005457576,0.00075646926,0.0006763571,0.00019854849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010641233,0.000025665384,0.99659604,0.00003688453,0.000114605566,0.00014185382,0.00031002075,0.00043397726,0.000049494825,0.00003141723,0.00016065653,0.001992998],"study_design_scores_gemma":[0.0000013713849,0.000058478945,0.9982407,0.000014204029,0.000025924026,0.0000991126,0.0007449892,0.00059549906,0.000035558078,0.0000087001135,0.00017133306,0.0000041803282],"about_ca_topic_score_codex":0.055978812,"about_ca_topic_score_gemma":0.035491385,"teacher_disagreement_score":0.055978812,"about_ca_system_score_codex":0.00095823436,"about_ca_system_score_gemma":0.0008002536,"threshold_uncertainty_score":0.11130595},"labels":[],"label_agreement":null},{"id":"W4385812711","doi":"10.1080/14737167.2023.2248389","title":"How can environmental impacts be incorporated in health technology assessment, and how impactful would this be?","year":2023,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Health technology; Environmental economics; Economics; Medicine; Management science; Health care; Economic growth","score_opus":0.28094057900534125,"score_gpt":0.6069572899336678,"score_spread":0.32601671092832657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385812711","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004316309,0.04995008,0.00055314996,0.14239211,0.8044135,0.000040876635,0.00022298409,0.000052483785,0.002331622],"genre_scores_gemma":[0.0012628196,0.060775526,0.0011086265,0.08332766,0.84780866,0.000080127786,0.000108537955,0.00008586468,0.0054422],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97404593,0.009484634,0.00393609,0.0014238385,0.010484969,0.00062456453],"domain_scores_gemma":[0.76340246,0.16979174,0.008099625,0.0034487902,0.051067986,0.0041894494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.056039874,0.0022996059,0.004658883,0.0042803925,0.0016711822,0.011027853,0.0044068126,0.022010561,0.008741251],"category_scores_gemma":[0.19518068,0.0010562727,0.0040673185,0.0027602843,0.003971034,0.007666549,0.0015391251,0.025971167,0.0067035104],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000574892,0.000016304972,0.000046447745,0.0015172476,0.00015682665,0.000053248434,0.000021012649,0.00010449965,0.000040470193,0.002532773,0.9734163,0.022037344],"study_design_scores_gemma":[0.00019145267,0.00003814758,0.00052869995,0.0069953683,0.00046785886,0.00012990163,0.00010074444,0.00040570903,0.00016999141,0.014758699,0.9761378,0.00007568045],"about_ca_topic_score_codex":0.005491337,"about_ca_topic_score_gemma":0.011976294,"teacher_disagreement_score":0.056039874,"about_ca_system_score_codex":0.004287247,"about_ca_system_score_gemma":0.009664948,"threshold_uncertainty_score":0.2963707},"labels":[],"label_agreement":null},{"id":"W4387115725","doi":"10.1080/14737167.2023.2263167","title":"Is Palbociclib a cost-effective strategy in the second-line treatment of metastatic breast cancer in Iran?","year":2023,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Palbociclib; Fulvestrant; Medicine; Metastatic breast cancer; Oncology; Breast cancer; Cost effectiveness; Internal medicine; Cancer; Gynecology; Statistics; Estrogen receptor; Mathematics; Risk analysis (engineering)","score_opus":0.11914498741705118,"score_gpt":0.578111293209492,"score_spread":0.4589663057924408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387115725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92492527,0.038462974,0.008541662,0.010656122,0.00019989378,0.0004667084,0.0014047,0.00006219664,0.015280445],"genre_scores_gemma":[0.9948561,0.0033401453,0.0011219225,0.00022197718,0.000030358004,0.000053745793,0.0001613202,0.0000038552976,0.00021060195],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9989624,0.0006398866,0.00003156273,0.00006967046,0.00017384467,0.00012266873],"domain_scores_gemma":[0.99827945,0.001125042,0.00030459432,0.0000302964,0.00018073675,0.000079819765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028900593,0.0005236422,0.0007358624,0.00081903016,0.00014838799,0.00132548,0.0007656694,0.00074814097,0.0027931784],"category_scores_gemma":[0.00597866,0.00022059858,0.0014034978,0.0008157899,0.00045645447,0.0009640428,0.00039052847,0.00072045415,0.00008503795],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008780577,0.0010152205,0.06665345,0.0033061337,0.0028518979,0.0012531291,0.00012799884,0.6485405,0.0017399269,0.012659493,0.005700372,0.24737121],"study_design_scores_gemma":[0.005424848,0.010558635,0.13761732,0.0030773592,0.009545488,0.0033038114,0.0022303993,0.7632452,0.003863847,0.03339251,0.027554544,0.0001859282],"about_ca_topic_score_codex":0.008708123,"about_ca_topic_score_gemma":0.009267435,"teacher_disagreement_score":0.008708123,"about_ca_system_score_codex":0.003877527,"about_ca_system_score_gemma":0.0044444916,"threshold_uncertainty_score":0.028133512},"labels":[],"label_agreement":null},{"id":"W4387392904","doi":"10.1080/14737167.2023.2268275","title":"Canadian English translation and linguistic validation of the 13-MD to measure global health-related quality of life","year":2023,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Debriefing; Linguistics; Quality (philosophy); Face (sociological concept); Translation (biology); Psychology; Computer science; Process (computing); Natural language processing; Social psychology","score_opus":0.412003259558339,"score_gpt":0.603219038429849,"score_spread":0.19121577887151003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387392904","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04259172,0.67278683,0.039957635,0.045985334,0.013084813,0.020099642,0.02900419,0.0004804294,0.13600947],"genre_scores_gemma":[0.33785996,0.4438742,0.12091907,0.015201266,0.0011316594,0.026092472,0.025979523,0.0006618226,0.028280031],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9488808,0.01647034,0.0068065487,0.0021129346,0.024599895,0.0011296077],"domain_scores_gemma":[0.81654024,0.026087467,0.0059937513,0.0041677807,0.1455933,0.0016173933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07773167,0.00090914004,0.0014659447,0.006536874,0.0026513543,0.002863035,0.0038779539,0.0015477312,0.0071584154],"category_scores_gemma":[0.1577722,0.00050565583,0.0017930322,0.00700228,0.0021829002,0.001139102,0.002403475,0.0022995807,0.0015693039],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004192336,0.00014575491,0.0141387805,0.10816932,0.0010602858,0.0014014152,0.018583998,0.0012188882,0.0032424578,0.01870555,0.23508799,0.5978263],"study_design_scores_gemma":[0.00030274893,0.00016606945,0.055144098,0.13631263,0.0014794936,0.0008977489,0.0057224915,0.0006290582,0.001886303,0.0013077719,0.79594284,0.00020865722],"about_ca_topic_score_codex":0.6962978,"about_ca_topic_score_gemma":0.76644164,"teacher_disagreement_score":0.30370218,"about_ca_system_score_codex":0.02323449,"about_ca_system_score_gemma":0.1274208,"threshold_uncertainty_score":0.61098146},"labels":[],"label_agreement":null},{"id":"W4387421037","doi":"10.1080/14737167.2023.2267764","title":"System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual model","year":2023,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Computer science; Management science; Conceptual model; System dynamics; Process management; Computational biology; Data science; Biology; Business; Artificial intelligence; Engineering","score_opus":0.32241142791698596,"score_gpt":0.6864850684453035,"score_spread":0.3640736405283176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387421037","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046161585,0.0030603088,0.9624545,0.0036170841,0.00030487837,0.00053007505,0.00085830817,0.00057689624,0.023981776],"genre_scores_gemma":[0.17583092,0.014006204,0.78814894,0.0009178579,0.0004722423,0.0038947938,0.0014381872,0.00030093506,0.014989936],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99926966,0.00037440902,0.000052419655,0.000094620475,0.00015396623,0.000054859935],"domain_scores_gemma":[0.99726784,0.002145477,0.00012411113,0.00006379451,0.00033366284,0.00006510581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002372833,0.0014289368,0.0006514703,0.0015692747,0.00056806643,0.0016158473,0.0015410064,0.0021293396,0.012632868],"category_scores_gemma":[0.0057210713,0.0005224695,0.001512571,0.0012653983,0.00057035725,0.0021112603,0.0015250592,0.0020623705,0.0015097548],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039761882,0.00010447496,0.0017420391,0.0007934147,0.00005457065,0.00021878725,0.0003173725,0.64577043,0.00066651235,0.26636174,0.0101508275,0.07378005],"study_design_scores_gemma":[0.0000260999,0.00006335713,0.00034433065,0.00049880956,0.000029905708,0.00008792124,0.000131021,0.8783678,0.0005068674,0.08473234,0.03517722,0.00003439724],"about_ca_topic_score_codex":0.010031607,"about_ca_topic_score_gemma":0.0076107658,"teacher_disagreement_score":0.012632868,"about_ca_system_score_codex":0.0021836804,"about_ca_system_score_gemma":0.0030425352,"threshold_uncertainty_score":0.042261183},"labels":[],"label_agreement":null},{"id":"W4388772098","doi":"10.1080/14737167.2023.2284217","title":"Interview with Julie Frappier, health economist, and creator of the TOWWERS™ System","year":2023,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health economics; Healthcare system; Sociology; Management; Public relations; Operations research; Marketing; Psychology; Business; Economics; Health care; Political science; Economic growth; Engineering","score_opus":0.3671094316761847,"score_gpt":0.612837646528279,"score_spread":0.24572821485209428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388772098","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042311987,0.0012198526,0.00012126919,0.9925835,0.0028289338,0.000030288165,0.00011878205,0.000016824592,0.0026574829],"genre_scores_gemma":[0.007548611,0.002298263,0.0003744785,0.9657188,0.0027071284,0.00019288997,0.00009843347,0.00007155481,0.020989781],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99320555,0.0033396669,0.00033141152,0.0005645341,0.0014968897,0.0010619287],"domain_scores_gemma":[0.96864825,0.015556143,0.0014318702,0.00039741522,0.008117494,0.005848915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019674791,0.0005282349,0.0009545438,0.0016291715,0.009270943,0.006285939,0.0018994766,0.012741967,0.024732733],"category_scores_gemma":[0.063907534,0.0009816202,0.0005467992,0.0019404349,0.003145559,0.009834512,0.0034963938,0.028974175,0.008031972],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005479388,0.0000073826736,0.00025003016,0.000024622716,0.0000016402086,0.00006615613,0.0011453603,0.0000173602,0.000016650889,0.0011163644,0.9958508,0.0014981402],"study_design_scores_gemma":[0.000021150556,0.000016206119,0.0019037762,0.0003671023,0.00000464128,0.00025066643,0.0110353995,0.00013985392,0.000060690905,0.0013458339,0.9847943,0.000060321032],"about_ca_topic_score_codex":0.09617498,"about_ca_topic_score_gemma":0.09915354,"teacher_disagreement_score":0.09617498,"about_ca_system_score_codex":0.013091192,"about_ca_system_score_gemma":0.017585704,"threshold_uncertainty_score":0.19123036},"labels":[],"label_agreement":null},{"id":"W4390663836","doi":"10.1080/14737167.2024.2302431","title":"Adapting Health Technology Assessment agency standards for surrogate outcomes in early stage cancer trials: what needs to happen?","year":2024,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada; AstraZeneca (Canada); McMaster University; Impact","funders":"","keywords":"Surrogate endpoint; Outcome (game theory); Agency (philosophy); Risk analysis (engineering); Health technology; Medicine; Clinical trial; Management science; Intensive care medicine; Process management; Health care; Political science; Business; Economics; Sociology","score_opus":0.5092149834095347,"score_gpt":0.701929790476751,"score_spread":0.19271480706721622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390663836","genre_codex":"commentary","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035187001,0.18062861,0.26008287,0.4913898,0.024716193,0.0045767757,0.0059373365,0.0015023188,0.027647441],"genre_scores_gemma":[0.09827486,0.11722436,0.50860065,0.22238682,0.020602498,0.021317719,0.006189878,0.001587733,0.0038154684],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.41375864,0.4562815,0.06044531,0.008773579,0.057632737,0.0031081035],"domain_scores_gemma":[0.115446895,0.6791413,0.048769835,0.036981445,0.1161151,0.0035454342],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5861999,0.0018895342,0.0053297654,0.0064763967,0.002471325,0.016631791,0.00829023,0.011983547,0.008272251],"category_scores_gemma":[0.7848769,0.0016982647,0.006776937,0.0094273705,0.0092258705,0.01511837,0.008254284,0.02996812,0.0048651984],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012207553,0.00015957211,0.0057649463,0.039201118,0.0016907316,0.00012530501,0.0026012904,0.0055360007,0.00059416547,0.23720123,0.2655715,0.44033343],"study_design_scores_gemma":[0.00083584024,0.00091978826,0.0114953695,0.121813305,0.0015571133,0.00050628826,0.0010620761,0.007876822,0.0016011726,0.31569588,0.53609943,0.0005368796],"about_ca_topic_score_codex":0.0054308823,"about_ca_topic_score_gemma":0.0031770803,"teacher_disagreement_score":0.41380012,"about_ca_system_score_codex":0.009509641,"about_ca_system_score_gemma":0.031359043,"threshold_uncertainty_score":0.51028925},"labels":[],"label_agreement":null},{"id":"W4391932062","doi":"10.1080/14737167.2024.2321244","title":"A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health?","year":2024,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Burden of disease; Disease burden; Low and middle income countries; Global health; Disease; Business; Public economics; Medicine; Economic growth; Environmental health; Economics; Health care; Developing country","score_opus":0.08758215786166451,"score_gpt":0.5685803775351641,"score_spread":0.4809982196734996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391932062","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000282739,0.0077900523,0.00033057446,0.15987977,0.8305053,0.0001039559,0.00014136749,0.000100928606,0.0011197015],"genre_scores_gemma":[0.0005542345,0.011680776,0.0013040836,0.20031862,0.7786413,0.00022356094,0.00013362044,0.00010070254,0.0070431093],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97814995,0.0077623692,0.0033068345,0.0014949137,0.008010813,0.0012751645],"domain_scores_gemma":[0.87618965,0.069583036,0.0055506844,0.0026171298,0.035618264,0.01044129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.058719996,0.0040566623,0.0063989777,0.0041983845,0.00428073,0.011565654,0.007136056,0.04932993,0.019714428],"category_scores_gemma":[0.1260468,0.001512103,0.006586127,0.0022591087,0.005797165,0.013210634,0.003698076,0.04261579,0.01745815],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004294029,0.000020733203,0.00001927629,0.00078070577,0.00003119608,0.000068572794,0.000050760544,0.000038685735,0.00004608521,0.0013370932,0.9910116,0.006552254],"study_design_scores_gemma":[0.00016386394,0.000060284125,0.0001694977,0.002151398,0.00016935164,0.00015483079,0.00015018354,0.00016653506,0.00009514245,0.0068783243,0.9897848,0.00005581302],"about_ca_topic_score_codex":0.003327902,"about_ca_topic_score_gemma":0.0069447653,"teacher_disagreement_score":0.058719996,"about_ca_system_score_codex":0.005510507,"about_ca_system_score_gemma":0.02619699,"threshold_uncertainty_score":0.31054473},"labels":[],"label_agreement":null},{"id":"W4394610499","doi":"10.1080/14737167.2024.2339945","title":"Expert review of pharmacoeconomics and outcomes research: high impact articles from 2023","year":2024,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacoeconomics; Outcomes research; Medicine; Intensive care medicine; Management science; Alternative medicine; Economics","score_opus":0.34486167875434853,"score_gpt":0.6521262729667608,"score_spread":0.3072645942124123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394610499","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036203244,0.03303444,0.0002919099,0.060441203,0.90191525,0.00008981204,0.00019420448,0.00008747799,0.0039095515],"genre_scores_gemma":[0.00065621984,0.027669508,0.0005378472,0.05082484,0.90753263,0.00012456636,0.00027706183,0.00014737113,0.012230105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9789448,0.0040518255,0.0027293547,0.0014978453,0.011740861,0.0010353092],"domain_scores_gemma":[0.867176,0.041806694,0.0067337,0.0022111877,0.07388406,0.008188323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025433263,0.0030790882,0.004492757,0.009335622,0.0027949228,0.009417833,0.004483738,0.014311278,0.025636239],"category_scores_gemma":[0.10099843,0.0013723694,0.0033047115,0.0044062817,0.0020899414,0.0051703155,0.0023468114,0.01327149,0.022097306],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020960031,0.000003893683,0.000009434767,0.00044505397,0.00001571955,0.00003019658,0.000007143564,0.0000067696756,0.000023285113,0.000116848474,0.9933207,0.006000069],"study_design_scores_gemma":[0.00010100642,0.00002064954,0.0003078441,0.0042607803,0.000109796616,0.00024753198,0.000031118117,0.000092830946,0.00009796799,0.0012529967,0.99344844,0.00002913702],"about_ca_topic_score_codex":0.0036195025,"about_ca_topic_score_gemma":0.010887318,"teacher_disagreement_score":0.025636239,"about_ca_system_score_codex":0.0064894496,"about_ca_system_score_gemma":0.0102811605,"threshold_uncertainty_score":0.13450551},"labels":[],"label_agreement":null},{"id":"W4396871527","doi":"10.1080/14737167.2024.2352006","title":"Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review","year":2024,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Lembaga Pengelola Dana Pendidikan; Universitair Medisch Centrum Groningen; Rijksuniversiteit Groningen","keywords":"Trastuzumab; Breast cancer; Medicine; Context (archaeology); Quality of life (healthcare); Oncology; Stage (stratigraphy); Human Epidermal Growth Factor Receptor 2; Quality-adjusted life year; Internal medicine; Cancer; Cost effectiveness; Gynecology; Risk analysis (engineering)","score_opus":0.611588411691947,"score_gpt":0.6841194547494396,"score_spread":0.07253104305749258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396871527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009318293,0.99813664,0.00012562754,0.0001680204,0.00005922505,0.000111545196,0.00032190324,0.000004354001,0.00014082613],"genre_scores_gemma":[0.026814999,0.9709838,0.0007836804,0.00046611435,0.00014612782,0.00046901766,0.00027720825,0.0000069281546,0.000052026364],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98639655,0.0046336814,0.0054955967,0.0009034132,0.0023014825,0.00026933025],"domain_scores_gemma":[0.9403258,0.045552127,0.01025617,0.000498939,0.0030848929,0.0002820155],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01397677,0.0015952635,0.011321598,0.014248716,0.0004466258,0.0036255573,0.0016670767,0.0016382047,0.0033209946],"category_scores_gemma":[0.06361146,0.0010071113,0.01134708,0.0117768375,0.0007908571,0.0024466643,0.0011887578,0.0013640969,0.00017461143],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029521761,0.000019257785,0.0014789323,0.93441874,0.025458619,0.000069049805,0.00008065361,0.00020023336,0.00010857529,0.00027321192,0.0008434739,0.036754034],"study_design_scores_gemma":[0.00041244415,0.00030327647,0.008617465,0.8075278,0.1687705,0.00049919024,0.0002029592,0.00024780503,0.0002136759,0.00071909046,0.012427465,0.000058312045],"about_ca_topic_score_codex":0.004615273,"about_ca_topic_score_gemma":0.010507141,"teacher_disagreement_score":0.98602325,"about_ca_system_score_codex":0.0038933835,"about_ca_system_score_gemma":0.0065044854,"threshold_uncertainty_score":0.07391709},"labels":[],"label_agreement":null},{"id":"W4399678254","doi":"10.1080/14737167.2024.2369293","title":"Preferences of people with diabetes for diabetes care in Germany: a discrete choice experiment","year":2024,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen; Bundesministerium für Gesundheit; Ministry of Education; Ministry of Health, British Columbia; Bundesministerium für Bildung und Forschung","keywords":"Diabetes mellitus; Medicine; Health care; Gerontology; Psychology; Economics; Economic growth","score_opus":0.08269079251722773,"score_gpt":0.439098469279045,"score_spread":0.3564076767618173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399678254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870276,0.000016138898,0.0004205601,0.000052506006,0.0000066735056,0.000307863,0.00012656343,0.0000026771486,0.00036415315],"genre_scores_gemma":[0.9966665,0.000040061117,0.0016409283,0.00012647762,0.0000079216115,0.0008395514,0.00013316,7.982825e-7,0.00054450444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964289,0.0024871149,0.00019431603,0.00024059744,0.0002880357,0.00036096363],"domain_scores_gemma":[0.99413824,0.003983067,0.0008450205,0.0004140052,0.00013855494,0.00048115643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068576373,0.0007966616,0.00075291074,0.00036343,0.00069376413,0.0013382675,0.0004241802,0.0012298416,0.0044527003],"category_scores_gemma":[0.006223291,0.0003656003,0.0008375635,0.0003826985,0.0010715903,0.0006653994,0.0006742548,0.00083371793,0.00040873786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12298574,0.16603641,0.45470712,0.0018566098,0.002627011,0.0022629672,0.027770441,0.044365626,0.04982304,0.016610432,0.0044618445,0.10649277],"study_design_scores_gemma":[0.030554187,0.14560303,0.6730035,0.00040048733,0.0016200375,0.0006015416,0.016126577,0.08885277,0.02016764,0.0124901375,0.009937556,0.000642486],"about_ca_topic_score_codex":0.0020269607,"about_ca_topic_score_gemma":0.0017291642,"teacher_disagreement_score":0.0068576373,"about_ca_system_score_codex":0.001217909,"about_ca_system_score_gemma":0.0007919284,"threshold_uncertainty_score":0.036267042},"labels":[],"label_agreement":null},{"id":"W4401289591","doi":"10.1080/14737167.2024.2388814","title":"Next-generation sequencing in oncology: challenges in economic evaluations","year":2024,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University","funders":"Genome British Columbia; Genome Canada","keywords":"Medicine; Oncology; Internal medicine; Intensive care medicine","score_opus":0.7971121697630614,"score_gpt":0.7021634550004131,"score_spread":0.09494871476264832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401289591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010209298,0.9410967,0.013919844,0.037929825,0.001606596,0.00049920165,0.000549541,0.00003870519,0.003338643],"genre_scores_gemma":[0.05769028,0.8688377,0.045615803,0.019738251,0.0032180827,0.0035968982,0.00060000864,0.00011437897,0.00058855553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7425481,0.22654127,0.014364957,0.0028416181,0.01272953,0.00097458245],"domain_scores_gemma":[0.25415674,0.71979517,0.01073675,0.0037668068,0.0106851095,0.0008594558],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2179927,0.0013965958,0.0073969723,0.005899788,0.0009345181,0.0075952127,0.0034494346,0.004750826,0.007903985],"category_scores_gemma":[0.45731184,0.0009081915,0.00545746,0.009690403,0.0036887832,0.008610573,0.0035305077,0.008029336,0.00074202474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006639888,0.0001100805,0.0018222994,0.17206171,0.0067014745,0.00016241374,0.0005730189,0.0076950886,0.00010458056,0.09177567,0.027307786,0.69102186],"study_design_scores_gemma":[0.0006193527,0.0005517001,0.0044242186,0.50271094,0.0073169116,0.0004210459,0.0010512674,0.008048004,0.00040139485,0.2986669,0.1755941,0.00019411073],"about_ca_topic_score_codex":0.006962684,"about_ca_topic_score_gemma":0.008058622,"teacher_disagreement_score":0.2179927,"about_ca_system_score_codex":0.008763487,"about_ca_system_score_gemma":0.018996608,"threshold_uncertainty_score":0.9643542},"labels":[],"label_agreement":null},{"id":"W4403606431","doi":"10.1080/14737167.2024.2416240","title":"Time from approval to reimbursement recommendations in healthcare systems with centralized HTA processes. Focus on the Polish HTA agency","year":2024,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Uniwersytet Medyczny w Lublinie","keywords":"Reimbursement; Agency (philosophy); Health care; Focus (optics); Healthcare system; Health technology; Business; Actuarial science; Medicine; Public economics; Public administration; Political science; Economics; Economic growth; Sociology","score_opus":0.3156745927788572,"score_gpt":0.599350890603793,"score_spread":0.2836762978249358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403606431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9458286,0.017757902,0.005701397,0.004496974,0.00015287718,0.00033050805,0.00777504,0.00012388545,0.017832829],"genre_scores_gemma":[0.9919218,0.0021779134,0.0019574908,0.00023326183,0.00006346675,0.00010984787,0.0025059409,0.00002153351,0.0010087222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9852808,0.005135523,0.0026959255,0.002230544,0.002963248,0.001693855],"domain_scores_gemma":[0.921768,0.031243239,0.03871377,0.0016469056,0.0043894364,0.0022386746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0121071655,0.00026872073,0.0006157682,0.0025110992,0.0005745227,0.0037176425,0.00062633713,0.00094930525,0.0066654985],"category_scores_gemma":[0.06556076,0.00038919554,0.0013717486,0.003932182,0.00060747465,0.0031043666,0.0019628438,0.0013881148,0.000989452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019189116,0.00033584744,0.8066822,0.0018297876,0.0010234697,0.0007261988,0.0023419915,0.0077969143,0.0004920516,0.0068694954,0.008188016,0.16179512],"study_design_scores_gemma":[0.00009491456,0.00059427007,0.9696546,0.00051042286,0.00035357173,0.0006842437,0.002508762,0.0045860955,0.0005749603,0.0014699701,0.018904641,0.00006353245],"about_ca_topic_score_codex":0.018693669,"about_ca_topic_score_gemma":0.016564405,"teacher_disagreement_score":0.018693669,"about_ca_system_score_codex":0.0048482637,"about_ca_system_score_gemma":0.0045944634,"threshold_uncertainty_score":0.064029574},"labels":[],"label_agreement":null},{"id":"W4403606859","doi":"10.1080/14737167.2024.2416255","title":"A methodological guide for implementing and interpreting results of probabilistic analysis","year":2024,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Public Health Ontario; Hospital for Sick Children; University of Toronto; SickKids Foundation; Public Health Agency of Canada","funders":"","keywords":"Probabilistic logic; Risk analysis (engineering); Computer science; Management science; Actuarial science; Operations research; Medicine; Economics; Mathematics; Artificial intelligence","score_opus":0.7320955617676691,"score_gpt":0.7292265722188557,"score_spread":0.0028689895488134276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403606859","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005233065,0.02442545,0.85687906,0.03739969,0.005084539,0.034881756,0.012589095,0.0040521515,0.024164887],"genre_scores_gemma":[0.0018032045,0.010341901,0.94269127,0.004853056,0.00072267913,0.033454996,0.0015361883,0.00060101884,0.0039957473],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.851009,0.10371643,0.024005493,0.0033239333,0.017250039,0.00069501944],"domain_scores_gemma":[0.63452244,0.2670058,0.017487297,0.020131893,0.059094176,0.0017583942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14042081,0.0033911609,0.0034267057,0.011592844,0.0019234363,0.007049715,0.0072977883,0.00781492,0.036223736],"category_scores_gemma":[0.33613047,0.0030625707,0.006124424,0.010182808,0.005107036,0.005686683,0.005200672,0.013314269,0.02315616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024890437,0.00019762297,0.0005392198,0.033154454,0.0005646795,0.000540526,0.002807604,0.0047931704,0.0012126107,0.12778203,0.43135267,0.3968065],"study_design_scores_gemma":[0.00025585006,0.00018557374,0.0006411132,0.023415873,0.00029356848,0.00052161294,0.00044133357,0.0034361049,0.0010709913,0.101893544,0.8676641,0.00018029546],"about_ca_topic_score_codex":0.005722173,"about_ca_topic_score_gemma":0.008396179,"teacher_disagreement_score":0.14042081,"about_ca_system_score_codex":0.00432282,"about_ca_system_score_gemma":0.030354446,"threshold_uncertainty_score":0.7426251},"labels":[],"label_agreement":null},{"id":"W4404937014","doi":"10.1080/14737167.2024.2431234","title":"Regulatory perspectives on post-market evidence generation schemes for high-risk medical devices: a systematic review","year":2024,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Horizon 2020 Framework Programme","keywords":"Context (archaeology); European union; Risk analysis (engineering); Authorization; Conformity; Systematic review; Business; Conformity assessment; European market; Public economics; Medicine; MEDLINE; Computer science; Political science; Computer security; Economics; Operations management; International trade; Law","score_opus":0.4093159125879611,"score_gpt":0.6435808321891229,"score_spread":0.2342649196011618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404937014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001372186,0.9702908,0.003055201,0.016165728,0.0012265359,0.0040056566,0.0014005865,0.000044264638,0.002439044],"genre_scores_gemma":[0.066670455,0.87894773,0.017064668,0.015375369,0.0012967093,0.01848363,0.0014578864,0.00007061081,0.00063300214],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.69635624,0.19842377,0.0652847,0.007814438,0.029899662,0.002221182],"domain_scores_gemma":[0.2737023,0.63156617,0.053753812,0.011371631,0.028208327,0.0013977885],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23702124,0.001527509,0.0066327564,0.016502231,0.0014857647,0.007465316,0.0037251315,0.0051828413,0.00981483],"category_scores_gemma":[0.543291,0.0016201038,0.008054723,0.016049217,0.0054160315,0.010615497,0.0042273803,0.003919501,0.0009284862],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000374807,0.000023712171,0.0010066022,0.9109697,0.005487312,0.000080123194,0.0009614587,0.00021734988,0.00013716337,0.0071747014,0.0074160527,0.0661511],"study_design_scores_gemma":[0.00023325278,0.000070468384,0.00116503,0.9645189,0.0068151304,0.00008873403,0.00034309912,0.00009749207,0.000096997675,0.00255401,0.023986822,0.000030163123],"about_ca_topic_score_codex":0.004623901,"about_ca_topic_score_gemma":0.010713122,"teacher_disagreement_score":0.7629788,"about_ca_system_score_codex":0.011364794,"about_ca_system_score_gemma":0.044755913,"threshold_uncertainty_score":0.94088864},"labels":[],"label_agreement":null},{"id":"W4405082694","doi":"10.1080/14737167.2024.2438631","title":"Cost-effectiveness studies of brexu-cel for relapsed/refractory B-cell acute lymphoblastic leukemia and mantle cell lymphoma: a systematic review","year":2024,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mantle cell lymphoma; Medicine; Lymphoblastic Leukemia; Lymphoma; Refractory (planetary science); Systematic review; Oncology; Cost effectiveness; Cancer research; Intensive care medicine; Leukemia; Internal medicine; MEDLINE; Chemistry; Risk analysis (engineering); Biology","score_opus":0.0933936379289574,"score_gpt":0.5306788897060208,"score_spread":0.43728525177706346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405082694","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015838455,0.99467826,0.0001952724,0.000623951,0.00019501947,0.0010242114,0.0012790832,0.0000147149685,0.00040564485],"genre_scores_gemma":[0.025499979,0.9685923,0.0010954824,0.0009366039,0.00019845563,0.0027478929,0.0007259735,0.000010669852,0.00019268983],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98754245,0.0049860226,0.0040740026,0.0008144579,0.002173333,0.00040985612],"domain_scores_gemma":[0.9527886,0.034441143,0.008747302,0.00060497544,0.0030543928,0.00036350402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0134170465,0.0016290799,0.008881536,0.0118987635,0.00063721795,0.0031731369,0.0022024969,0.0024924325,0.009458803],"category_scores_gemma":[0.074905865,0.0010540526,0.009245303,0.011843373,0.0010026289,0.0028731304,0.0016156903,0.0016513161,0.0003966355],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021838259,0.000009765132,0.00043375118,0.97804797,0.006720582,0.000051277835,0.000059076574,0.00008594517,0.000053728207,0.00018363158,0.0011126443,0.0130232815],"study_design_scores_gemma":[0.0004821175,0.00021333396,0.0033108192,0.9216705,0.06399025,0.00023932291,0.00021364342,0.00009932035,0.00009420031,0.00037798463,0.009277411,0.0000311033],"about_ca_topic_score_codex":0.008940219,"about_ca_topic_score_gemma":0.019578984,"teacher_disagreement_score":0.0134170465,"about_ca_system_score_codex":0.0062885135,"about_ca_system_score_gemma":0.014840654,"threshold_uncertainty_score":0.070957005},"labels":[],"label_agreement":null},{"id":"W4406152811","doi":"10.1080/14737167.2025.2450310","title":"A retrospective observational analysis of the real-world care pathway of people with hereditary transthyretin amyloidosis with polyneuropathy in Italy","year":2025,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Transthyretin; Observational study; Polyneuropathy; Medicine; Amyloidosis; Epidemiology; Retrospective cohort study; Intensive care medicine; Health care; Pediatrics; Internal medicine; Economic growth","score_opus":0.018688752952264444,"score_gpt":0.41826006964223655,"score_spread":0.3995713166899721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406152811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449956,0.00045655662,0.0001414913,0.000097239244,0.000010279423,0.00007193738,0.0039907536,0.000006514362,0.00072551676],"genre_scores_gemma":[0.9959346,0.00026003443,0.00018531508,0.000115351286,0.00002707709,0.00011113821,0.0032585205,0.0000041875855,0.00010378433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846727,0.00039775978,0.00021753438,0.00043772126,0.00019153963,0.00028812193],"domain_scores_gemma":[0.9956279,0.00046330295,0.0028148126,0.0004002779,0.00031775577,0.000375994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012700146,0.0003654189,0.00048964284,0.0015653798,0.00048209136,0.0008874747,0.0005502077,0.0005346628,0.0015446197],"category_scores_gemma":[0.0040845904,0.0004175231,0.00074454,0.0026988368,0.00043964153,0.0006327101,0.0009871809,0.00059450744,0.00039542888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082727856,0.000040061463,0.99832267,0.000042238913,0.000058579368,0.00009932229,0.00015707151,0.000041397136,0.000034502187,0.00001952328,0.0003931406,0.00070882833],"study_design_scores_gemma":[0.000017131726,0.000101559985,0.9982387,0.000036251822,0.000046975525,0.00037674134,0.0003167643,0.00019087642,0.000016055963,0.00001713421,0.00063518016,0.000006592868],"about_ca_topic_score_codex":0.023277486,"about_ca_topic_score_gemma":0.021008028,"teacher_disagreement_score":0.023277486,"about_ca_system_score_codex":0.0014072842,"about_ca_system_score_gemma":0.0013690263,"threshold_uncertainty_score":0.04628402},"labels":[],"label_agreement":null},{"id":"W4409886001","doi":"10.1080/14737167.2025.2496217","title":"Expert review of pharmacoeconomics and outcomes research: high impact articles from 2024","year":2025,"lang":"en","type":"editorial","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacoeconomics; Outcomes research; Medicine; Intensive care medicine; Health economics; Management science; Alternative medicine; Economics; Nursing; Public health","score_opus":0.3080545253757029,"score_gpt":0.6488333467064591,"score_spread":0.3407788213307562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409886001","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038628612,0.03345121,0.00034536482,0.060462702,0.9003704,0.0001222225,0.0002492252,0.000108538596,0.0048516816],"genre_scores_gemma":[0.000717034,0.03126155,0.0006814701,0.049878918,0.90065706,0.00017054405,0.0003844245,0.0001707395,0.016078195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9786345,0.0041426998,0.0028166636,0.0014506923,0.011969228,0.0009862172],"domain_scores_gemma":[0.8619885,0.037935138,0.006566936,0.0021213468,0.082904674,0.008483465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024842745,0.0030007605,0.0042124507,0.00969716,0.002640879,0.009001272,0.0041050822,0.0128415255,0.031713083],"category_scores_gemma":[0.09900117,0.0013010206,0.0032317303,0.004452945,0.0019184346,0.0050286357,0.0023384155,0.011982892,0.027326407],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019555075,0.0000038607786,0.000009299655,0.0004795163,0.000013574696,0.000028923332,0.000007405393,0.0000067283113,0.00002239528,0.00009899455,0.9928219,0.006487852],"study_design_scores_gemma":[0.00009033097,0.000017270757,0.00023718493,0.004047444,0.0000870426,0.00020318365,0.000030047171,0.00007801905,0.00008592473,0.0010487195,0.99404943,0.000025353438],"about_ca_topic_score_codex":0.0034275185,"about_ca_topic_score_gemma":0.010333495,"teacher_disagreement_score":0.031713083,"about_ca_system_score_codex":0.0059462893,"about_ca_system_score_gemma":0.010739341,"threshold_uncertainty_score":0.13138252},"labels":[],"label_agreement":null},{"id":"W4411490252","doi":"10.1080/14737167.2025.2521445","title":"Cost-effectiveness analysis of 20-valent anti-pneumococcal vaccination in the Spanish pediatric population","year":2025,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Medicine; Pneumococcal disease; Pneumococcal conjugate vaccine; Cost effectiveness; Cost-effectiveness analysis; Population; Vaccination; Dominance (genetics); Environmental health; Immunology; Streptococcus pneumoniae; Risk analysis (engineering); Antibiotics","score_opus":0.06658409783944592,"score_gpt":0.5548339014185718,"score_spread":0.4882498035791259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411490252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97792894,0.00851988,0.006029653,0.0012886059,0.00006198878,0.00029723957,0.0030822235,0.000050895454,0.0027404742],"genre_scores_gemma":[0.99507254,0.0016635816,0.0016644989,0.00012965163,0.000021321874,0.00011646318,0.0010275409,0.0000086765385,0.00029570592],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99724257,0.0021034037,0.00007691114,0.0001960226,0.00016496624,0.0002160728],"domain_scores_gemma":[0.9927816,0.0055777933,0.00083611935,0.00015737239,0.0003657064,0.0002813987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062334174,0.0010695119,0.0012688604,0.0007158782,0.000115384144,0.0008929533,0.0009927531,0.00081056345,0.0024526266],"category_scores_gemma":[0.015075891,0.0003614689,0.0027889514,0.00068116945,0.00030072642,0.0006131399,0.0006124022,0.00087002944,0.00011793224],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068070763,0.0007668529,0.079326585,0.0011001392,0.004037027,0.00033164094,0.00006381552,0.87300724,0.0005941474,0.0025702086,0.0013006272,0.030094557],"study_design_scores_gemma":[0.0033019502,0.011548555,0.1510226,0.0008971014,0.006754334,0.00060189405,0.00049487676,0.81122196,0.0014052105,0.007149414,0.005499953,0.000102173195],"about_ca_topic_score_codex":0.02851865,"about_ca_topic_score_gemma":0.010500683,"teacher_disagreement_score":0.02851865,"about_ca_system_score_codex":0.0048654038,"about_ca_system_score_gemma":0.0043127094,"threshold_uncertainty_score":0.056705296},"labels":[],"label_agreement":null},{"id":"W4411792574","doi":"10.1080/14737167.2025.2525224","title":"Challenges with integrating early-stage cancer trial endpoints into economic models: review of health technology recommendations for adjuvant or neoadjuvant therapies in Canada","year":2025,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); University of Ottawa","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Adjuvant; Stage (stratigraphy); Intensive care medicine; Neoadjuvant therapy; Oncology; Cancer; Internal medicine; Breast cancer","score_opus":0.4498060777623968,"score_gpt":0.6315270038445076,"score_spread":0.18172092608211077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411792574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016379976,0.94758916,0.0030337556,0.03687999,0.0011891035,0.00076950033,0.0022610156,0.00006566399,0.0065738903],"genre_scores_gemma":[0.07744213,0.8735924,0.02876167,0.014540541,0.0008604754,0.0022405237,0.0015247762,0.00015463814,0.0008828911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8180284,0.09118451,0.035988618,0.004279139,0.04739939,0.0031199844],"domain_scores_gemma":[0.39748153,0.40146786,0.038083665,0.006949269,0.15278395,0.0032336772],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20629199,0.0019973258,0.0055437386,0.017671958,0.0023430297,0.013150949,0.007699551,0.003695568,0.0032458387],"category_scores_gemma":[0.5247472,0.0019974445,0.009636587,0.022905732,0.00284447,0.0038792286,0.003998037,0.0059317104,0.0003879209],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066252146,0.00005104706,0.0051325304,0.34785756,0.010326663,0.0002474654,0.002474806,0.010863989,0.00028424614,0.028125132,0.07342465,0.5205493],"study_design_scores_gemma":[0.00052328844,0.00013812903,0.010118646,0.7270517,0.015053691,0.00016912742,0.0007516828,0.005577114,0.0005050595,0.010948782,0.22890347,0.00025937115],"about_ca_topic_score_codex":0.7338824,"about_ca_topic_score_gemma":0.79258615,"teacher_disagreement_score":0.8776939,"about_ca_system_score_codex":0.12230611,"about_ca_system_score_gemma":0.28422204,"threshold_uncertainty_score":0.9787833},"labels":[],"label_agreement":null},{"id":"W4417365539","doi":"10.1080/14737167.2025.2603944","title":"Conceptualization of a decision-analytic model in youth mental health: an application of stakeholder engagement in model development in the Netherlands","year":2025,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Excellence in Mining Innovation","funders":"","keywords":"Conceptualization; Stakeholder; Credibility; Stakeholder engagement; Conceptual model; Stakeholder analysis; Complement (music)","score_opus":0.6390673024868326,"score_gpt":0.738332056164848,"score_spread":0.09926475367801535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417365539","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12598053,0.0004173462,0.83711874,0.004169259,0.00006826253,0.0027660332,0.00042904474,0.00013020773,0.028920619],"genre_scores_gemma":[0.47661477,0.00033691537,0.51765114,0.00012868339,0.000011978989,0.0035664977,0.0003893681,0.00004231247,0.0012583373],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97236866,0.024027508,0.0008809715,0.0008596762,0.0013109823,0.00055222714],"domain_scores_gemma":[0.9605923,0.03459212,0.0011248044,0.0009900006,0.0020096737,0.0006910458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032720562,0.0012540622,0.0008343057,0.0028860893,0.0026123482,0.0073643164,0.0036328267,0.0023595765,0.0040485314],"category_scores_gemma":[0.047286227,0.0009590143,0.0022710725,0.0030142916,0.0040253047,0.005764694,0.0052265627,0.0025716287,0.00028680323],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017084947,0.00048554092,0.008095981,0.0009834361,0.00021532898,0.00095894036,0.0454078,0.22480084,0.00081186614,0.67025685,0.0016417721,0.046170827],"study_design_scores_gemma":[0.00016176478,0.0002015756,0.0012617017,0.001074975,0.000097727374,0.00021207158,0.024895286,0.66884845,0.0006765141,0.27716827,0.025307745,0.000093974],"about_ca_topic_score_codex":0.017968034,"about_ca_topic_score_gemma":0.014963306,"teacher_disagreement_score":0.032720562,"about_ca_system_score_codex":0.011685386,"about_ca_system_score_gemma":0.015288964,"threshold_uncertainty_score":0.17304498},"labels":[],"label_agreement":null}]}